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Abstract 
Dihydrofolate reductase (DHFR) is the enzyme that catalyses the reduction of 7,8-dihydrofolate 
(DHF) to 5,6,7,8-tetrahydrofolate (THF) in the presence of the cofactor reduced nicotinamide 
adenine dinucleotide phosphate (NADPH). The DHFR catalysed reaction has often been used to 
study the contribution of protein dynamics to enzyme catalysis. To better understand protein 
dynamics and to investigate how it relates to electrostatic changes in DHFRs, the dynamics of 
DHFR from human (HsDHFR), Escherichia coli (EcDHFR), the cold-adapted Moritella 
profunda (MpDHFR), the moderately thermophilic Geobacillus stearothermophilus (BsDHFR) 
and the thermophilic enzyme from Thermatoga maritima (TmDHFR) are studied using kinetic 
isotope effects and vibrational Stark effects spectroscopy. Chapter 1 gives a brief introduction to 
the thesis. In Chapter 2, the purification of HsDHFR was optimised due to the kinetic complexity 
introduced by the purification strategy. The study showed that using a truncated ligand lessens 
the complexity that has prevented detailed kinetic characterisation of HsDHFR for three decades. 
The work presented in Chapter 3 involves optimisation of kinetic conditions to reveal the 
chemical step of HsDHFR and to study the effects of dynamics on it. The result showed that 
tunnelling did not contribute to the dynamics of HsDHFR, in contrast to reports for its bacterial 
homologs. It also showed that protein dynamics are not coupled to the chemical step of the 
enzyme at its physiological temperature. In Chapter 4, vibrational Stark effect spectroscopy was 
employed to study ligand interaction in EcDHFR, its conformationally impaired variant 
EcDHFR-S148P, BsDHFR, MpDHFR and TmDHFR. A site-specific nitrile probe was inserted 
at a conserved position to monitor electrostatic changes in the enzymes. The results obtained 
suggest that electrostatics in DHFRs are generally conserved despite exhibiting different 
dynamic flexibilities. In addition, the preorganisation of cofactor-substrate interaction in the 
enzyme was found to play a major role in their catalysis. A summary of the work presented in 
this thesis is provided in Chapter 5 and the materials and methods used in evaluating this work is 
reported in Chapter 6. 
. 
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1.1 Catalytic power of enzymes 
Enzymes catalyse chemical reactions at rates of up to 1021 relative to uncatalysed reactions. 
Generally, chemical reactions occur when reacting molecules have sufficient energy to 
overcome the activation energy barrier.1 Hence, the height of this barrier and the energy 
possessed by the reacting molecules dictate the speed of chemical reactions. In the case of 
enzymes, reducing the height of the energy barrier of reactions is believed to lead to enormous 
rate enhancement that is essential for cellular functions.1 Such that, in the absence of enzymes, 
these barriers are high that some of the chemicals would require several decades to react, 
especially under the mild conditions of pH, temperature and pressure where enzymes function 
(Figure 1.1).1 Therefore, understanding how enzymes achieve this barrier reduction has 
attracted scientific interest for several decades. 
 
Figure 1.1. Reaction pathway of an uncatalysed reaction (black) versus an enzyme-catalysed reaction 
(red). The tight binding of enzymes to the activated enzyme-substrate complex (ES‡) reduces the energy 
required for the reaction compared to the uncatalysed activated substrate (S‡) 
This quest (that is, the quest to comprehend how enzymes function) has led to several studies 
and has engineered significant progress in the field of enzymology.2–7 The history of 
enzymology probably started in 1849 when Emil Fischer postulated the “lock and key” model 
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to suggest that enzymes interact with their ligands via rigid contacts.8 Almost a decade later, in 
1946, Pauling proposed that enzymatic rate enhancements arise from the preferential binding of 
enzymes to the activated transition-state complex, a proposition that was based on the transition 
state theory (TST) introduced by Eyring in 1935 (This theory will be described later in this 
chapter).9 However, Koshland was the first to suggest that changes in protein structures may be 
important for enzyme catalysis when he proposed the “induced fit” model to explain the 
reorganisation of enzymes active site as a result of ligand binding.10 Recently, some authors 
have expanded on Koshland’s proposal to suggest that protein motions are not only crucial for 
enzyme-ligand interactions but that they also promote the chemical step of enzyme-catalysed 
reactions.11–15 For these models (dynamics-based models), promotion of the chemical step is 
linked to the compression of the energy barrier and believed to be modulated by the several 
fluctuations in a protein structure.16 Hence, they propose that conformational changes in 
proteins are directly coupled to enzyme’s catalytic mechanism and link the energy involved in 
breaking and making non-covalent bonds in the enzyme structure to the energy changes that 
transform reactants into products.13,17–19 The implications of the dynamic-based proposals 
have led to current debates about the basis of enzyme catalysis. 
To support their different proposals, several experimental tools are employed to investigate the 
diverse timescales of protein motions and how each might contribute to enzyme-catalysed 
reactions (Figure 1.2).20 Some of these techniques include X-ray crystallography, nuclear 
magnetic resonance (NMR) spectroscopy, kinetic analysis, kinetic isotope effects (KIEs) and 
in recent times, vibrational Stark effects (VSE) spectroscopy,11–15 which provide insights into 
the mechanism of enzyme catalysis and serve as benchmarks for theoretical calculations into 
the basis of enzymes’ catalytic power.16 Overall, they have been applied to enzymes such as 
dihydrofolate reductase, alcohol dehydrogenase, alanine racemase and others to investigate the 
role of protein motion in enzyme catalysis.14,16,21 Although studies have revealed that protein 
motions are important for enzyme catalysis,22 their role in the chemical step is not fully 
understood. 
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Figure 1.2 Timescales of protein motion (blue, above) and experimental and theoretical methods (red, 
below). Experimental methods like X-ray scattering are shown over the timescale of fluctuation they 
can detect. Motion on faster timescales averages during the experiments. (Adapted with modification 
from reference 20) 
In this thesis, protein dynamics of dihydrofolate reductase (DHFR) - from Escherichia coli 
(EcDHFR), human (HsDHFR), as well as DHFR from psychrophilic Moritella profunda 
(MpDHFR), the moderately thermophilic Geobacillus stearothermophilus (BsDHFR) and the 
hyperthermophilic Thermatoga maritima (TmDHFR)- are studied using tools such as KIE 
measurements and VSE spectroscopy. The investigation of protein dynamics in these enzymes 
is crucial because they catalyse the same chemical reaction while exhibiting diverse protein 
motions. This chapter will be discussed according to the following outlines: in the first section, 
specific tools that are employed to investigate protein dynamics in enzymology will be 
examined briefly and in the second section, DHFRs and the previous studies on their dynamics 
will be reviewed. 
1.2 Investigation of protein dynamics 
The three major tools employed in our study of DHFRs include pre-steady and steady-state 
kinetics, KIEs and VSE spectroscopy. 
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1.2.1 Pre-steady-state and steady-state kinetics 
Kinetic analysis of enzymatic reactions relies on a simplified scheme that involves the 
conversion of substrate (S) to product (P) by an enzyme (E) (Eq. 1.1): 
E + S ES P
k1 k2
k-1   (1.1) 
The velocity (v) of this reaction correlates with the change in the formation of the product (δP) 
as a function of time or concentration, which is represented below (Eq. 1.2). 
  (1.2) 
Note that this mathematical expression can be written as a linear plot of y = mx, where y is the 
dependent variable ( ), m is the slope (k2) and x is the independent variable [ES]. This will 
be a first-order rate equation with a constant slope of (k2). However, the formation of the 
enzyme-substrate (ES) complex in enzymatic reactions is not a linear function of the 
concentration of S, which in turn affects the rate of product formation. 
Instead, enzymes exhibit a biphasic time course due to changes in the concentration of the ES 
complex. In the first instance, a rapid formation of the complex is observed within a short 
period known as pre-steady-state or burst phase; after which, a steady-state phase is observed 
when the [ES] complex reaches an equilibrium (Figure 1.3).23  
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Figure 1.3. Graphical description showing the change in product concentration over the reaction 
time. The initial burst represents the pre-steady state region (red) that takes place before the 
reaction reaches equilibrium termed steady state region (blue). 
To study the burst phase, one needs instruments that can mix chemical reagents rapidly and 
measure rate constants of up to a few milliseconds. Examples of such instruments are stopped-
flow, quench flow and continuous flow (Figure 1.4).23,24 For example, the pre-steady-state 
kinetics of DHFRs are measured using a stopped-flow apparatus, which allows the rapid 
conversion of the substrate to the product to be monitored by fluorescence energy transfer. 
Another requirement for pre-steady-state kinetics is that the concentration of the substrate 
must be low to measure single-turnover of the product before reaching equilibrium. 
 
Figure 1.4. A schematic diagram of a stopped-flow apparatus indicating the major components: mixer, 
reaction cell, and detector. 
The linear steady-state phase also called multiple turnover kinetics represents the 
accumulation of the ES complex due to a slow catalytic step in the reaction. In most biphasic 
Introduction  
7 
 
time course kinetics, the steady-state phase is limited by product release step.24 To determine 
steady-state kinetics, the concentration of the substrate must be high and saturating, and the 
corresponding steady-state approximation can be applied. The steady state-approximation is 
described mathematically by the Michaelis-Menten equation (Eq. 1.3).24 
   (1.3) 
where  represents the velocity of the reaction, [E]0 is the total enzyme concentration, [S] is 
the substrate concentration, kcat is the steady state rate constant, and  is the Michaelis 
constant, which represents the ratio of the rate constants for the dissociation of the ES complex 
to that of its formation. (Note: the derivation of the Michaelis-Menten equation is given in 
nearly all biochemistry textbooks, and it is unnecessary to reproduce it here.)  
The Michaelis-Menten equation is applicable to most enzymes and is critically important to 
understand enzyme action in biological systems. At least for simple systems, the Michaelis-
Menten equation describes the way that the reaction velocity depends on the substrate 
concentration. At low substrate concentration, the velocity of the reaction increases linearly 
with increasing substrate concentration [S]. But at high substrate concentration, the velocity of 
the reaction reaches , representing the maximum velocity achieved by the system at 
saturating substrate concentration. KM is obtained as the substrate concentration when the 
reaction velocity is half of  (Figure 1.5), while kcat equals /[E]0. KM and kcat are 
intrinsic properties of enzymes under steady-state conditions. 
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Figure 1.5. A graphical representation of the Michaelis-Menten plot showing the relation between 
the reaction velocity (v0) and substrate concentration [S]. The maximum velocity (Vmax) and 
Michaelis constant (KM) are shown on the graph. 
As a result, pre-steady state and steady state rate constants are characteristic of a property of 
an enzyme and can provide insight into the mechanism and order of events that occur during 
enzyme catalysis. When these kinetic parameters are altered upon mutagenesis, change in pH, 
temperatures or solvents, these effects can be related to how the enzyme’s reaction is affected. 
To use this approach to elucidate protein dynamics, amino acid residues implicated in the 
catalytic mechanism of an enzyme can be mutated to elucidate their function in the enzyme’s 
reaction, observing how pre-steady state rate constants, KM or kcat are affected. For example, 
mutation of residues at the centre of the mobile loop of EcDHFR was shown to cause a 500-
fold reduction in its pre-steady-state rate constant, which was interpreted to suggest that the 
loop played a crucial part in the enzyme’s catalysis.25 In addition, the pre-steady and steady-
state rate constants are also employed to determine the KIEs of enzymatic reactions. 
1.2.2 Kinetic isotope effects (KIEs) 
KIE has emerged as a tool for probing the basis of enzymatic reactions because experimental 
findings from the application of KIEs are reproduced by meticulous computations calculations 
to gain better insight into enzyme catalysis.16 KIEs are measured by comparing the rate of the 
reaction of two isotopologues, that is, molecules that differ only in isotopic compositions, 
which are observed when isotopic substitution of atoms that contribute (directly or indirectly) 
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to the bonds that are formed or broken during the reaction leading to a change in the reaction 
rate. Primary (1°) isotope effect is when the atom substituted is directly involved in the 
reaction, and secondary (2°) if the atom is not directly involved.26 Therefore, KIEs are 
employed to probe the transition state of chemical reactions.7 Popular applications of KIEs to 
enzymatic reaction is the isotopic substitution of atoms on either on the substrate or enzyme. 
1.2.2.1 Substrate KIEs 
Substrate KIE (klight/kheavy) represents the ratio of rate constants when an atom on the substrate 
is substituted for heavy isotope. Accordingly, quantitative activation parameters of reactions 
involving the light and heavy isotopes can be deduced from the Arrhenius equation (Eq. 1.4).27 
   (1.4) 
where k is the rate constant, A is the Arrhenius frequency factor or pre-exponential factor, Ea is 
the activation energy in kJ mol-1, R is the gas constant in JK-1 mol-1 and T is the temperature in 
Kelvin.  
Hence, with KIE (klight/kheavy), the Arrhenius equation (Eq. 1.4) can be written as: 
  (1.5) 
where kx is the rate constant, Ax is the Arrhenius pre-exponential factor, and Eax is activation 
energy for the transfer of isotope x. h and l represent the heavy and light isotopes, 
respectively. Ea(h-l) represents the difference in activation energies for the reaction with heavy 
and light isotopes.  
A linear form of Eq. 1.5 can be obtained by taking the natural logarithm of both sides of the 
equation. When In (KIE) is plotted as a function of 1/T, a linear plot is obtained. The y-axis 
intercept represents the logarithm of the ratio of Arrhenius pre-exponential factor for the light 
and heavy isotopes (In Al/Ah) and the slope represents the difference in the activation energy 
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between the two isotopes . The temperature-dependence of the slope of KIEs are 
employed to explain experimental results. Some of the models used to interprete KIEs are 
briefly outlined below. (For a comprehensive review, readers are referred to references 16,28). 
1.2.2.1.1 Semi-classical models 
Semi-classical models refer to those models that ignore contributions of quantum mechanical 
tunnelling, i.e., only consider quantum mechanical effects on vibrational zero-point energy 
(ZPE). TST assumes that a reaction coordinate may be described by a minimum in free energy 
that represents the reactant well, and a maximum in free energy called saddle point or transition 
state, which leads to the product well. In addition, it also infers an equilibrium relationship 
between the ground state and the transition state.16 The rate constant (k) described by TST 
derived from Eyring equation is  
    (1.6) 
where  is the equilibrium constant between the transition state and ground state and given as 
,  is the transmission coefficient, T is the absolute temperature, h is the Plank’s constant 
and kB is the Boltzmann’s constant. 
According to this model, KIEs result from the difference in vibrational zero-point energy (ZPE 
= 1/2hν) of light and heavy isotopes (Figure 1.6A).19 Because heavier isotopes have lower 
vibrational ZPEs at ground and transition states, they will require different amounts of 
activation energies to reach the transition state complex.19 For example, substituting a 
hydrogen atom for heavier isotopes is predicted to yield a maximal KIE of 6.9 for kH/kD and 
15.8 for kH/kT.
28 This is thought to arise from the vibrational stretching frequencies of C-H, C-
D and C-T at 298K being 3000, 2200 and 1800 cm-1, respectively.
19  
Deviations from semi-classical behaviour may show up as a nonlinear Arrhenius plot, a low-
temperature regime in which the reaction rate is independent of temperature, anomalous 
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values of Arrhenius pre-exponential factor, an unusual KIE, or a reaction rate that is faster 
than expected.29 For examples, smaller KIEs can be observed if the primary motion along the 
reaction coordinate is a bending mode, which has lower ground state-ZPE or if recrossing is 
significant, in cases of exothermic or endothermic reactions. A typical use of 1° KIEs is to 
determine the symmetry and structure of the TS.28 An example of a KIE value that is greater 
than the upper limits of 6.9 predicted by TST has been observed in soybean lipoxygenase 
(kH/kD of ~ 80)
30 and in many other enzymes. 
1.2.2.1.2 Bell’s tunnelling correction 
In 1980, Bell introduced a tunnelling correction ( ) (Eq. 1.7) to overcome the limitation of 
TST analysis.31  
   (1.7) 
where  is the tunnelling correction factor defined as the ratio of quantum mechanical to the 
classical barrier transmission rates, which approaches unity at high temperatures.31  
Tunnelling occurs when small particles (such as electrons, protons, hydrogen atoms or 
hydrides) pass through the energy barrier below the saddle point because of their dual wave-
particle nature.11 The Bell’s tunnelling correction defines the wave property of atoms as a 
function of mass using de Broglie theory. This phenomenon suggests that the difference in the 
ZPEs of isotopes could result in a mass-dependent quantum mechanical tunnelling of the 
atoms through-the-barrier rather than over-the-barrier (Figure 1.6B).31,32. 
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Figure 1.6. (A) Reaction profiles for hydrogen transfer. The origin of the semi-classical hydrogen 
isotope effect, arising from differences in the zero-point energy for protium, deuterium and tritium. (B) 
Illustration of the crossing of the barrier below the transition state, where this occurs in an isotope-
dependent manner (H˃D˃T). (Adapted from reference 19,33) 
In other words, a light isotope has higher zero-point energy and its probability function is less 
localized in its well (more diffuse wavefunction); thus, it has a higher tunnelling probability.31 
Such association suggests that different hydrogen isotopes will have varying tunnelling 
probabilities, which can result in large KIE values.31  
Using this approach, tunnelling contributions to chemical reactions were categorised based on 
the temperature-dependence of their rate constants and KIEs as well as the ratio of the 
Arrhenius pre-factor of the isotopes (Al/Ah) (Figure 1.7).
28 Importantly, Figure 1.7 has been 
employed to characterise tunnelling in both solution and enzymatic reactions.16 However, 
tunnelling correction model is inadequate to explain the origin of temperature-independent 
KIE when each isotope exhibits temperature-dependent rates.28 Consequently, current 
propositions are also aimed at revising this limitation. 
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Figure 1.7. Arrhenius plot of rates (top panel) and KIEs (bottom panel, green line) of light (L, in blue) 
and heavy (H, in red) isotopes. In region I, tunnelling is negligible, so AlAh is close to unity. Region II 
is the moderate tunnelling region where only the lighter isotope tunnels and the corresponding AlAh is 
much smaller than unity. Both isotopes tunnelling region III, making the AlAh much higher than unity 
(Adapted from reference 28). 
1.2.2.1.3 Other modern models 
Recent models that are employed to interpret the temperature-dependence of substrate KIEs 
are generally divided on whether protein dynamics contribute to the chemical step or not. 
Statistical protein motions are those in thermal equilibrium with the surrounding environment 
and encompass the majority of enzyme motions. On the other hand, non-statistical motions are 
not in equilibrium with the surrounding thermal environment.34 In the the dynamic-based 
models, non-equilibrium motions modulate the transition state, compress the width of the 
energy barrier and promote tunnelling.35 These models generally utilise Marcus theory of 
electron transfer, which links tunnelling probabilities to distance between the donor and 
acceptor atoms.36 These models are referred to as vibrationally enhanced tunnelling, rate-
promoting vibrations, environmentally-coupled tunnelling and other similar 
propositions.30,37,38 For example, Scrutton and co-workers suggest that short-range dynamic 
motions of protein and solvents are coupled to the reaction coordinate.37 While Schwartz hold 
a view that networks of long-range motions contribute to the chemical step and promote 
tunnelling,38 Klinman and Kohen however, suggested that two types of protein motions might 
 
Image removed by author due to 
copyright. 
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be involved in influencing the chemical step.39 The first which involves large-scale 
reorganisational motion brings the enzyme into a tunnelling-ready configuration or near-attack 
configuration. The second is referred to as “passive dynamics” or “gating motions” that 
actively compress the width of the energy barrier.30 
In contrast, other scientists emphasise that since tunnelling is not unique to enzymatic 
reactions, it is insufficient to account for enzyme’s rate enhancement.40 Hence, they utilise 
modified-transition state theories to account for experimental findings.6,40 For instance, the 
work of Truhlar and co-workers introduced more quantum mechanical corrections such as 
zero-point energy, tunnelling and recrossing to the TST.41 Their approach, named ensemble 
average variational TST and multidimensional tunnelling model (EA-VTST/MT) has been 
employed to replicate and interpret several experimental observations.41,42 They propose that 
coupling of protein dynamics to the chemical coordinate have negligible effects on enzyme 
catalysis.41 Warshel and co-workers also disagree with the importance of protein dynamic 
effects and are of the opinion that protein motions result from the equilibrium of the potential 
energy surface.40 In addition, the work of Allemann and co-workers investigated the role of 
electrostatic and dynamic contribution to enzyme catalysis using isotope effects of solvents, 
substrates and enzyme applied to dihydrofolates from diverse ecological niches as well as to 
alcohol dehydrogenase.7 Their results support that electrostatic preorganisation rather than 
protein dynamics play a vital role in the chemical transformations of enzyme-catalysed 
reactions.7  
1.2.2.2 Enzyme KIEs 
Enzyme KIE strategy involves isotopic substitution of non-exchangeable and natural 
abundance 1H, 12C and 14N atoms in a “light” enzyme with heavier isotopes, 2H, 13C and 15N, 
to produce a “heavy” enzyme. According to Born-Oppenheimer approximation, decreased 
molecular vibrations in the heavy enzyme due to isotopic substitution would not affect the 
electrostatics of the reaction.43 Hence, enzyme KIE is believed to measure the extent to which 
slow molecular vibration in the heavy enzyme limits the rate of the reaction. It is taken as the 
ratio of rate constants of the light to the heavy enzyme (kLE/kHE).43 Values of enzyme KIEs 
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greater than unity suggest that protein dynamics are coupled to the kinetic step observed. And 
enzyme KIE of unity indicates the absence of contributions from non-equilibrium protein 
fluctuations.7 Consequently, enzyme KIE is employed to investigate the role of fast protein 
vibration in enzyme catalysis. Enzymes such as alcohol dehydrogenase, dihydrofolate 
reductases, HIV protease, alanine racemase, formate dehydrogenase, and others have all been 
examined using this approach.7,21,44–48  
1.2.3 Vibrational Stark effect (VSE) spectroscopy 
Recently, VSE spectroscopy have also been employed to study protein dynamics by 
connecting conformational changes in enzymes to the electrostatic changes at their active 
sites.49–51 Vibrational Stark effect (VSE) reveal the influence of electric field on the vibrational 
frequency of a molecular probe. The linear frequency response of this probe to electrostatic 
perturbation arises from the difference in the dipole moment of the probe at the ground and 
excited states. Previously, insights into the complex nature of protein electrostatics typically 
depend on computational models and indirect techniques such as binding studies and pKa 
shifts.52 But with VSE, electrostatic changes in macromolecules can be elucidated using direct 
infrared spectroscopic probes.53,54 A description of infrared spectroscopy, instrumentation and 
how they are applied to investigate electrostatic changes in protein are discussed below. 
1.2.3.1 Infrared Spectroscopy 
Infrared spectroscopy (IR) is an absorption technique that measures the frequency dependent 
transmittance of quantized infrared radiation through a sample. Each absorbed energy leads to 
vibrational transitions. The selection rule for infrared absorption is that the vibrational mode 
must lead to changes in the dipole moment of the molecule with displacement along its 
vibrational coordinate.55 Molecular symmetry operation and point groups are required for 
understanding absorption of high-symmetry species but in the case of a protein, which has 
low-symmetry, the dipolar character of the absorbing molecule can be employed to provide 
qualitative interpretation of the vibrational modes.56 The absorption of infrared light by 
diatomic molecules can be represented by Hooke’s law (Eq. 1.8), which relate the vibrational 
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frequency of a normal mode directly to the force constant of the bond and inversely to the 
mass of the oscillators. 57  
    (1.8) 
where  represents the vibrational frequency, K represents the force constant of the bond and 
 is the reduced mass of the diatomic molecule. Hence, the vibrational frequency of molecules 
will be unique when composed of discrete atoms or different bond hybridizations.57 The 
relative intensity of the absorption peak is proportional to the amount of absorbing species in 
the molecule according to Beer Lambert’s law (Eq. 1.9). 
   (1.9) 
where I is the transmitted beam intensity, Io represents the intensity of the incident beam,  is 
the molar absorptivity coefficient which is unique for each vibration, c is sample concentration 
and l is the pathlength of the cell.57 This can be rearranged by taking the natural logarithm of 
the equation to produce a linear relationship between the parameters. 
Additionally, Hooke’s law describes harmonic oscillations as a continuous diatomic vibration 
based on the assumption that vibrational energy levels are equally spaced by a factor of hv. 
However, interatomic forces are not perfectly harmonic, having both anharmonicities in the 
normal modes and anharmonic coupling between the modes (Figure 1.8).58 Therefore, the 
Morse potential function described as an anharmonic correction (Eq. 1.10) accounts for 
quantum mechanical effects observed in vibrational spectroscopy such as coupling of 
vibrational modes at higher energy levels. These anharmonicities also lead to intramolecular 
energy redistribution, overtone, and combination mode absorption, vibrational 
solvatochromism, Fermi resonance, as well as contribute to VSE.58 
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Figure 1.8. Potential energy curves for harmonic oscillator approximation (dotted) and anharmonic 
correction (solid). 58 
   (1.10) 
De represents the well depth,  is the width of the potential well (the smaller  is, the larger 
the well) and q is the displacement of the atoms from equilibrium positions along the 
vibrational coordinate, which is the midpoint of the parabolic well. 
1.2.3.2 Instrumentation 
Infrared electromagnetic radiation is divided into three regions: near-infrared, mid-infrared 
and far-infrared. The region employed in the conventional analysis is the mid-infrared, which 
spans the frequency of 4000 to 650 cm-1.  
The two major spectrometers used to collect infrared spectra are dispersive and Fourier-
transform infrared spectrometers (FTIR). In dispersive infrared spectrometer, the beam from 
the infrared source (often Nernst glower or globar rod) is simultaneously incident on the 
sample and reference sample to minimize the effects of water vapour and carbon dioxide, both 
of which absorb strongly in the mid-infrared region.59 The beams are collimated by a 
monochromator and diffraction grating before it is passed to the detector.59 However, in 
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contemporary spectrometers, a Michelson interferometer is utilized to simultaneously scan all 
the frequency of light projected onto the sample. In this case, the beam enters into the 
interferometer where a beam splitter divides the beam into two halves; one half is directed 
towards the moving mirror while the other is incident on a stationary mirror (Figure 1.9). A 
beam splitter is an optical device that splits an incident light beam into two or more beams that 
may or may not have the same optical power. In Michelson interferometer, the beams from the 
different mirrors recombine at the beam splitter before it is directed towards the sample. Due 
to the moving mirror, the recombined beam results in constructive or destructive interference 
that creates a path-dependent pattern called an interferogram.60 The interferogram is then 
directed towards the sample and later to the detector. After digitization, the interferogram is 
sent to a computer that uses Fourier transforms to convert the path-dependent function to the 
frequency domain (spectrum).57 The difference in the intensity of the radiation from the light 
source and the spectrum obtained after the sample’s absorption gives the final spectrum.60 
 
Figure 1.9. Representation of the beam paths within Michelson interferometer of Fourier Transform 
infrared (Adapted with modification from reference 61) 
FTIR spectrometer has three advantages over the dispersive instrument. First, the multiplex 
(Fellgett) advantage results from the simultaneous measurement of all wavelengths of light in 
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FTIR instrument whereas dispersive setup records a single wavelength. As a result, FTIR 
spectrometers collect and average multiple scans in a very short amount of time compared to 
dispersive instrument.60 The second is called throughput (Jacquinot) advantage. This refers to 
the higher signal-to-noise ratio of FTIR spectrum because the use of slit in dispersive 
instrument results in low throughput.60 Finally, the wavelength (Connes) advantage arise from 
the use of internal reference (HeNe-helium-neon laser), leading to better wavelength 
resolution of FTIR.60 
The advantages of FTIR are associated with the Michelson interferometer, but the use of 
appropriate detectors for various sample types and applications can also offer significant 
benefits. The three main types of detectors used in FTIR spectroscopy are thermal, 
pyroelectric and photon detectors. Thermal detectors follow the temperature-dependent 
changes in the material that are converted to electrical outputs. This class of detectors are cost-
effective, easy to use, and can operate at room temperature but they have lower sensitivity and 
response time.57 Pyroelectric detectors are made from a single crystalline wafer of pyroelectric 
material. When a field is applied across the crystal, the charges become polarised and the 
temperature-dependence of their capacitance is thus converted to electrical outputs. An 
example of this is the deuterated triglycine sulfate (DTGS) used in conventional FTIR 
instruments. The last class is the photon detectors. These are made from semiconductors that 
create electrical outputs through changes in the electronic energy distribution of the material. 
Photon detectors have a fast response time and high sensitivity and are thus the most 
commonly used commercial detectors. However, they must be kept at cryogenic temperatures 
to reduce thermal noise.57 Mercury cadmium telluride (MCT) represents an example of this 
type of detector, which is used to study mid- and near IR regions. Different detectors are 
needed for qualitative and quantitative analysis of infrared absorption. VSE spectroscopy as a 
quantitative technique requires highly sensitive detectors to accurately determine the 
vibrational shifts of the infrared probes, which are then correlated with electrostatic changes in 
macromolecules.  
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1.2.3.3 Electrostatics interactions and VSE spectroscopy 
The role of electrostatic interactions has been recognised in biomolecular processes, in signal 
transduction, protein folding, enzyme-ligand binding and conformational changes.62,63 During 
enzyme catalysis, enzyme-ligand and enzyme-solvent interactions are reorganised to 
accommodate and stabilise reaction intermediates, which might involve charge separation, 
charge transfer, proton exchange, bond polarization or changes in ligand structures. The 
elucidation of electrostatic forces in proteins and nucleic acids are advanced by the work of 
Boxer and co-workers.52,64–68 Importantly, they noted that the insertion of infrared probes into 
macromolecules can report local electrostatic changes in them.51,69,70  
Charged particles create electric fields in the space surrounding them. Because electric field is 
vector quantity, the principle of superposition allows for the combination of two or more 
electric fields. Hence, resultant electrostatic forces observed in protein are a vector sum of the 
electric field of individual charges.71 
To apply VSE to study electrostatic changes in macromolecules, the infrared probe must be 
characterised by its sensitivity to electric fields. Two approaches developed by Boxer and co-
workers to calibrate the sensitivity of the probe involve direct application of electric field and 
solvent field to characterise the Stark shifts. In the first strategy called electrochromism, the 
probe is immobilised between a frozen glass of polymer films before a voltage corresponding 
to about 1 MV/cm of electric field is applied directly to the capacitor containing the polymer.52 
Spectral difference between the electric field of the ‘off’ and ‘on’ state relates to the 
vibrational dipole difference experienced by the probe.52  
In the second approach, the probe is dissolved in solvents of different polarities, which exerts 
an electric field (the solvent reaction field) depending on the size of the probe’s dipole 
moment. The solvent reaction field results in vibrational frequency shifts (solvatochromism), 
which can be characterised by dielectric constants or other empirical polarity scales such as ET 
(30) and pi scale.72  
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The sensitivity of infrared probes such as azides, carbon-deuterium bonds, nitriles, carbonyls 
and phosphates to electric fields have been reported in previous studies.49,66,73–75 Once the 
probe is calibrated, it can be inserted to report local electrostatic changes between two states of 
a protein as a result of vibrational frequency shift in their infrared absorptions.65 The 
relationship between vibrational frequency shift and the local electric field experienced by the 
probe in the system can be written as  
  (1.11) 
where h is Planck’s constant; c the speed of light,  is the difference in dipole moment 
between the ground and excited states expressed as linear Stark tuning rate (cm-1/(MV/cm), 
 is the local electric field change experienced by the probe in the protein (in MV/cm), 
Δνobs is the vibrational frequency shift (cm-1) and  is the angle between the vectors defined by 
 and .65 Electric field is a vector quantity; hence, the absolute direction of the probe must 
be determined by crystal structure or molecular dynamics (MD) simulations.76  
Nitrile probes are preferred for VSE spectroscopy because they have higher extinction 
coefficient, absorb in the uncrowded region of macromolecules (2100 – 2240 cm-1) and can be 
incorporated readily into proteins by genetic code expansion or via post-translational 
modification of cysteine side chains.53 However, nitrile probes often deviate from the Stark 
model when they are involved in direct hydrogen bonding. Hence, a tandem technique, which 
plots the infrared frequencies and NMR chemical shifts of the probe in different protic and 
aprotic solvents was introduced to decompose such deviation.77 An alternative method 
developed by Romesberg measures Stark shifts as a function of temperature and their degree 
of deviation in different solvents.78 In both approaches, aprotic solvents give linear plots 
distinct from when the probe is hydrogen bonded. Recently, Webb and co-workers have 
shown that nitrile probes can retain electrostatic sensitivity even when they participate in 
hydrogen bonding.79,80  
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Since its development, VSE has been applied to investigate electric field changes in enzymes 
bound to different inhibitors.70 It was also used to measure the solvent accessibility of 
membrane proteins.81 In one report on ketosteroid isomerase, nitrile probes were employed to 
report the extremely large electric field imposed on the substrate by the active site of the 
enzyme.82 Comparison between different variants of the enzyme suggests that electric fields at 
the active site of the enzyme correlated with catalytic rate enhancement.82 Another enzyme 
investigated extensively with this technique is DHFR from Escherichia coli (EcDHFR) using 
nitrile and carbon-deuterium probes.49–51 
1.3 Dihydrofolate reductase (DHFR) 
DHFR has long been used as a paradigm to investigate the mechanism of enzymatic rate 
enhancements. DHFR catalyse the transfer of the pro-R hydride from the C4 of NADPH to C6 
of 7,8-dihydrofolate (DHF) and the protonation of N5 to give 5,6,7,8-tetrahydrofolate (THF) 
and NADP+ (Figure 1.10). Earlier studies have shown that some DHFRs follow a stepwise 
mechanism where the substrate is protonated before the hydride transfer step, but concerted 
steps were also observed in other DHFRs.83 This concerted mechanism is native to TmDHFR 
catalysis at neutral pH but occurs only in EcDHFR when the reaction is carried out at high pH 
(~pH 9.0).83  
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Figure 1.10. The reaction catalysed by DHFR showing the transfer of a hydride from C4 of the cofactor 
(NADPH) to the C6 of the substrate (DHF) to produce THF and NADP
+. 
The product from this reaction (THF) is utilised by the cell as a one-carbon carrier in the cycle 
that produces DNA nucleoside and other important amino acids such as serine and glycine 
(Figure 1.11).84,85 The dependence of cellular function on THF makes DHFR a potential drug 
target. Thus, inhibitors of the enzyme such as methotrexate (MTX), trimethoprim and 
pyrimethamine are used in the treatment of cancer, bacterial infection, malaria and 
autoimmune diseases.86  
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Figure 1.11. A selection of biological reactions that use different THF derivatives as a cofactor during 
one-carbon transfer reactions. THF is converted to 5,10-methylene-THF. The 5,10- methylene-THF is 
then converted to 5-methyl-THF by reduction with NADPH. The methyl group is in turn transferred to 
homocysteine generating methionine in the presence of cobalamin (Vit B12). The 5,10-methylene-THF 
is also used in the presence of thymidylate synthase (TS) to methylate the pyrimidine base uracil in 
deoxyuridine monophosphate (dUMP) to thymine to produce deoxythymidine monophosphate (dTMP) 
which is essential for DNA synthesis. 5,10-methylene-THF and 5-formyl-THF can be converted into 
5,10-methenyl-THF, which is in turn converted to 10- formyl-THF, which acts as a cofactor during 
purine biosynthesis. (Adapted from reference 84 and 85). 
The simplicity of the reaction catalysed by DHFRs and their relatively small size (159–170 
amino residues) are a few reasons why they are attractive for enzymology studies. Another 
crucial motive for employing DHFRs is the extensive protein motion observed in EcDHFR. 
1.3.1 Structural characterisation of DHFRs 
All the chromosomally encoded DHFRs adopt similar secondary and tertiary structural 
arrangements.87 Generally, DHFRs consists of four α-helices, eight β-sheets and three 
structural subdomains that surround the active site cleft (Figure 1.12A).87 The β-sheets are all 
parallel with the exception of the anti-parallel βH at the C-terminal of the protein. The α-
helices are named by their proximity to the β-sheets. Using EcDHFR as a template, their 
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subdomains can be divided into three: the cofactor binding domain (CBD) (residues 38-88) 
where the adenosine moiety of NADP(H) binds, the substrate binding domain (SBD) 
(residues 23-37) where DHF binds to the enzyme and the loop domain (LD).88 The loop 
domain forms approximately 40-50% of the major subdomains and is dominated by a set of 
three loops on the ligand binding face that surround the active site, the M20 (residue 9-23), 
FG (residues 116 – 132) and GH (residues 142 – 149) loops (Figure 1.12B).89 
  
Figure 1.12. (A) Cartoon representation of EcDHFR (PDB 1RX2) showing the secondary structural 
elements; α-helices (red), β -strands (yellow) and connecting loops (green). (B) The structural domain 
rotated by ~90° and showing the cofactor binding domain (purple), the substrate domain (blue) and 
the three-active loops: M20 (orange), FG (cyan) and GH (green). The ligands are also shown with 
colours corresponding to their domains.  
This general description fits EcDHFR, but other homologs have slight structural 
modifications. For example, DHFR obtained from Geobacillus stearothermophilus bacterium 
that thrives at 60 °C (BsDHFR) is structurally well-aligned with EcDHFR except at αE 
(Figure 1.13A). Because this α-helix is in the cofactor binding domain, the affinity of the 
enzyme for the cofactor is lesser than those of other homologs.90 Similarly, DHFR isolated 
from Thermatoga maritima bacterium that survives at 80 °C (TmDHFR), forms a quaternary 
homomeric structure.91 This enzyme has an extra β-sheet, which participates in the dimer 
interface along with its loop domain (M20, FG and GH loops). The dimerisation contributed to 
its thermostability with melting temperature (Tm) of 82 °C (Figure 1.13B).
91,92  
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Figure 1.13. Structural overlay of (A) EcDHFR in brown (PDB: 1RX2) and BsDHFR in purple (PDB: 
1ZDR) indicating the difference in the αE helix. (B) EcDHFR in brown (PDB:1RX2) and TmDHFR in 
blue and sky blue (1D1G). The domains participating in the dimer interface is shown as red.  
Besides the extra β-sheet extension of TmDHFR, HsDHFR also has three functional 
phylogenetic extensions relative to EcDHFR (G51PEKN, L28F and N23PP) (Figure 1.14A).93 
These extensions were reported to be common to vertebrate DHFRs93 and are thought to 
influence their ligand interaction and kinetic character.12,94 For example, weak inhibition of 
HsDHFR by trimethoprim was associated with the extension region, but studies showed that 
the extensions only alter the affinity of the enzyme for NADP+ with no effect on 
trimethoprim’s inhibition.94 In addition, this difference is believed to dictate their catalytic 
cycle (Figure 1.14B).95,96 
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Figure 1.14. (A) Structural overlay of EcDHFR (brown, PDB: 3QL3) and HsDHFR (cyan, PDB: 
4M6K) bound to ligands (FOL and NADP+ in purple). Extension sequence identified in phylogenetic 
analysis as orange in HsDHFR.94 (B) The catalytic rate of HsDHFR and EcDHFR (in parenthesis). 
Rate constants are written as clockwise (red) and anticlockwise (blue). The lower half of the catalytic 
cycle represents the major kinetic path of EcDHFR while HsDHFR follows the full cycle. First and 
second-rate constants are given in the unit of s-1 and µMs-1 respectively. (Adapted from reference 95 
and 96). 
In EcDHFR, the turnover rate is limited by the release of THF, but in the case of HsDHFR, 
both THF and NADP+ can be released from the active site leading to complex kinetics.97 
These sequence extensions also influenced diversity in the flexibility of vertebrate DHFRs in 
comparison to their bacterial counterparts.98 
1.3.2 Protein motions in DHFRs 
Extensive structural studies of EcDHFR bound to different ligands have identified ligand-
dependent conformational changes in the enzyme.99 These conformational transitions involve 
structural and spatial changes in the M20 loop. In the apo form (the unliganded state), the M20 
loop of EcDHFR adopts an open conformation where the substrate binding cleft widens and 
the nicotinamide binding site opens by ~8 Å.99 But in the holoenzyme (enzyme/NADPH) and 
Michaelis complex (enzyme/NADPH/substrate), the loop assumes a closed conformation 
where it folds over the active site. A short anti-parallel sheet formed by the central residues of 
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the loop in this conformation seals the active site and forms hydrogen bonding interactions 
with Asp122 in the FG loop (Figure 1.15B). In the remaining steps of the catalytic cycle, the 
M20 loop remains in the occluded conformation after switching upon hydride transfer. To 
stabilise this state, the M20 loop forms hydrogen bonding interaction with Ser148 of the GH 
loop. Also, the central region of the M20 loop protrudes into the active site and prohibits the 
binding of the nicotinamide-ribose moiety (Figure 1.15C).99 Although a disordered 
conformation was noted in their report, this configuration was suggested to be an intermediate 
between the other conformations.99 These loop movements were also observed in subsequent 
NMR investigation.88,100,101 
 
Figure 1.15. (A) The catalytic cycle of EcDHFR showing the conformations adopted along with it. 
Crystal structure of EcDHFR showing (B) the closed conformation (PDB: 1RX2) and the hydrogen 
bonding interaction with D122 of the FG loop (C) the occluded conformation (PDB: 1RX6) and 
stabilising interaction with S148 of the GH loop. 
In the same manner, DHFRs from other organisms were studied by X-ray crystallography and 
NMR techniques. 92,93,102,103 Both MpDHFR and TmDHFR were reported to also adopt the 
open conformation.92,102,104 Though MpDHFR only assume this conformation when in the apo 
form,104 TmDHFR maintains an open conformation throughout its catalytic cycle because its 
loop domain is locked in the dimer interface.92,102 In most DHFRs however, the M20 loop 
remained closed over the active site in most of their complexes to shield the reactants from the 
solvent.99 The closed conformation is thought to be crucial for DHFR catalysis because it 
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places an active site Asp/Glu 27-30 (depending on the source organism of the enzyme) at a 
relative distance where it is believed to coordinate water molecule that protonates the substrate 
(DHF).87,105 This interaction possibly modulate the pKa of the substrate and facilitates hydride 
transfer.105 
The resistance of DHFRs to antifolate-inhibitors also propelled scientific investigation of 
DHFRs. For example, mutation of L22, F31 and F34 in HsDHFR were identified to confer 
methotrexate resistance to the enzyme.106–108 The quest to improve upon current inhibitors 
contributed to the necessity of understanding the enzymes transition state structure. Although 
the complex of methotrexate with NADPH is said to mimic the transition state structure, 
methotrexate binds DHFRs in a different orientation to those observed with 4-oxo-folate 
derivatives (FOL, DHF and THF).87 This is because the pteridine ring of MTX is flipped at 
C6-C9 bond by 180°; thus, place the pro-R hydride of the cofactor in proximity to the si-face of 
the inhibitor. Trimethoprim is another inhibitor mentioned earlier that selectively inhibit 
bacterial DHFRs without adverse effects on humans due to its weak binding to human 
DHFR.107 Hence, it is commonly used in the treatment of bacterial infections.86 
1.4 Investigation of protein dynamic effects in DHFRs 
Studies of DHFRs adapted to different temperatures are crucial to understanding how protein 
dynamics influence their chemical step.109–117 A review of selected experimental findings that 
support and oppose the importance of protein dynamics are presented below. 
1.4.1 Kinetic characterisation and flexibility studies 
Notably, most investigations are focused on EcDHFR due to the substantial movement in its 
loop domain during catalysis.12,118 To probe the relevance of this motion, site-directed 
mutagenesis was employed to change residues in the different loops. When residues at the 
centre of the M20 loop (residue 16-19) were mutated to Gly, hydride transfer rate constant of 
the variant was reduced by 500-folds relative to the wild-type.119 NMR study of the same 
variant later showed that cross-peak conformation averaging spotted in the spectra of the wild-
type apoenzyme was absent from that of the variant.120  
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Another experiment mutated Gly121 in the FG loop to other amino acid residues to destabilise 
the closed conformation.121 NMR studies have previously shown that the Gly121 undergoes 
large-amplitude motion on the nanoseconds timescale.89,121 These mutations were reported to 
alter hydride transfer rate constant. The authors alleged that long-range motion of the distal 
residue, which was about 19 Å from the active site, was essential for the chemical step.121 
However, thermal unfolding experiment of G121V variant revealed that the160-fold reduction 
in its hydride transfer rate constant was due to a trapped intermediate structure.122  
The evolutionary differences in the primary sequence of prokaryotic and eukaryotic DHFRs 
were also employed to mutate residues in the M20 and GH loops of EcDHFR 
(N23PP/S148A).25 The low hydride transfer rate constant of this variant was explained to 
result from a ‘knockout’ of dynamic motions.25 However, the work of Allemann and co-
workers on the variant revealed that the observed effect resulted from increased fluctuation at 
the transition state of the variant despite reduced structural flexibility.123,124 This suggests that 
lack of flexibility on one timescale might not indicate the absence of motion on other 
timescales. In fact, when a mutation that favoured the adoption of the occluded conformation 
was introduced into the GH loop of MpDHFR (P150S), hydride transfer rate was not 
affected.117  
Protein dynamics are heterogeneous in both bacterial and vertebrate DHFRs. Other flexibility 
studies using H-D exchange experiment revealed a faster isotopic exchange of the amide 
proton of MpDHFR and BsDHFR relative to EcDHFR.125,126 Solution NMR report using 
residue-specific isotopic labelling of Trp and Met showed that TmDHFR has lower dynamic 
fluctuations along its catalytic cycle compared to the other homologs.100 The lack of flexibility 
in the loop domain of TmDHFR, due to their dimer interface association, was thought to 
impact its low catalytic rate. However, a monomeric version of the enzyme did not show 
improved catalytic function.92  
Vertebrate DHFRs are known to exhibit different dynamic flexibilities compared to their 
bacterial counterparts.99 Backbone and side chain averaging in HsDHFR was reported to have 
a lower amplitude than that of EcDHFR.127 Unlike loop motions in EcDHFR, an aromatic 
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active site residue in vertebrate DHFRs was reported to change conformations depending on 
the ligand bound, particularly in HsDHFR and chicken DHFR.128 This motion has been 
implicated in the kinetic complexity of vertebrate DHFRs.129  
Complexity, as well as protein instability, has particularly discouraged detailed 
characterisation of HsDHFR’s kinetics.130 Kinetics of HsDHFR and other vertebrate enzymes 
showed that their substrate KIEs were lesser than those of their bacterial counterparts.129 In 
addition, apo-HsDHFR could not be isolated without significant aggregation due to structural 
instability in the absence of a ligand.131,132 Consequently, most investigation of protein 
dynamics and how it influences hydride transfer in DHFRs have focussed on bacterial 
homologs. 
1.4.2 KIEs studies 
As earlier mentioned, the effect of protein dynamics on the chemical step of DHFRs can be 
investigated using the temperature-dependence of KIEs. These results are complicated by 
inconsistent observations. Studies have shown that many DHFRs exhibited temperature-
dependent substrate KIE under pre-steady-state kinetic measurements, which indicate that H-
tunnelling contribute to their catalysed reaction.133–135 However, different temperature-
dependence of substrate KIEs are observed when the pH is changed.126,136 For example, 
substrate KIE in EcDHFR showed a mild temperature-dependence at pH 9.0 but showed 
biphasic temperature-dependence at pH 9.5. It this case, substrate KIE was temperature-
independent above 15 °C, but at lower temperatures, the substrate KIE becomes strongly 
temperature-dependent.113,134  
Because co-solvent changes the physical properties of the reaction by modifying the dielectric 
constant and viscosity of the medium, their effect on DHFR’s catalysis was also examined. 
Reduction in the dielectric constant will strengthen hydrogen bonding within an enzyme, 
making it less flexible and increased viscosities would also slow protein motions.126,137 
Overall, solvent studies of EcDHFR, MpDHFR, BsDHFR and TmDHFR revealed that hydride 
transfers were insensitive to solvent viscosities but are changed in relation to the dielectric 
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constant of the solvent mixture.39,90,126,137 This indicates that electrostatics rather than protein 
motion plays a major role in the catalysis of DHFRs.7 
Nevertheless, these reports could not rule out the importance of fast protein vibrations to 
DHFR catalysis, which can be elucidated by enzyme KIE measurements. Pre-steady-state 
kinetics of EcDHFR showed a slight increase in enzyme KIE from 0.93 (10 °C) to 1.18 (40 
°C).114,138 In other investigations, the cold-adapted MpDHFR45 and the moderately 
thermophilic BsDHFR116 showed enzyme KIEs near unity at their physiological temperatures 
but exhibit increased enzyme KIEs at non-physiological temperatures.45,116. To complement 
these studies, computational analyses confirmed that when DHFR’s performance is hampered 
by mutations or change in temperature, additional recrossing events on the dividing surface of 
the energy barrier may occur.45,114,123 Based on these observations, the coupling of protein 
vibrations to hydride transfer appears to happen under unfavourable conditions.7,45  
1.4.3 VSE spectroscopic investigations 
Apart from KIEs, VSE spectroscopy has also been employed to investigate protein dynamics 
in enzymes. Carbon-deuterium bond was introduced into EcDHFR by selective deuterium 
labelling of specific Met residues in the enzyme while the other Met(s) are replaced with 
Leu.49 But the interpretation of the absorption line shapes was non-trivial.49 In a different 
report, non-canonical deuterated tyrosines were incorporated via genetic code expansion at 
position 100 and 111 to probe electrostatic changes of EcDHFR.50 This is because Tyr100 is 
implicated to form direct contact with the nicotinamide hydride donor and was thought to 
stabilise the developing charge on the cofactor at the transition state.50 The two analyses 
suggested that the catalytic cycle of EcDHFR is both electrostatically and dynamically 
heterogeneous.  
A recent investigation applied a combined VSE spectroscopy and computational analysis to 
probe the relationship between protein dynamics and electrostatic changes in EcDHFR.51 This 
work employed a site-specific cysteine labelling to insert a nitrile probe at the active site.51 
Experimental infrared spectroscopic characterizations showed that electrostatics at the active 
site changed dramatically depending on the bound ligand.51 Further detailed analysis was 
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obtained with mixed quantum mechanics/molecular mechanics (QM/MM), which identified 
residues that caused the observed electrostatic change.51 To this end, the authors suggested 
that the enzymes motions play a significant role in facilitating hydride transfer.15,51 
Previous investigations of dynamics at the microenvironment of DHFRs using VSE 
spectroscopy were conducted solely with EcDHFR. Therefore, the application of VSE 
spectroscopy to other homologs of DHFR is important to reveal the link between electrostatic 
changes and conformational transitions. 
1.4.4 Project Aims 
The aim of my project is subdivided into the following objectives and analysed in each 
chapter.  
The first is, to optimise the isolation of HsDHFR and reduce purification-associated kinetic 
complexity. HsDHFR is an enzyme of interest for the study of protein dynamics but the 
instability of the enzyme under different purification conditions have stalled its 
characterisation for several decades. To overcome this, binding of folate to the enzyme has 
been shown to enhance protein stability. However, folate is a substrate for HsDHFR and form 
inhibitory complex that prevents ideal kinetic investigation. Hence, we explored and reported 
new strategies to produce a stable enzyme that is viable for kinetic studies. 
To determine the effects of protein dynamics on the chemical step of HsDHFR using KIE 
techniques. Steady and pre-steady-state kinetics of HsDHFR have been reported to be unusual 
because measured rate constants were isotope insensitive under different conditions. As a 
result, the chemical step of the enzyme could not be measured reliably. We hereby report 
techniques to reveal the chemical step of HsDHFR and probe how protein dynamics 
influenced it. 
Lastly, to elucidate the relationship between conformation and electrostatic changes in 
DHFRs. Previous studies have focussed on EcDHFR; here we investigated electrostatic 
changes in DHFRs such as EcDHFR, BsDHFR, MpDHFR, and TmDHFR using vibrational 
Stark effects (VSE) spectroscopy. 
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2.1 Preface 
The reaction catalysed by human DHFR (HsDHFR) has been a target for cancer treatment for 
several decades. Consequently, the enzyme is often crystallised with different potential lead 
compounds being tested for inhibition. However, characterisation of HsDHFR is still 
associated with significant difficulties, especially regarding enzyme purity and stability. First, 
HsDHFR copurifies with an unidentified 28.9 kDa protein as well as an endogenous ligand 
(NADPH/NADP+) when produced in E. coli.139 Hence, accurate rate constant could not be 
measured without subjecting the enzyme to several chromatographic steps. In addition, the 
apoenzyme is also unstable and often aggregates during purification.131,132,139 Last, kinetic 
analysis of HsDHFR exhibits a complex kinetic time course under both steady and pre-steady 
state measurements.96 Hence, for the last three decades, works on HsDHFR has been stalled 
because of these challenges. 
Previous purification approach to remove bound impurities lead to a poor yield of stable 
enzyme.139 In the proposed method, an extra purification step using High-Performance Liquid 
Chromatography (HPLC) was introduced to produce an enzyme that is free of protein and 
ligand impurities.139 However, this step involves unfolding the enzyme. Since apo-HsDHFR is 
unstable, the refolding step leads to 80% loss of enzyme yield, except when refolded in the 
presence of folate or folate and cofactor.139 Even when the two ligands are bound, about 20% 
of the enzyme still aggregates. 
The next challenge is the kinetic study of folate-bound HsDHFR. Because the enzyme is 
unstable when produced in E. coli host,130,140,141 the method recommended to overcome this 
challenge is purification of the enzyme with folate to enhance stability.139 The problem with 
the use of folate in HsDHFR’s purification is that both folate, as well as dihydrofolate (DHF), 
can be reduced by the enzyme and both are bound with similar affinities.96 Consequently, 
kinetic assays of folate-bound HsDHFR can be difficult to isolate when NADPH and DHF are 
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added to the reaction mixture. This is because simultaneous reduction of both folate and DHF 
may be observed leading to complex kinetic rates. 
Finally, even in the absence of ligand impurities, HsDHFR has been reported to exhibit 
complex kinetics under steady and pre-steady-state measurements.96 Consequently, the 
absolute rate constant of hydride transfer in the enzyme has not been measured for 
decades.96,129 
To resolve these challenges, an alternative approach to removing the bound 28.9 kDa protein 
impurity was developed without the loss of protein yield. In addition, a different ligand that is 
not a substrate for HsDHFR was identified and employed to enhance its stability. This strategy 
significantly reduced the complexity observed during pre-steady state measurements, which 
afforded the determination of its hydride transfer rate constant. This chapter will focus on the 
identification of the protein impurity and the discovery of a new stabilising ligand for 
HsDHFR while the pre-steady and steady-state measurement of HsDHFR will be discussed 
later in Chapter 3.  
2.2 Identification of protein impurity and gene cloning 
Mass spectrometric sequence analysis was employed to elucidate the identity of the tightly 
bound 28.9 kDa protein impurity. The initial experiment carried out by Dr Luk L. and 
Williams T. comprises the isolation of the protein by HPLC, treatment of the impurity with 
trypsin for 2 hrs at 37 °C and analysing the fragments by MS (See Appendix I, Figure A1, A2 
and A3,). Trypsin is a protease that cleaves protein/peptide chains mainly at the carboxyl side 
of the amino acid of lysine or arginine to give unique fragmentation pattern that can be 
correlated to the parent protein or peptide. The fragments identified here were searched within 
the protein sequence library and found to align with 80% of TEM-1 β-lactamase as shown 
below (The signal sequence cleaved in vivo is shown in green). In addition, ampicillin was 
hydrolysed when incubated with the protein and monitored by LC/MS over 24-hours (Figure 
2.1) 
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TEM-1-BLAC         1 MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLN     50 
                                            |||||||           ||||||||| 
MS-MS FRAG         1 -----------------------HPETLVK-----------VGYIELDLN     16 
 
TEM-1-BLAC        51 SGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDL    100 
                     |||||||||||||||||||||||||||||||||||||||| ||||||||| 
MS-MS FRAG        17 SGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLG-RIHYSQNDL     65 
 
TEM-1-BLAC       101 VEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL    150 
                     ||||||||||||||||||                          |||||| 
MS-MS FRAG        66 VEYSPVTEKHLTDGMTVR--------------------------ELTAFL     89 
 
TEM-1-BLAC       151 HNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA    200 
                     ||||||||   |||||||||||||||||||||||||||| |||||||||| 
MS-MS FRAG        90 HNMGDHVT---RWEPELNEAIPNDERDTTMPAAMATTLR-LLTGELLTLA    135 
 
TEM-1-BLAC       201 SRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD    250 
                     |||||||||||||||||||||||||||||||||||||   |||||||||| 
MS-MS FRAG       136 SRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGE---RGIIAALGPD    182 
 
TEM-1-BLAC       251 GKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW    286 
                     ||||||||||||||||||||  ||||||||||||   
MS-MS FRAG       183 GKPSRIVVIYTTGSQATMDE--RQIAEIGASLIK--    214 
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Figure 2.1. LC trace of ampicillin hydrolysis by the isolated 28.9 kDa protein (TEM-1 β-lactamase). 
(Obtained from Dr Luk L. and Williams T.)  
The source of TEM-1 β-lactamase was identified to eliminate the interaction with HsDHFR. It 
was reasoned that since HsDHFR was produced in a pET-21 plasmid vector, which codes for 
TEM-1 β-lactamase, the likely origin of TEM-1 β-lactamase would be the plasmid vector 
(TEM-1 β-lactamase yields resistance to ampicillin antibiotic and helps bacterial cells to retain 
recombinant plasmids during growth). To remove the strong association of the enzymes, the 
gene encoding HsDHFR was excised from the pET-21 plasmid vector using restriction 
enzymes (NdeI and BamHI) that flanked the 5’ and 3’ ends. This fragment was ligated into 
pET-28 digested with the same enzymes. As this reading frame gave an unwanted N-terminal 
His-tag and thrombin cleavage coding sequence, primers were designed to delete them. Figure 
2.2 shows the scheme used for the gene cloning. Interestingly, the expression of HsDHFR 
gene in the kanamycin vector resulted in a protein that is free of the tightly bound β-lactamase. 
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Figure 2.2. Schematic diagram showing sub-cloning of HsDHFR gene and the step of His-tag coding 
sequence removal. Blue circle and arc show pET 21(a) and HsDHFR gene, respectively. The brown 
circle and arc are for pET 28(a) plasmid vector while the orange region of the pET 28(a) plasmid 
codes for His-tag and thrombin cleavage site. 
2.3 Optimisation of purification techniques to produce stable HsDHFR 
After successfully isolating DHFR from the protein impurity, an alternative ligand was sort for 
stabilising it. Initial attempts to substitute folate for other ligands failed. Once folate is added 
to the enzyme at any stage of the purification, it remained tightly bound and cannot be 
removed without significant loss of protein yield. Hence, antifolate inhibitors were considered 
as replacements. These are broadly classified into classical (that is, inhibitors that have the 
glutamate tail) and non-classical (those that lacked the tail).142 Trimethoprim was preferred as 
a non-classical inhibitor of DHFRs because of its 105-fold binding selectivity for bacterial than 
for vertebrate DHFRs.143 We, therefore, hypothesise that trimethoprim would adequately 
stabilise HsDHFR while allowing the exchange for DHF substrate prior to kinetics study. 
However, substantial aggregation was observed, which is likely a combination of the poor 
solubility of trimethoprim in aqueous buffers and its lower affinity for HsDHFR.143 
The second strategy was the use of truncated substrates. Previous crystallographic and NMR 
studies have identified about 14 amino acid residues that participate in the binding of folate 
(Figure 2.3 and Table 2.2).103,144 Importantly, 65% of these residues are responsible for 
binding to the para-aminobenzoyl glutamate (pABG) moiety of folate. For example, residues 
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F31 and F34 have been reported to respectively form pi-stacking and van der Waal interaction 
with the benzoyl group of pABG.145 We believe these interactions are sufficient to stabilize 
HsDHFR; hence, pABG was used as ligand during protein purification. The addition of 2 mM 
pABG into the lysis buffer, followed by the supplement of another 3 mM during size 
exclusion chromatography, afforded nearly homogeneous complex which is stable at a 
concentration over 1 mM. Because pABG absorbs at the same wavelength as the enzyme (280 
nm), the UV detector of the chromatographic system is often saturated during size exclusion. 
Thus, SDS-PAGE was employed to identify elution fractions containing the enzyme. Figure 
2.4 shows the different stages of the protein production. Further examination employed 
LC/MS, circular dichroism, NMR spectroscopy and kinetic analysis. 
 
Figure 2.3. Crystal structure of HsDHFR (light sea green, PDB:4M6K) bound to folate (magenta). 
Residues interacting with pABG are shown in sea green according to reference 103,144 and 146. 
NADP+ was omitted for clarity. 
Protein purity was assessed by LC/MS. The mass of 21454.25 ± 1.65 determined by electron 
spray ionisation-mass spectrometry (ESI-MS) agreed well with the calculated mass of 21452 
with intact first methionine. However, a mass of 21323.5 ± 1.53 was also detected by ESI-MS 
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which was due to the post-translational modification of HsDHFR where the first methionine of 
the protein sequence has been cleaved. The peak corresponding to this mass indicates that 
~40% of HsDHFR has the first methionine cleaved (Appendix I, Figure A4 – A5). 
 
Figure 2.4. SDS-PAGE showing the HsDHFR expressions and purification (1: Protein marker in kDa; 
2-4: HsDHFR before IPTG; 5-7: HsDHFR after IPTG;8-10: Selected fractions from Q-sepharose 
purification; 11: purified HsDHFR (without β-mercaptoethanol); 12-13: cell pellet; 14-15: purified 
HsDHFR after size exclusion.  
The tolerance of the pABG-bound HsDHFR to ligand exchange was tested and the enzyme-
ligand complexes were also investigated by temperature unfolding experiment using circular 
dichroism. The replacement of pABG with folate produced a more stable enzyme while 
attempts to displace folate with pABG in folate-bound HsDHFR resulted in instantaneous 
aggregation. This precipitation signifies that the binding of pABG to HsDHFR is weak, 
whereas that of folate is strong; thus, causing protein instability on attempts to exchange the 
strong ligand. The stability of the enzyme-ligand complexes was examined by noting the 
alterations in the circular dichroism spectra. A change in the secondary structure is reflected as 
a shift in the spectra from folded to unfolded when the enzyme is heated between 5 and 85 °C. 
The change in the ellipticity of the backbone structure is plotted against temperature to give 
the melting curve. The midpoint of the curve taken at a specific wavelength where maximum 
change in ellipticity is observed, 215 nm in the case of HsDHFR, represents the melting 
temperature (Tm) (Figure 2.5). The pABG-bound enzyme shows a melting temperature of 40 
°C, which is substantially lower than that of the HsDHFR-folate complex (52 °C) (Table 2.1). 
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Figure 2.5. Melting temperature of HsDHFR (10 μM) in phosphate buffer (10 mM) pH 7.0 at 215 nm 
without ligand (blue), with pABG (red) and folate (orange). 
Table 2.1. Melting temperature of HsDHFR (10 μM) in the absence and presence of ligands 
10 mM phosphate buffer Melting Temperature at 215 
nm 
(Tm) (°C) 
Enzyme at pH 7.0 37.16 ± 0.10 
Enzyme with 100 μM pABG at pH 7.0 40.49 ± 0.13 
Enzyme with 100 μM folate at pH 7.0  52.46 ± 0.25 
 
The pABG-bound HsDHFR was further examined by 1H-15N HSQC NMR spectroscopy. 
Enzyme complexes with pABG:NADP+, folate:NADP+, DHF:NADP+ and THF:NADP+ were 
acquired. The spectrum of the enzyme complexed with pABG:NADP+ shows distinct 
chemical shifts that are different from that of the enzyme:folate:NADP+ complex (Figure 
2.6A). This result suggests that a number of residues are exposed to a different chemical 
environment when pABG is used. In contrast, spectra of the enzyme complexed with either 
DHF:NADP+ or THF:NADP+ were almost superimposable to that of the folate:NADP+ 
complex (Figure 2.6B). These complexes respectively are thought to mimic the product and 
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Michaelis complexes, since HsDHFR can catalyse the reduction of both folate and DHF. This 
finding agrees with previous works indicating that HsDHFR does not undergo substantial 
conformational changes after its chemical step.98 Overlay of other complexes can be found in 
Appendix I, Figure A6. We now analysed the kinetic difference between the previous 
purification strategy where the enzyme is stabilised by binding to folate and our new 
developed protocol, which employed pABG instead. 
 
Figure 2.6. 1H-15N HSQC overlay of HsDHFR complexed with (A) folate (blue) and pABG:NADP+ 
(red) and (B) folate:NADP+ (blue) and THF:NADP+ (red). 
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Table 2.2. The interaction of residues of HsDHFR with folate ligand from crystal structure and 
solution NMR 
Folate 
component 
Residues 
interacting 
with ligands 
PDB: 1DHFa 
Type of interaction 
NMR averaging experiment 
of hydrophobic and aromatic 
residuesb 
Pteridine 
ring 
I7 
Backbone carbonyl: 
hypothesized H-bond with 
N8 DHF, not observed 
with folate 
Side chain: Hydrophobic 
Significant side chain and or 
backbone averaging identified 
F31, F34 Van der Waal/hydrophobic 
Significant side chain and or 
backbone averaging identified 
W24, E30 
H-bonding network 
involving structural 
waters, N3, O4 and 2-
amino group 
NA 
T136 
H-bonding network 
involving structural 
waters, N3, O4 and 2-
amino group 
Significant side chain and or 
backbone averaging identified 
para-
aminobenzo
ic acid 
F31, F34, 
I60, P61, L67 
Van der Waal/hydrophobic 
Significant side chain and or 
backbone averaging identified 
N64 
H-bond to the carbonyl 
oxygen of p-ABA 
NA 
L-glutamic 
acid 
R28 
Carbonyl backbone: H-
bonding network between 
H2O and γ-COOH folate 
NA 
Q35 
In proximity to both α- and 
γ-COOH folate 
NA 
R70 
Salt bridge with α-COOH 
folate 
NA 
Others 
Y33, V50, 
T38, V115 
NA 
Significant side chain and or 
backbone averaging identified 
NA= not applicable (a) and (b) are from reference 144 and 103, respectively. 
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2.4 Kinetic investigation of purified HsDHFR 
Our study revealed that the use of folate ligand during purification contributes to the kinetic 
complexity of HsDHFR. Folate was initially employed to stabilise the enzyme, prior to the 
discovery of a suitable substitute. During this period, attempts to measure the kinetics of the 
folate-bound enzyme were unsuccessful. The kinetic traces, measured with stopped-flow 
apparatus, were either incomplete, inconsistent or results in low kinetic isotope effects (KIE) 
(Figure 2.7). A summary of the different attempts is presented in Table 2.3. Notably, the KIE 
(kH/kD) with folate was inverse whereas that of DHF was normal (at pH 10.0). However, when 
the pABG-purified enzyme was used, consistent kinetic traces and results were measured. In 
fact, a rate constant measured with NADPD gave 603.67 ± 60.93 s-1 at 0 °C and pH 7.0, which 
is similar to the previous report of 600 s-1 measured at 6.0 °C and pH 7.65 where isoelectric 
focusing was employed to remove bound impurities.129 Although the kinetics of HsDHFR 
have been reported to be complex,96 the use of folate as ligand during purification significantly 
enhanced the unusual behaviour.  
 
Figure 2.7. Stopped-flow fluorescence relaxation of folate-bound HsDHFR after pre-equilibration with 
NADPH and initiation of reaction with DHF showing (A) increasing intensity and (B) wobbly 
relaxation. 
In contrast to folate bound HsDHFR, the enzyme complex with endogenous NADPH/NADP+, 
as reported previously,139 did not create a problem during kinetic measurements. When 
expressed in E. coli, HsDHFR has been reported to form a tight complex with the cofactors.139 
Analysis of the complex of the enzyme with folate and with folate:NADP+ from 1H-15N HSQC 
NMR spectra indicated that NADPH/NADP+ remain partly bound. Using a similar approach, a 
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truncated version of the cofactor, which comprises of ribose, nicotinamide and adenine 
diphosphate, were employed to displace the bound cofactor(s). But this attempt was 
unsuccessful. Interestingly, this limitation did not pose a challenge for kinetic measurements 
because NADPH is often pre-equilibrated with the enzyme, which should lead to the exchange 
of NADP+ for NADPH. 
Table 2.3. Trials of pre-steady-state measurements of HsDHFR (20 μM) using a stopped-flow 
apparatus. 
 Reaction 
syringe 1 
(enzyme)  
Reaction 
syringe 2  
pH F 
/A
bs 
 kH kD KIE Remark 
Pre-equilibration with NH/ND 
1 10 μM 
NH/D 
200 μM 
DHF 
9.0 F 32.81 
± 2.97 
29.81 
± 2.4 
1.07 Low KIE 
2 10 μM NH buffer only 9.0 F ND ND ND No relaxation.  
3 10 μM 
NH/D 
200 μM 
FOL 
9.0 F 583.32 
± 41.7 
490.71 
± 1.18 
1.18 Not reproducible. 
4* 40 μM 
NH/D 
400 μM 
FOL 
9.0 F 523.94 
± 21.7 
 
ND 
ND Not reproducible 
pH 10.0 to slow down the transient kinetics147 
5 10 μM 
NH/D 
200 μM 
DHF 
10.0 F 15.27 
± 2.85 
8.67 
± 1.27 
1.76 Low KIE 
6 10 μM 
NH/D 
200 μM 
FOL 
10.0 F 80.35 
± 5.38 
123 
± 4.23 
0.65 Low KIE 
Pre-equilibration with FOL/DHF 
7 200 μM 
FOL 
10 μM NH 9.0 F ND ND ND No relaxation.  
8 200 μM 
FOL 
50 μM NH 9.0 F ND ND ND No relaxation.  
9 200 μM 
FOL 
200 μM NH 9.0 F ND ND ND No relaxation.  
10 40 μM 
FOL 
200 μM NH 9.0 F ND ND ND No relaxation.  
11 200 μM 
DHF 
10 μM NH 9.0 F 6.32 
± 3.7 
ND ND Not consistent 
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Continued from the previous page 
12 200 μM 
DHF 
50 μM NH 9.0 F 7.95 
± 1.4 
ND ND Consistent 
* measured with 40 μM enzyme concentration. ND = not determined 
2.5 Discussion 
HsDHFR forms both in vivo and in vitro complexes with many macromolecules, which makes 
it an enzyme of great interest. For example, HsDHFR binds to its own mRNA, regulating its 
own translation.148 It also forms an in vitro complex with human thymidylate synthase,149 with 
a prediction that the two enzymes might be involved in substrate channelling.150 HsDHFR also 
has 92% sequence identity with DHFR-like-1, a second DHFR localized in human 
mitochondria.151 Hence, HsDHFR might interact with more partners because mitochondria 
proteins are known to form many complexes.152  
It is commonly accepted that β-lactamase is responsible for the hydrolysis of β-lactam, but β-
lactamases have also been found in eukaryotic cells catalysing seemingly unrelated 
reactions.153,154 One prominent example is human mitochondrial metallo-β-lactamase 
(LACTB2) which is an endoribonuclease.155 The crystal structure alignment between the 
bacterial TEM-1 β-lactamase and LACTB2 reveals conserved domains that form part of the 
active site (Figure 2.8). One may, therefore, predict that interaction between HsDHFR and 
TEM-1 β-lactamase signifies that HsDHFR might form other complexes in the cell that are yet 
to be identified. 
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Figure 2.8. The overlay of TEM-1 β -lactamase (PDB:1ERO, sky blue) and LACTB2 (PDB: 4AD9, 
brown) Their conserved domains and residues are shown as blue and orange, respectively. The 
covalently bound boron inhibitor of TEM-1 shown as purple while the two-zinc metals at the active site 
of LACTB2 are shown as yellow 
Adding of folate supplement to E. coli expression media of HsDHFR was suggested to 
improve the yield and recovery of a stable recombinant enzyme.139 This stability is thought to 
result from the formation of an in vivo ternary complex where both folate and cofactor are 
bound to the enzyme. However, most bacteria such as E. coli which makes folate de novo do 
not use exogenous folate.156 Instead, they have been shown to uptake and grow on pABG as 
well as catabolise folate to pABG.157 Therefore, it is possible that the enhanced expression 
reported when E. coli is grown in folate-rich media result from the uptake of pABG.  
Although minimal media expressions were produced with vitamin mix (composed of folate), 
the different chemical shifts observed in the overlay of the enzyme folate:NADP+ and enzyme 
pABG:NADP+ complexes indicate that folate was not endogenously bound. Endogenous 
folate and NADPH would form an inhibitory enzyme DHF:NADP+ complex, which has been 
reported to trap approximately 90% of HsDHFR under steady-state conditions.96 The 
formation of such a complex would not be exchanged for pABG during purification. 
Consequently, minor peaks from the complex would have been observed in the 1H-15N HSQC 
NMR spectra of the enzyme pABG:NADP+ complex, but these impurities were not noted. 
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Consequently, this purification strategy would encourage further kinetic and structural 
investigations of HsDHFR. Blakley and co-workers first reported the challenge with 
measuring the kinetics of HsDHFR in 1989.129 Since then, other experimental attempts to 
measure the rate constant of the enzyme have failed,96,147,158 which has led to the use of 
computational models as alternatives.42,159 We have shown that part of this complexity 
originates from the use of folate because of its tight interaction.96 However, with pABG, the 
contact was only strong enough to prohibit aggregation while allowing the exchange of tight-
binding ligands. Previously, the interaction of pABG with DHFR from Lactobacillus casei 
(LcDHFR) was reported to be 400-fold weaker than that of DHF.160 Earlier inhibition studies 
of HsDHFR have focussed on crystallographic evidence,93,110,127,146 which usually involves 
extensive dialysis of inhibitors against the tightly bound folate. Therefore, stabilising the 
enzyme with pABG, which require less time to exchange for an inhibitor, will encourage more 
kinetic and inhibition studies. 
2.6 Conclusions 
Accurate identification of TEM-1 β-lactamase played a central role in developing a high-
yielding purification protocol for HsDHFR. Importantly, our result also supports the 
interactive nature of HsDHFR binding to biomolecules other than its substrates. Instead of 
folate, a weaker binding ligand pABG was used during purification. This renders the 
chromatographic procedure from five to only two steps, involving only the use of anion 
exchange and size exclusion chromatography.139 The newly developed purification procedure 
also enables the facile exchange of different ligands, opening up opportunities to gain valuable 
structural and kinetic insights of this enzyme. This approach will consequently encourage 
further studies, which will be useful in the determination of the hydride transfer rate constant 
and the study of its dynamics. 
 
  
 
 
 
 
 
 
 
3 . Effects of protein dynamics on the hydride transfer 
reaction catalysed by human dihydrofolate 
reductase 
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3.1 Preface 
In most bacterial DHFRs, the chemical step can be revealed by measuring the kinetics at high 
pH under steady-state, or neutral pH under pre-steady-state conditions.7,95,161 However, the 
steady-state kinetics of HsDHFR and other vertebrate DHFRs at elevated pH could not reveal 
their chemical step.129 Other attempts to measure the chemical step by standard stopped-flow 
techniques were similarly unsuccessful because the rate is faster than the detection limit of the 
instrument.96,129,147,158 Hence, rate constant for the isotope-sensitive step of vertebrate DHFRs 
could not be determined, a challenge that was suggested to originate from the isomerization of 
an active site residue in the enzymes.103,128,129 Consequently, protein dynamic effects of 
HsDHFR and other vertebrate homologs could not be studied using conventional aproaches that 
employ subtrate and enzyme KIEs.  
Although competitive KIE (H/T) method was recently employed to investigate the dynamics of 
HsDHFR, the approach could not reveal the effect of mass modulation on the hydride transfer 
rate constant.158 Based on the success of our purification strategy in the previous chapter and 
the reduced kinetic complexity from the use of pABG (being a non-substrate ligand), 
alternative approaches were explored to reveal the hydride transfer step of HsDHFR. Here, the 
temperature-dependence of the hydride transfer rate constants are measured using steady-state 
and pre-steady-state kinetics. The method with the most isotope-sensitive rate constant was 
then employed to determine the hydride transfer rate constant of HsDHFR and later applied to 
elucidate the contribution of protein dynamics to the chemical step. 
3.2 Substrate KIE of the reaction catalysed by HsDHFR 
The experiments were optimised for conditions where hydride transfer is significantly rate-
limiting based on the sensitivity of the rate constant to isotopic substitution. The rate constants 
were also measured as a function of temperature for the investigation of protein dynamics. The 
conditions employed for rate constants are therefore discussed below.  
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3.2.1 Substrate KIE (KIEcat) measured using steady-state kinetics at high pH 
In earlier studies, hydride transfer in bacterial DHFRs was shown to be rate-limiting at pH 
above 8.4 under steady-state.129,95 For example, in EcDHFR, hydride transfer is rate-limiting at 
pH 9.0 but more limiting at pH 9.5.134 But for vertebrate DHFRs, their cross-over pH (that is, 
the pH where hydride transfer rate become rate limiting) were reported to be higher than those 
of their bacterial homologs.129 Consequently, hydride transfer in HsDHFR under steady-state 
condition was measured at pH 10.0 with MTEK buffer (50 mM MES, 25 mM Tris, 25mM 
ethanolamine and 150 mM KCl) 
At 20 °C, the hydride transfer rate constant measured was 1.58 ± 0.01 s-1, which reduced by 
two-folds when NADPD was substituted for NADPH (0.78 ± 0.04 s-1). This ratio corresponds 
to a substrate KIEcat (kcat
H/kcat
D) of 2.0. The measurement revealed that hydride transfer rate 
constant is two-fold faster in HsDHFR than in EcDHFR (0.72 ± 0.009 s-1) measured at a lower 
pH (pH 9.5 and 20 °C).134 Further measurement between 5 and 35 °C gave linear Arrhenius 
plots for both kcat
H and kcat
D (Figure 3.1, Figure 3.2 and Table 3.1). The KIEcat was mildly 
temperature-dependent and approximately 2.0 (Table 3.1). 
Although this KIEcat is lower than the KIEcat expected for DHFRs as proposed in an earlier 
study,129 it is slightly higher than previous reports. Previously, the KIEcat of Lactobacillus casei 
DHFR (LcDHFR) was set as a ‘standard’ for DHFRs.129 This is because the KIEcat of LcDHFR 
did not increase above 3.4 when the pH of the reaction was raised from pH 5.0 to 10.0.129 
However, the KIEcat measured here for HsDHFR is higher than in the previous report 
determined under identical conditions of buffer, pH and temperature (KIEcat = 1.7).
129 This 
discrepancy might result from the 150 mM KCl used in our case instead of 100 mM NaCl 
employed in the previous study.129 Different salt ions and concentrations have been reported to 
influence the kinetics of DHFRs.95 Also, in a previous report, high salt concentration (~800 
mM) has been shown to slow the kinetics of mouse DHFR.162 The KIEcat measured here is also 
identical to the KIE (H/D) of 2.01 [at 25 °C] calculated for the enzyme using competitive KIE 
measurement of H/T and D/T at pH 9.0.158  
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Figure 3.1. Arrhenius plots for hydride (circle) and deuteride (square) transfer plotted on a logarithmic 
scale against inverse temperature, measured under steady-state conditions at pH 10.0 
 
Figure 3.2. (A) Temperature-dependence of substrate KIE measured under steady-state conditions at 
pH 10.0 and (B) Arrhenius plot of substrate KIE on a logarithmic scale against inverse temperature 
Activation energy of the hydride transfer reaction at pH 10.0 was found to be 65.00 ± 3.08 
kJ·mol-1, compared to 67.21 ± 3.24 kJ·mol-1 for deuteride transfer (Table 3.1). The 
corresponding activation energy difference (ΔEa) is 2.2 ± 5.4 kJ·mol-1 with an Arrhenius 
prefactor ratio of (AH/AD) of 0.83 ± 0.04 (Table 3.1). Typically, lower activation energy was 
expected for HsDHFR, because the enzyme is known to be extremely fast.96 However, changes 
in pH alter the net charge of an enzyme, which has been reported to affect the mechanism of 
reaction for EcDHFR.83 EcDHFR has been suggested to switch from a step-wise mechanism at 
pH 7.0 to a concerted mechanism when the pH is increased to 9.0.83 However, such a pH 
change did not significantly perturb the activation energy of the reaction.124 Furthermore, 
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effects of pH on the enzyme’s structure was also examined using circular dichroism (CD). By 
employing buffers with different pHs, the effect of pH on the Tm of the enzyme can be 
investigated. The Tm of HsDHFR measured as changes to the ellipticity of the secondary 
structure at 215 nm suggests the enzyme stability increases with pH. For example, at pH 7.0 in 
phosphate buffer, the Tm is 37.0 °C, this increased to 40 °C at pH 8.0 in borate buffer. 
However, the secondary structure of the enzyme appears not to be fully melted at 85 °C in pH 
10.0 borate buffer because the melting curve did not exhibit the characteristic sigmoid curve 
observed at other pHs (Figure 3.3). The suitability of borate buffer for CD spectra higher pH 
has been reported due to its buffering capacity at high pH and its low absorption in the region 
of interest (˂210 nm).163  
 
Figure 3.3. Melting temperature of HsDHFR (10 µM) in different buffers (10 mM) measured at 215 nm: 
light in phosphate pH 7.0 (blue), boric acid pH 8.0 (red) and boric acid pH 10.0 (orange) 
Despite the rate constants measured under our steady-state conditions were more isotope-
sensitive, other kinetic steps appear to contribute to the determined rate constants. For example, 
at 5 °C, two fast rates were observed at the beginning of the UV trace, which lasted for about 
120 sec (three kinetic time-course, each lasting 40 sec, see Appendix II, Figure A7). These 
rates were then followed by a slower rate. Importantly, only the slowest rate gave a linear 
Arrhenius plot with rate constants measured at higher temperatures. This indicates that other 
kinetic steps occur at higher temperatures but are too fast to be detected under steady state 
conditions. The unusual and complex kinetic time-course discovered at lower temperatures was 
similarly noted at neutral pH and with natural and isotopically labelled cofactors NADP(H/D). 
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Infact, the use of low enzyme concentration did not alleviate the multiple-time course (Figure 
3.4), suggesting the steady-state kinetics is not being observed. Earlier studies have revealed 
that HsDHFR shows multiple time-course kinetics under different conditions, comprising of a 
burst, intermediate and a steady-state phase.129 According to the study, the steady-state kinetic 
of HsDHFR exhibits complex behaviour with turnover rate constant kcat of 12 s
-1 that has 
kinetic contributions from the release of both THF and NADP+ from the product ternary 
complex (E:THF:NADP+).96 Such multiple-time course kinetics suggest other steps contribute 
to the observed rate constant; hence, pre-steady-state kinetics was attempted as a strategy to 
lessen the kinetic complexity of the isotope-sensitive step.  
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Figure 3.4. Normalised UV/Vis absorbance trace of steady-state kinetics measured over 40 sec with 10 
pM enzyme concentration at 10 °C showing three different kinetic rates. NH = NADPH and ND = 
NADPD (pH 7.0). 
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Table 3.1. Temperature-dependence of steady-state kinetic parameters of HsDHFR in MTEK buffer pH 
10.0 
Temperature (℃) kcatH (s-1) kcatD (s-1) kcatH/kcatD 
5.0 0 38 ± 0.01 0.19 ±0.02 2.0 ± 0.21 
10.0 0.56 ± 0.04 0.25 ± 0.01 2.2 ± 0.19 
15.0 1.06 ±0.02 0.50 ± 0.06 2.1 ± 0.12 
20.0 1.58 ± 0.01 0.78 ± 0.04 2.0 ± 0.06 
25.0 2.67 ± 0.13 1.22 ± 0.09 2.2 ± 0.09 
30.0 4.42 ± 0.19 2.23 ± 0.04 2.0 ± 0.05 
35.0 4 95± 0.08 2.60 ± 0.09 1.9 ± 0.04 
Ea (kJ·mol
-1) 65.00 ± 3.08 67.21 ± 3.24 AH/AD= 0.83 ± 0.04 
3.2.2 Substrate KIE (KIEH) measured using pre-steady state kinetics at 
cryogenic temperatures 
Earlier studies have reported that the fast kinetics of HsDHFR can be reduced by lowering the 
temperatures of the pre-steady-state kinetics is measured.96,129 However, rate constant was only 
measured at a single temperature (6 °C) because higher temperatures resulted in complexity.129 
To overcome this, a cryo-stopped-flow kinetics approach was developed to measure the 
temperature-dependence of the reaction at sub-zero temperatures. To prevent the solution from 
freezing, methanol (30%) was added to the buffer as a cryoprotectant. The reaction was studied 
at pH of 8.5 to reduce the transient kinetics and afford proper study. The analysis focussed first 
on obtaining more significant substrate KIE measurements, after which the effect of the 
cosolvent on the reaction was analysed. 
The chemical step measured with NADPH and NADPD at -20 °C were 51.4 ± 2.4 and 20.8 ± 
3.5 s-1, respectively, giving a substrate KIEH (kH/kD) of 2.5 ± 0.10. The slightly higher KIEH 
measured by this approach (cryo-kinetics) reveals that hydride transfer was more rate-limiting 
under this condition than the steady-state rate constant determined at pH 10.0. Hydride and 
deuteride transfer rate constants were measured from -20 to +5 °C (Figure 3.5 and Table 3.4) 
leading to a temperature-independent KIEH of ~2.3 (Figure 3.6 and Table 3.4). The Arrhenius 
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plot of KIEH was linear within the measured temperature range similar to steady-state kinetics. 
Non-linear Arrhenius plots of substrate KIEs were reported for EcDHFR when studied at 
extreme conditions of high pH and for TmDHFR at low temperatures.134,164 However, the 
breakpoint of Arrhenius plot of KIE for TmDHFR shifted from 25 °C to lower temperatures 
when methanol cosolvent was used;39 this suggests the cosolvent influence the observed 
kinetics. 
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Figure 3.5. Arrhenius plots for hydride (circle) and deuteride (square) and the corresponding KIEs 
(square) plotted on a logarithmic scale against inverse temperature, measured under pre-steady-state 
conditions at pH 8.5 
 
Figure 3.6. (A) Temperature-dependence of substrate KIE measured under pre-steady-state conditions 
at pH 8.5 and (B) Arrhenius plot of substrate KIE plotted on a logarithmic scale against the inverse 
temperature 
Organic cosolvents often alter the physical properties of aqeous solvent including the dielectric 
constant and viscosity.137 Therefore, the effect of cosolvent (30% methanol) on the reaction 
was investigated by measuring pre-steady state kinetics in the absence of methanol. The 
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deuterated cofactor (NADPD) was employed for measurement between 0 to 20 °C to avoid the 
complexity introduced by high temperatures.96,129 The kD values measured in the presence and 
absence of methanol at 0 °C were 71.89 ± 3.25 and 97.88 ± 3.06 s-1, respectively (Table 3.5). 
On the average, the rate constants reduced by 25% similar to the effect of 33% methanol on the 
rate constants of bacterial DHFRs, which lead to ~30% reduction.39,83,126,137 However, the slope 
of Arrhenius plots of kD in the presence and absence of methanol were identical within 
experimental errors (Figure 3.7). This similarity suggests that the cosolvent did not alter the 
activation energy of the reaction. The compatibility of methanol as a cosolvent for enzyme 
kinetics at cryogenic temperatures have been reported for other enzymes. For example, in a 
previous kinetic study on two thermophilic enzymes determined between +90 and -70 °C, 
methanol as a cosolvent gave linear Arrhenius plots that were parallel to those measured when 
cosolvents were not used.165 Earlier studies have also reported that the KIEH(s) of DHFRs are 
insensitive to methanol cosolvent, between 17 - 33% (Table 3.6).39,90,126,137 For example, when 
EcDHFR was measured in 0% methanol the KIEH
 was 2.92 ± 0.10 but only reduced to 2.41 ± 
0.08 in the presence of 33% methanol.137 On the other hand, KIEH measured in the presence 
and absence of 33% methanol for BsDHFR was unaltered (3.44 ± 0.23).90 Therefore, the 
parallel Arrhenius plots (in the presence and absence of methanol) and the insensitivity of KIEH 
to cosolvent indicate that the KIEH measured using cryo-kinetics represents the precise 
substrate KIE of HsDHFR. The KIEH measured here is slightly higher than when standard 
stopped-flow was employed previously at only 6 °C where KIEH of 2.1 was reported at pH 
7.65.129 
3.36 3.51 3.66 3.81 3.96
1.5
3.5
5.5
-25-15-551525
1000 / T (K -1)
In
 (
k
D
)
T (°C)  
Figure 3.7. Arrhenius plot of the pre-steady-state hydride transfer rate constant of HsDHFR without 
methanol (blue) and with 30% methanol cosolvent(red). 
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Although methanol did not alter the kinetics of the reaction, it appears to have a destabilising 
effect on the enzyme’s structure. This influence was noted when the rate constant measured in 
methanol gradually decrease instead of increasing above 10 °C. Analysis by circular dichroism 
and steady-state kinetics revealed that the tertiary structure of the enzyme, as well as the 
turnover rate constant (kcat), were affected by the cosolvent. The kcat dropped four-folds (Table 
3.2) while the melting temperature (Tm) of the enzyme was lower by 10 °C when measured in 
the presence of methanol (Table 3.3). A structurally important water molecule has been 
previously detected in the enzyme,166 which may be perturbed by the cosolvent at a higher 
temperature. However, the Michaelis constants (KM) measured with and without cosolvent 
shows that the enzyme-ligand interface was not affected (Table 3.2). The declining rate 
constant at a higher temperature and structural instability in the presence of cosolvent could 
arise from conformational perturbation or the onset of a denaturation process. 
Table 3.2. Steady-state kinetic parameters in different buffers at 20 °C 
Buffer kcat (s
-1) 
KM DHF 
(μM) 
KM NADPH 
(μM) 
Phosphate pH 7.0 10.43 ± 0.87 0.14 ± 0.03 3.81 ± 1.33 
Phosphate with 30% 
MeOH pH 7.0 
2.82 ± 0.86 0.14 ± 0.06 2.90 ± 0.80 
MTEK pH 10.0 1.38 ± 0.68 5.29 ± 1.88 26.01 ± 9.60 
 
Table 3.3. Melting temperature determined in different buffers. 
Enzyme and conditions 
Melting temperature 
Tm 215 nm (°C) 
10 mM phosphate pH 7.0 37.16 ± 1.04 
10 mM Boric acid pH 8.0 40.74 ± 0.20 
10 mM Boric acid with 30% MeOH pH 8.0 30.25 ± 0.10 
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Table 3.4. Temperature-dependence of pre-steady state kinetic parameters in phosphate-boric-
30%methanol buffer pH 8.5 
Temperature (°C) kH (s
-1) kD (s
-1) kH /kD 
-20. 51.41 ± 2.40 20.79 ±3.48 2.5 ± 0.10 
-15 73.35 ± 3.63 32.29 ± 1.90 2.3 ± 0.09 
-10 104.91 ±3.76 45.27 ± 1.61 2.3 ± 0.05 
-5 123.63 ± 3.93 57.60 ± 1.88 2.1 ± 0.09 
0 161.66 ± 4.17 71.89 ± 3.25 2.2 ± 0.05 
5 217.77 ± 6.70 94.80 ± 6.32 2.3 ± 0.05 
Ea (kJ·mol
-1) 32.52 ± 1.54 34.32 ± 1.82 AH/AD= 1.01 ± 0.06 
 
Table 3.5. Temperature-dependence of pre-steady-state kinetic parameters in the presence and absence 
of methanol cosolvent 
Temperature (°C) 
No solvent 
kD (s
-1) 
30% methanol 
kD (s
-1) 
-20 ND 20.79 ±3.48 
-15 ND 32.29 ± 1.90 
-10 ND 45.27 ± 1.61 
-5 ND 57.60 ± 1.88 
0 97.88 ± 3.06 71.89 ± 3.25 
5 124.55 ± 1.92 94.80 ± 6.32 
10 158.65 ± 6.54 ND 
15 202.15 ± 6.54 ND 
20 268.29 ± 6.05 ND 
Ea (kJ·mol
-1) 33.23 ± 1.00 34.32 ± 1.82 
ND = not determined 
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Table 3.6. Substrate KIE of DHFR homologs in the presence and absence of methanol cosolvent 
Enzyme 
kH /kD 
(0% methanol) 
kH /kD 
(33% methanol) 
EcDHFRa 2.92 ± 0.10 2.41 ± 0.08 
BsDHFRb 3.44 ± 0.23 3.44 ± 0.18 
TmDHFRc 4.52 ± 0.20 5.02 ± 0.04 
MpDHFRd 1.91 ± 0.13 1.65 ± 0.10 
(a), (b), (c) and (d) are from ref 39,90,126,137 respectively. 
3.3 Estimation of hydride transfer in HsDHFR 
Because hydride transfer reaction in HsDHFR is fast and could not be determined at 
physiological conditions previously, earlier studies have estimated different rate constants that 
ranged from 1,360 to 3,000 s-1 at 20 °C pH 7.65.96,129 In the first case, a computational model 
was employed to predict the hydride transfer rate constant.96 whereas deuteride transfer rate 
constant determined by pre-steady-state kinetics was converted to hydride transfer using the 
substrate KIE of LcDHFR (3.4) in the later.129 The use of KIE of 3.4 here appears to be an 
overestimation since recent kinetic studies have shown that substrate KIEs vary between 
DHFRs and could take values from 2.0 – 5.0.117,133,134 Therefore, hydride transfer rate constant 
in HsDHFR was estimated using our measured KIEH of 2.3 determined from cryo-kinetics 
above (section 3.2.2). Since deuteride transfer reactions are inherently slower than hydride, 
NADPD was used for the reaction at much higher temperatures at pH 8.5, 8.0 and 7.0. The rate 
constants at pH 8.5 and 8.0 were determined from 0 – 20 °C (Figure 3.8 and Table 3.7), while 
pH 7.0 was measured only at 0 °C (because the rate constant at pH 7.0 was extremely fast). At 
0 °C the deuteride transfer rate constant at pH 8.5 was 97.88 ± 3.06 s-1, 219.27 ± 9.93 s-1 at pH 
8.0 and 603.67 ± 60.39 s-1 at pH 7.0. Using KIEH of 2.3, hydride transfer at 20 °C and pH 8.0 
was 1,093 ± 31 s-1, which is very similar to the 1,360 s-1 estimated previously at 20 °C and pH 
7.65 by the computational model.96 Furthermore, the Arrhenius plots for pH 8.5 and pH 8.0 
were extrapolated to higher temperatures, converging at 88.55 °C. The rate obtained at this 
temperature corresponds to a deuteride transfer rate constant of 3,474.1 s-1 (hydride transfer 
rate constant of 7,990.5 s-1) (Figure 3.8). A new Arrhenius plot was derived using the rate 
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constant measured at 0 °C and pH 7.0 and the convergence rate constant (Figure 3.8) (assuming 
is the pH-independent rate constant of the reaction). From the new Arrhenius plot, hydride 
transfer rate at pH 7.0 constant after the conversion was determined to be 2,263 ± 226 s-1 (20 
°C) and 3,260 ± 558 s-1 (37 °C) ( 
Table 3.8). 
 
Figure 3.8. (A) Arrhenius plots of deuteride transfer rate constant in HsDHFR measured at pH 8.0 
(blue) and pH 8.5 (red) (B) Arrhenius plots of deuteride transfer rate constant extrapolated at pH 7.0 
(orange), pH 8.0 (blue) and pH 8.5 (red). Some points in the linear estimations were removed for 
clarity. 
Linear extrapolations of Arrhenius plots have been employed previously to estimate rate 
constant of hydride transfer in some DHFRs at their physiological conditions. These values 
were reported as 317.3 ± 1.6 s-1 for EcDHFR at 37 °C, 255.0 ± 6.4 s-1 for MpDHFR at 2 °C and 
8.2 ± 0.1 s-1 for TmDHFR at 90 °C.126 Hydride transfer rate constant of HsDHFR estimated 
here shows that the enzyme is ten-fold faster than its mesophilic counterpart (EcDHFR) at their 
physiological conditions. 
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Table 3.7. Deuteride transfer measured at pH 8.0 and 8.5 in phosphate-boric acid buffer 
Temperature (°C) 
pH 8.0 
kD (s
-1) 
pH 8.5 
kD (s
-1) 
0 219.27 ± 9.93 97.88 ± 3.06 
5 309.24 ± 11.92 124.55 ± 1.92 
10 374.56 ± 5.25 158.65 ± 6.54 
15 422.50 ± 13.56 202.15 ± 6.54 
20 475.22 ± 13.59 268.29 ± 6.05 
Ea (kJ·mol-1) 24.7 ± 3.43 33.2 ± 1.00 
 
Table 3.8. Estimated hydride transfer rate constant in HsDHFR determined from Arrhenius plots at pH 
8.5 and 8.0 using substrate KIE of 2.3 
Temperature (°C) pH 8.5 pH 8.0 pH 7.0 
 kD (s
-1) kH (s
-1) kD (s
-1) kH (s
-1) kD (s
-1) kH (s
-1) 
0 
97.88 ± 
3.06 
225.12 ± 
7.04 
219.27 ± 
9.93 
504.32 ± 
22.84 
603.67 ± 
60.39 
1388.44± 
138.89 
20 
268.29 ± 
6.05 
617.07 ± 
13.92 
475.22 ± 
13.56 
1093.01 
± 31.23 
983.70 ± 
120.78* 
2262.51 ± 
226.32 
37 
552.53 ± 
13.30* 
1270.83± 
30.59 
878.88 ± 
27.85* 
2021.42 
± 64.89 
1417.48 ± 
242.78* 
3259.50 ± 
558.39 
*Estimated hydride transfer rate constant from linear extrapolation of Arrhenius plots 
3.4 Enzyme KIE measured using pre-steady state kinetics at cryogenic 
temperatures 
Although HsDHFR is structurally rigid, the active site residue Phe31 has been reported to adopt 
different conformations in the enzyme by rotating its Cα–Cβ bond.128 This motion was 
proposed to regulate solvent accessibility to the active site and substrate binding.107,128 It is also 
said to induce the isomerisation that suppresses the substrate KIE of the enzyme.129 Hence, the 
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role of fast protein vibrations in HsDHFR was investigated by enzyme heavy atom labelling. 
Light (12C, 14N) and heavy HsDHFR (13C, 15N) were produced, as reported previously.44 The 
heavy enzyme labelling led to a mass increase of 5.1% (Appendix II, Figure A8) but did not 
alter the kinetics and the tertiary structure of the enzyme as revealed by steady-state kinetics 
(kcat and KM) (Table 3.9) and circular dichroism (Table 3.10 and Figure 3.9). Enzyme 
substituted with heavy atoms that included deuterium isotope (2H) has been reported previously 
to cause a minor structural alteration in the thermal unfolding of EcDHFR.167 However, 
deuterium labelling was not employed in our case. Notably, the exclusion of deuterium in 
enzyme labelling has been shown not to alter the effects of mass modulation on studied 
reaction.116 
Table 3.9. Steady-state kinetic parameters of light and heavy enzymes in phosphate buffer pH 7.0 and 
20 °C 
HsDHFR kcat (s
-1) KMDHF (μM) 
KM NADPH 
(μM) 
Light 10.43 ± 0.87 0.14 ± 0.03 3.81 ± 1.33 
Heavy 10.55 ± 0.78 0.10 ± 0.02 3.91 ± 1.19 
Enzyme 
KIE 
0.99 ± 0.11 1.40 ± 0.41 0.97 ± 0.45 
 
Table 3.10. Melting temperature of light and heavy enzymes bound to folic acid  
Enzyme and conditions 
Melting temperature 
(Tm)215 nm (°C) 
Light HsDHFR with folate 54.99 ± 0.20 
13C, 15N heavy-HsDHFR with folate 55.05 ± 0.10 
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Figure 3.9. Circular dichroism spectra of HsDHFR (10 μM) at 20 ºC in the different buffers (10 mM) 
reported: light enzyme in phosphate pH 7.0 with folate ligand (cyan), in boric acid pH 8.0 (green), in 
boric acid with 30% methanol pH 8.0 (dark blue) and in boric acid pH 10.0 (yellow). Heavy enzyme in 
phosphate pH 7.0 with folate ligand (red), 
Since cryo-kinetics gave the highest substrate KIE, pre-steady-state kinetics using cryo-stopped 
flow technique was employed to investigate the effect of protein dynamics on hydride transfer 
rate. The rates were measured for the light and heavy enzyme between -20 and 0 °C, which 
showed similar rate constants between 0 and 5 °C. However, the rate constants diverge 
significantly at lower temperature (< 0 °C), such that enzyme KIE (kH
LE /kH
HE) increased from 
1.07 ± 0.05 (5 °C) to 1.72 ± 0.15 (-20 °C) (Figure 3.10 and Table 3.12).  
The large enzyme KIE observed at sub-zero temperatures here agrees with previous reports on 
the effect of non-physiological temperatures on the enzyme KIEs of other homologs.45,116 For 
instance, enzyme KIE of the psychrophilic MpDHFR increased significantly at high, non-
physiological temperature (>1.45 above 25 °C),45 while that of the moderately thermophilic 
DHFR from Geobacillus stearothermophilus (BsDHFR) increased at low temperature (1.65 at 
5 °C).116 But in both enzymes, enzyme KIE was close to unity at their physiological 
temperatures.45,116 
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Figure 3.10. (A) Arrhenius plots of the hydride transfer rate constant of light (blue) and heavy HsDHFR 
(red) at pH 8.5 and (B) The resulting enzyme KIE (kLE/kHE) 
The enzyme KIEs were also determined with NADPD at -15, 0, 5 and 20 °C and the values 
were similar to when NADPH was used. The enzyme KIE were determined with 30 % 
methanol cosolvent (-15 and 5 °C) and in the absence of cosolvent (0 and 20 °C) (Figure 3.11, 
Table 3.13 and  
Table 3.14). 
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Figure 3.11. Temperature-dependence of enzyme KIE in HsDHFR, kH (blue) and kD (red). The kD values 
were measured with 30% methanol solvent (square) and without cosolvent (diamond). 
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In addition, the activation energies of the light and heavy enzymes were strikingly identical 
despite having different activation enthalpies and entropies. Such entropic-enthalpic 
compensation has also been observed in heavy enzyme studies of other homologs (Table 3.11). 
This phenomenon was proposed to originate from the balance of equilibrium conformational 
sampling and the electrostatic rigidity that enzymes require to form the reaction-ready-
configuration.45 
Table 3.11. Eyring activation parameters of light and heavy DHFRs under pre-steady-state conditions 
at pH 7.0 and 25 °C 
 HsDHFR* BsDHFRa MpDHFRb EcDHFRc TmDHFRd 
 Light Heavy Light Heavy Light Heavy Light Heavy Light Heavy 
ΔS‡ (kJ 
mol-1 K-1) 
-96 ± 
4 
-46 ± 4 
-112 
± 4 
-88 ± 8 
-126 ± 
4 
-163 ± 
4 
-109 ± 
4 
-126 ± 
8 
-96 ± 
4 
-96 ± 
4 
ΔH‡ (kJ 
mol-1) 
28.9 ± 
1.7 
42.7 ± 
1.3 
27.2 
± 1.3 
28.0 ± 
1.3 
19.7 ± 
0.8 
10.0 ± 
0.8 
28.0 ± 
1.3 
22.6 ± 
2.5 
49.0 ± 
0.4 
49.0 ± 
0.4 
ΔG‡ (kJ 
mol-1) 
55.2 ± 
1.3 
55.2 ± 
0.4 
61.1 
± 6.7 
61.5 ± 
7.5 
57.7 ± 
0.4 
58.2 ± 
0.4 
60.3 ± 
6.3 
60.3 ± 
6.3 
77.0 ± 
5.4 
77.0 ± 
8.0 
(a) - (d) are from ref 45,116,138 * Measured at pH 8.5 and 0 °C 
 
Substrate KIEs measured for the heavy enzyme at 5 and -15 °C was similar to the light enzyme. 
(Table 3.15 and Table 3.4). In a previous study, competitive KIE was employed to investigate 
the effect of protein dynamics on the catalysis of HsDHFR by comparing the substrate KIE 
(H/T) of light and heavy enzyme.158 Although this approach has been employed to study 
protein dynamics of other enzymes,167 it appears to be unsuitable for revealing the dynamics of 
HsDHFR. In fact, our finding shows that substrate KIE of the light and heavy HsDHFR 
measured were identical at 5 and -15 °C, whereas enzyme KIE has increased from 1.07 to 1.68 
within the temperature range. 
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Table 3.12. Temperature-dependence of the pre-steady state kinetic parameters light and heavy 
HsDHFR in phosphate-boric-30%methanol buffer pH 8.5 
Temperature (°C) Light kH (s
-1) Heavy kH (s
-1) Enzyme KIE 
-20.0 51.41 ± 2.40 29.90 ±2.44 1.72 ± 0.15 
-17.5 70.77 ± 3.83 40.39 ± 1.77 1.75 ± 0.12 
-15.0 73.35 ± 3.63 43.75 ± 1.33 1.68 ± 0.09 
-10.0 104.91 ±3.76 74.27 ± 3.95 1.44 ± 0.05 
-5.0 123.63 ± 3.93 102.29 ± 8.53 1.21 ± 0.08 
0.0 161.66 ± 4.17 154.04 ± 6.32 1.05 ± 0.06 
5.0 217.77 ± 6.70 202.99 ± 4.30 1.07 ± 0.05 
Ea (kJ·mol
-1) 31.3 ± 1.67 44.8 ± 1.34  
 
Table 3.13. Pre-steady-state kinetic parameters of light and heavy HsDHFR in phosphate-boric buffer, 
pH 8.5. Enzyme KIE measured in the absence of cosolvent. 
Temperature (°C) Light kD (s
-1) Heavy kD (s
-1) Enzyme KIE 
0 97.88 ± 3.06 100.76 ±1.82 0.97 ± 0.04 
20 268.29 ± 6.05 282.88 ± 18.00 0.95 ± 0.07 
Ea (kJ·mol-1) 33.5 ± 0.84 34.3 ± 1.84  
 
Table 3.14. Pre-steady-state kinetic parameters of light and heavy HsDHFR in phosphate-boric-30% 
methanol buffer pH 8.5. Enzyme KIE measured in the presence of cosolvent. 
Temperature (°C) Light kD (s
-1) Heavy kD (s
-1) Enzyme KIE 
-15 32.29 ± 1.90 17.83 ±1.57 1.81 ± 0.11 
5 94.80 ± 6.32 89.11 ± 8.27 1.06 ± 0.11 
Ea (kJ·mol
-1) 33.0 ± 0.75 48.7 ± 2.85  
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Table 3.15. Pre-steady-state kinetic parameters of heavy HsDHFR in phosphate-boric-30% methanol 
buffer pH 8.5. Substrate KIE of heavy HsDHFR. 
Temperature (°C) Heavy kH (s
-1) Heavy kD (s
-1) kH/kD 
-15 43.75 ± 1.33 17.83 ±1.57 2.5 ± 0.09 
5 202.99 ± 4.30 89.11 ± 8.27 2.3 ± 0.10 
Ea (kJ·mol-1) 44.0 ± 2.05 48.66 ± 2.84  
3.5 Discussion 
Vertebrate DHFRs may have evolved to have a lower substrate KIE. The reason for low 
substrate KIE observed in most vertebrate DHFRs remain unidentified.129 Previously, the study 
of DHFR’s primary sequence has identified that while Phe/Tyr31 is conserved in most 
vertebrate DHFRs, Leu is conserved in the bacterial homologs.94 An experiment designed to 
change Leu28 in EcDHFR to Phe, alongside other identified functional mutations, led to a 
reduction in the substrate KIE of the enzyme from 2.7 to 2.1. The rate constant also increased 
four-fold, from 1100 to 5100 s-1.94 However, a report on chicken DHFR, which has low 
catalytic rate and a Tyr in place of Phe31, showed that the reduced substrate KIE might not be 
linked to fast hydride transfer rate constant.129 In addition, when competitive KIE method was 
employed to reveal the intrinsic KIE of HsDHFR, a lower intrinsic KIE was calculated (~5.0) 
compared to that of EcDHFR (~6.0).158,168 Furthermore, computational calculations have 
suggested that lower KIEs in enzymes could result from the smaller distance between the 
hydride acceptor and donor.40 
To avoid semantic confusion, protein dynamics is defined here as a time-dependent change in 
atomic coordinates, which includes both equilibrium and non-equilibrium motions of protein 
side-chains, loops or domains.169 Although it is generally recognised that protein dynamics are 
important for the physical step of ligand association and dissociation and for forming the 
reaction-ready configuration,7 their role in the chemical step is hotly debated. 11,12,170–172  
Substrate KIE results suggest that tunnelling did not contribute to the chemical step of 
HsDHFR. Based on previous studies where tunnelling is thought to promote enzyme catalysis, 
temperature-independent KIEs and Arrhenius prefactor ratios (AH/AD) that are close to unity 
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are interpreted to signify the lack of H-tunnelling contribution.30,173 Our study on HsDHFR 
using steady-state and pre-steady-state kinetics revealed that the substrate KIEs were largely 
temperature-independent while Arrhenius prefactor ratios from both techniques fell within the 
semi-classical limits.174 In addition, changes in conditions such as pH and temperature range 
were shown to influence the temperature-dependence of KIEs and tunnelling probabilities.136 
However, the different conditions investigated in this study showed virtually temperature-
independent substrate KIEs. Therefore, protein dynamics that are thought to reduce the barrier 
width and facilitate H-tunnelling may not influence the chemical step of HsDHFR. This finding 
is in contrast to studies on bacterial DHFRs where H-tunnelling contributed to hydride 
transfer.39,133,134,175  
Dynamic coupling was not observed at the physiological temperature of HsDHFR similar to 
bacterial DHFRs. While substrate KIE is often related to H-tunnelling probabilities, enzyme 
KIE is employed to probe the coupling of fast protein vibrations to the chemical step.43,174 The 
heavy atom substitution of HsDHFR revealed large enzyme KIE of 1.72 ± 0.15 at -20 °C while 
at 5 °C enzyme KIE was 1.07 ± 0.05. Similarly, the psychrophilic MpDHFR showed enzyme 
KIE of approximately unity at temperatures closer to its physiological temperature (2 °C) but 
increased significantly to 1.45 at 25 °C.116 Enzyme KIE of BsDHFR was also high (1.65) when 
measured at 5 °C but unity at 45 °C.45 These results show that dynamic coupling in DHFRs are 
minimal at their physiological temperatures. Although a mild increase in enzyme KIE of 
EcDHFR was reported at 40 °C,138 orthogonal isotopic labelling of the mobile M20 loop of the 
enzyme showed that this dynamics is not linked to the motion of the loop.114 Hence, protein or 
residue motions did not couple to the chemical step of HsDHFR under physiological 
conditions. 
An enzyme KIE that is greater than unity was proposed to signify increased recrossing events 
at the dividing surface of the enzyme’s chemical coordinate.45,116,123 Notably, various 
biophysical factors have been shown to induce recrossing events in DHFRs.45,116,123 
Equilibrium protein reorganizational motions and non-equilibrium dynamic coupling should be 
minimised at lower temperatures.45 However, studies have shown that the disruption of 
equilibrium motions at low temperatures increases internal friction along the reaction 
coordinate of enzymes, which prevents them from forming the optimal electrostatic 
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environment that is crucial for stabilizing the transition state.44,45 Consequently, non-
equilibrium motions that couple to the chemical coordinate is increased.45,116 The low 
activation entropy of heavy HsDHFR (Table 3.11) indicates diminished flexibility that results 
in the large enzyme KIE measured at sub-zero temperatures. Together with our previous works, 
this result indicates that protein dynamics are negligible when enzymes are at their 
physiological conditions but appears to drive hydride transfer reactions under conditions that 
the host organisms are not normally exposed to.45,116 
3.6 Conclusions 
In this work, the extremely fast and nearly undetectable chemical reaction catalysed by 
HsDHFR was measured using high pH and sub-zero temperatures. The substrate KIE measured 
by pre-steady-state was employed to estimate the hydride transfer rate of the enzyme close to 
the physiological conditions, 35 °C at pH 7.0 (This can be estimated for other temperatures). In 
addition, the substrate KIEs determined by steady and pre-steady-state kinetics were largely 
temperature-independent in both measurements, which signify that the contribution of quantum 
mechanical tunnelling to the observed chemical step was negligible.134 When enzyme KIE was 
investigated, fast protein vibrations did not contribute to the chemical step above 0 °C but only 
at lower temperatures (< 0 °C). This result clearly shows that dynamic coupling is likely an 
unfavourable factor in the catalysis of DHFRs since enzyme isotopic substitution caused no 
measurable effect under (nearly) physiological conditions in HsDHFR and in other studied 
bacterial DHFRs.7,45,114,116,123,138 This observation is different from that of purine nucleoside 
phosphorylases (PNP) where dynamic coupling was thought to be beneficial.176,177 Hence, the 
alleged importance of protein dynamics to enzyme catalysis remain disputable as a generalised 
model. In the next chapter, we will explore how conformational changes and ligand interactions 
alter electrostatic changes at the microenvironment of bacterial DHFRs. 
  
 
 
 
 
 
 
 
4 . Electrostatic changes at the microenvironment of 
DHFRs investigated by vibrational Stark effects 
spectroscopy 
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4.1 Preface 
Electrostatic forces have long been recognised as fundamental to protein functions.3,62,178 
Because partial charges have long-range effects and are widely distributed throughout a protein, 
the study of protein electrostatics can be complicated.179 In addition, protein electrostatics often 
change during ligand interaction and catalysis, which may be accompanied by motional 
reorganisation.3,53 Although it is generally accepted that protein motions and electrostatic 
changes are linked,63 it is not clear how ligand’s electric field and electrostatic changes in 
enzymes due to evolution can influence protein motion. 
Electrostatic changes that accompany the ligand-dependent motions of EcDHFR has been 
implicated in facilitating its hydride transfer.51 EcDHFR adopts three major conformations- 
open, closed and occluded- during its catalytic steps.99 These conformations refer to the 
configuration that is assumed by its active site loop (M20 loop).99 In a recent investigation of 
electrostatic changes in the enzyme, vibrational Stark effect (VSE) spectroscopy and 
computational analysis were employed to determine the total electric field projected toward its 
donor-acceptor axis.51 According to the study, this electric field is a resultant of the individual 
electric fields that originate from the ligands and several amino acid residues in the enzyme.15,51 
One-third of this total electric field was said to be from the protein.51 But because some of the 
identified residues have been implicated previously in a ‘network of coupled motion’,118 it was 
concluded that conformational changes drive the enzyme’s chemical step.51 On the other hand, 
the M20 loop of DHFRs from several other species adopts the closed conformation as their sole 
configuration,93,99,104,180,181 which is important for modulating the pKa of the substrate.
105 Hence, 
it is not clear how homologs that lack the conformational dynamics reported for EcDHFR would 
alter the electrostatics of their active site.  
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Figure 4.1. (A) Conformational changes along the catalytic cycle of EcDHFR indicated by blue (open), 
orange (closed) and red (occluded). Line arrows represent major cycle while the broken arrow represents 
the step that is rarely observed in vivo. (B) Overlay of the crystal structures of EcDHFR showing the 
direction of the thiocyanate probe (green spheres) and the configuration of the M20 loop in the open 
(blue, PDB: 1RA3), closed (orange, PDB: 4P66) and occluded (red, PDB:1RX6). Methotrexate and 
NADP+ are shown in purple with a mesh surface, while other ligands are removed for clarity. 
To characterise the dynamics of DHFRs, and how it influences electrostatic changes at their 
active site, VSE spectroscopy was employed to study electrostatics of monomeric DHFRs 
(EcDHFR, EcDHFR S148P-a conformationally impaired variant, BsDHFR and MpDHFR) and 
the dimeric TmDHFR. The complexes studied include the apoenzyme and holoenzyme (enzyme 
bound to NADPH) as well as enzyme complex with folate:NADP+ and THF:NADP+, which are 
thought to mimic the Michaelis and the product complex, respectively. Other enzyme complexes 
examined include NADP+ and MTX:NADPH. The methods employed to generate the labelled 
enzymes and measure the VSE spectroscopy for all the enzymes are first discussed before the 
electrostatic implication of the results obtained are outlined in the later section. 
4.2 Labelling of DHFRs for VSE spectroscopy 
To study these enzymes by VSE spectroscopy via nitrile probes, there are three stages to this. 
First is that native cysteine residues in the enzymes must be mutated, and a cysteine residue 
inserted at desired positions by site-directed mutagenesis.182 Other approaches to achieve 
selective labelling of protein with nitriles are discussed elsewhere.53 Next, would be the 
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production of high enzyme concentration to measure highly resolved infrared peaks and the last 
steps of the experiment comprised of nitrile labelling, FTIR and 13C-NMR measurements as well 
as data processing. 
4.2.1 Site-directed mutagenesis 
DHFRs from different species have a varying number of native cysteine residues. For instance, 
EcDHFR has two native cysteine residues (C85 and C152), BsDHFR and MpDHFR have only 
one (C73 and C105, respectively) while TmDHFR has no cysteine residue. Cysteine-free 
EcDHFR (C85A/C152S) (EcDHFRcf) has been studied previously in our group and elsewhere, 
where they showed that the variant has identical kinetic and structural characteristic with wild-
type EcDHFR (The cf subscript indicate cysteine-free).183,184 Similarly, cysteine-free MpDHFR 
has been studied previously where Cys105 of the enzyme was mutagenised to Ala, Val, Ser, and 
Phe. 185 The C105F variant has similar kinetics with the wild-type enzyme. The presence of Phe 
at the equivalent position in EcDHFR was reasoned to justify the wild-type character of the 
variant since MpDHFR and EcDHFR have high sequence identity (53%).185 However, cysteine-
free BsDHFR has not been generated previously. Sequence alignment with other homologs was 
therefore conducted. The result shows that other DHFRs have Ala or Val at the equivalent 
position where BsDHFR has a Cys (Figure 4.2). Computational analysis of the two possible 
variants was undertaken using a web-based server reported in previous studies (http://www-
cryst.bioc.cam.ac.uk/~sdm/sdm.php).186 The software used (Site Directed Mutator) is a statistical 
potential energy function that uses environment-specific amino-acid substitution frequencies 
within homologous protein families to calculate a stability score, which is analogous to the free 
energy difference between the wild-type and mutant protein.186 The analysis predicted that C73V 
mutagenesis has minimal impact on the enzymes hydrophobic packing. Hence, BsDHFR C73V 
variant was created by site-directed mutagenesis. 
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Figure 4.2. Sequence alignment of different homologues of DHFR. Enzymes and residues mutated are 
shown in red. The conserved Thr residue (T46 by EcDHFR numbering), labelled in this study are shown 
as orange in the different enzymes while the equivalent position of the residues mutated are shown in 
blue. 
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Figure 4.3. Crystal structures showing mutations introduced into (A) EcDHFR (brown, PDB 1RXA) (B) 
BsDHFR (purple, PDB 1ZDR) (C) MpDHFR (cyan, PDB 2ZZA) and (D) TmDHFR (blue, PDB 1D1G). 
The conserved threonine residue changed to cysteine is shown as the yellow spheres while native cysteine 
residues modified to other amino acid residues are shown as orange spheres. 
Once the native cysteine residues have been removed, a cysteine residue was inserted at 
equivalent positions in all the enzymes. Earlier, the crystal structure of EcDHFR revealed that a 
nitrile probe inserted at position 46 was ~ 5 Å from the donor-acceptor axis and did not perturb 
its steady and pre-steady-state kinetics.51 Interestingly, the sequence analysis vide supra (Figure 
4.2) shows that position 46 (EcDHFR numbering) is conserved in most DHFRs. In addition, the 
crystal structure overlay of the DHFRs studied in this report reveals that the orientation of this 
residue in the active site is also conserved (Figure 4.4). Therefore, positions equivalent to Thr 46 
of EcDHFR were mutated to cysteine in BsDHFR, MpDHFR and TmDHFR. The mutation is to 
ensure that the nitrile probe in the enzymes reports on identical events. Also, the nitrile probe in 
the other homologs might adopt the same orientation as γ-C-CN of EcDHFRcf T46C-CN shown 
in Figure 4.1.51 
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Figure 4.4. Structural overlay of EcDHFR (brown, PDB: 1RX2), MpDHFR (cyan, PDB: 2ZZA), BsDHFR 
(purple, PDB: 1ZDR) and TmDHFR (blue, PDB: 1D1G) showing the rotamer of the conserved threonine 
residue 
Because the different homologs have different dynamics, we introduced a mutation into 
EcDHFR to understand how conformational changes influence electrostatic changes at its active 
site. The formation of the occluded conformation of EcDHFR has been shown to depend on 
hydrogen bonding between the mobile M20 loop and Ser148 of the GH loop.99 The disruption of 
this interaction when Ser148 is mutated to other residues like Pro or Ala have been reported to 
impair the enzymes' ability to adopt the occluded conformation.117 A previous study has shown 
that the mutation of Ser148 to Pro in EcDHFR disrupts the enzyme-product interaction without a 
significant effect on the hydride transfer rate constant.117 Furthermore, both MpDHFR and 
BsDHFR have Pro at positions that are equivalent to Ser148 in EcDHFR. Hence, S148P 
mutation was introduced into EcDHFRcf T46C variant to produce EcDHFRcf S148P/T46C).  
4.2.2 Production of DHFRs for nitrile labelling 
After successful mutagenesis, the enzymes must be produced at high concentration to study their 
Stark shift. Currently, one of the constraints of studying protein by FTIR spectroscopy is low 
sensitivity.56 Although nitrile probes have higher extinction coefficients and increased absorption 
compared to other probes,54 high enzyme concentration is still required for the optimum dynamic 
range. Alternatively, the path length of the sample cell can be increased for enhanced absorption 
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but this would also raise the intensity of water absorption in the background spectrum, leading to 
suppression of relevant peaks.56 High protein concentrations were achieved with the monomeric 
DHFRs without significant aggregation but the dimeric TmDHFR could not be obtained at 
desired concentrations because of inadequate purification procedure and protein instability.91 
To resolve the limitation of TmDHFR’s concentration, the purification process was optimised for 
increased protein yield and stability. Earlier protocols for producing TmDHFR involves the use 
of cation exchange chromatography133 or repeated use of size exclusion chromatography. In the 
first case, the binding of the enzyme to this resin was not reproducible. In the second case, the 
clarified crude lysate (after E. coli proteins are precipitated by heating at 78 °C133) is usually 
above the sample size that is recommended for size exclusion and highly viscous for a 
concentration step. Hence, these methods were unsuitable for producing TmDHFR on the scale 
required for FTIR measurement. In addition, TmDHFR often aggregates at high concentration 
due to its low net charge.91  
A new protocol was developed using hydrophobic interaction chromatography (HIC) as the first 
purification step. Selective screening of binding and elution buffer was carried out because of the 
relative hydrophobicity of the enzyme and instability in at neutral pH (Appendix III, Table A3). 
Dam and co-workers previously recommended lower pH buffer for producing stable 
TmDHFR.91 Hence, low pH buffers and buffers known to increase protein hydrophobicity were 
prepared (based on Hoffmeister series) and employed to stabilise TmDHFR in the first step.187,188 
In the second step of the purification, equimolar concentration of glutamate and arginine were 
added to the buffer as reported in a protein solubility optimisation protocol.189 These additives 
led to significant structural stability of TmDHFR at high concentration. We also noted that the 
enzyme was more stable when concentrated at room temperature than when concentrated in the 
cold. Figure 4.5 shows the UV trace of the two purification steps. 
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Figure 4.5. UV trace for the purification of TmDHFR (A) hydrophobic interaction chromatography 
eluting over the 60 mL and (B) size exclusion chromatography with exclusion volume between 170 – 200 
mL 
4.2.3 VSE spectroscopic measurements 
VSE spectroscopy directly relates electric field changes at the active site of an enzyme to the 
shifts in their vibrational frequencies by using a specific infrared probe. After the high 
production of all the enzymes, side-chain labelling with Ellman reagent was carried out, 
followed by several washes with KCN or K13CN to produce the nitrile-labelled enzymes for 
FTIR and 13C-NMR, respectively (See Materials and Methods, Section 6.10).190 Initial 
optimisation of labelling conditions and FTIR measurement was carried out using glutathione, a 
well-known tripeptide containing N-terminal glutamate coupled via gamma carboxyl side chain 
to cysteine and glycine (Appendix III, Table A2 and Figure A9 – A11). Labelling of the enzymes 
was confirmed by LC/MS ( See Appendix III, Figure A12 – A22). 
The FTIR absorptions were analysed according to previous reports on VSE spectroscopy.51,191,192 
A high-resolution FTIR equipped with a Mercury-Cadmium-Telluride (MCT) detector was 
employed to measure the Stark shifts. Approximately 2.0 – 4.0 mM of the enzymes were 
employed to measure the vibrational frequency of the probe in the apoenzyme, holoenzyme 
(E:NADPH), Michaelis complex (E:folate:NADP+) and the product ternary complex 
(E:THF:NADP+). Unlike DHF, folate cannot be further oxidized in solution. Thus, the abortive 
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E:folate:NADP+ complex is an excellent mimic of the Michaelis complex (E:DHF:NADPH) and 
its stability makes it well suited for the study.99,120 Ten-fold excess of the ligands were 
equilibrated with the enzymes to form the complexes. The samples were purged under a streams 
of nitrogen gas prior to measurement and the temperature of the sample was kept at 20 °C by 
connecting the liquid cell to a thermocycler (water bath). The spectra were composed of 2000 
scans at 1 cm-1 spectra resolution. The peak of the absorption was obtained as the average of 
second derivative processing as well as first derivative processing and Gaussian fit of the 
background-subtracted spectra (See Appendix III, Figure A23 and A24). Origin 9.0 of OriginLab 
software was employed for the data analysis. Uncertainty in absorption energy is reported as the 
standard deviation of at least two independent measurements. 
Direct hydrogen bonding to the probe has been reported to deviate VSE from the Stark model.193 
Hence, a tandem of IR-NMR calibration curve was developed to correct the hydrogen bond 
induced deviation.193 Consequently, 13C-CN labelled enzymes were also produced and the 
chemical shifts of the 13C probe were determined in the same complex used for FTIR 
measurements. Deviations of the vibrational frequencies from the linear Stark model were 
elucidated using the reported IR-NMR cross peak analysis,193 which revealed that hydrogen 
bonding was formed with the nitrile probe in all the complex formed by all the DHFR studied 
with a deviation of ~7 cm-1. This result suggests that correction of the vibrational frequency is 
unnecessary in our case.193 
The difference in the vibrational frequency of the nitrile probe in two states (complexes) of the 
enzyme was converted directly to the local electric field change in the enzymes (Eq 4.1).51 
  (4.1) 
where h is Planck’s constant; c the speed of light,  is the difference in dipole moment 
between the ground and excited states expressed as linear Stark tuning rate (cm-1/(MV/cm), 
 is the local electric field change experienced by the probe in the protein (in MV/cm), 
and Δνobs is the vibrational frequency shift (cm-1).51 Equation 4.1 has been applied to EcDHFR 
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based on the convention that the angle between  and  are 180° according to 
reference 51,70. Previously, the Stark tuning rate for nitrile probes ( ) has been determined 
in different environments and given as ~0.7 cm-1/(MV/cm).194 However, the absolute direction of 
the probe must be determined by either crystallography or computational simulation.194 The 
direction of the probe is not a challenge here because it has been confirmed in EcDHFRcf T46C-
CN by X-ray crystallography.51 And it is likely that the nitrile probe in the other homologs will 
have the same direction with the probe of EcDHFRcf T46C-CN, vide supra. 
Results from VSE spectroscopy are also studied by computational simulation to predict the 
energy associated with the vibrational transitions of the probe.195 Preliminary theoretical 
calculations by our Spanish collaborators (Prof. Vicent Moliner and Dr. Katazyna Swiderek of 
Departament de Quimica Fisica I Analitica, Universitat Jaume I, Spain) suggests that hydrogen 
bonding difference in the complexes of EcDHFRcf T46C-CN contributed significantly to the 
Stark shifts observed. Although there appear to be some differences in the hydrogen bonding 
microenvironment of the probe in different complexes, the full-width at half maximum (FWHM) 
of the absorption peaks were identical for all the complexes formed by EcDHFR but vary from 
complex to complex in the other homologs.  
4.3 Electrostatic changes at the microenvironment of DHFRs 
To understand quantitative electrostatic changes at the microenvironment of DHFRs, the 
difference between the electric field at the active site of EcDHFRcf T46C-CN were first 
compared to its conformationally-impaired variant EcDHFRcf S148P/T46C-CN. This 
relationship was then extended to electrostatic changes in the monomeric DHFRs before the rigid 
dimeric TmDHFR was considered in the last section. The purpose of this study is to understand 
how DHFRs with diverse conformational dynamics regulate electrostatics at their active site. 
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4.3.1 Electrostatic changes in the conformationally impaired EcDHFR variant 
Earlier report has shown that when Ser148 of EcDHFR is replaced with a Pro, ability of the 
enzyme to adopt occluded conformation become impaired.117 In IR spectroscopy, this amino acid 
replacement leads to a redshift of -1.82 cm-1 in the apoenzyme (Figure 4.6 and Table 4.1). Using 
equation 4.1, this shift corresponds to -2.6 MV/cm difference in electric field between the 
enzymes.  
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Figure 4.6. (A) Bar charts of the vibrational frequencies of EcDHFRcf T46C-CN and EcDHFRcf 
S148P/T46C-CN in different complexes. (B) Bar chart comparison between the complexes formed by the 
enzymes. (C) Calibration of hydrogen bonding interactions of the complexes of EcDHFRcf T46C-
13CN 
(dark blue triangles) and EcDHFRcf S148P/T46C-
13CN (red diamond). The complexes of the enzymes are 
represented by 1 = apoenzyme, 2 = E:NADPH, 3 = E:FOL:NADP+, and 4 = E:THF:NADP+. Deviation 
of ~7 cm-1 from Stark calibration was observed. The Stark model is represented by the open circle 
connected by the broken line,51 indicating the fit for nitrile calibration in different solvents: a = 
cyclohexane, b = toluene, c = THF, d = chloroform, e = dichloromethane, f = dimethyl sulphoxide, g = 
acetone and h = dimethylformamide, obtained from reference 193  
The staggering difference in the electrostatic at the active site of the enzymes in their unliganded 
state indicates differences in the enzyme’s ground state structures. Previous NMR spectroscopic 
studies reported three conformers in the apoenzyme of EcDHFR, one of which resembles the 
occluded conformer.196 But molecular dynamics simulation revealed the existence of multiple 
conformers (up to six metastable states) in EcDHFR when no ligand is bound.197 Hence, it is 
possible that the S148P mutation shifted the populations in the enzyme towards other possible 
conformers. 
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Notably, the most significant difference between the enzymes is when their Michaelis and 
product complexes are compared. For EcDHFRcf T46C-CN, a redshift of -3.7 cm
-1 (-5.3 MV/cm) 
was observed when the ligand was changed from the substrate (folate/NADP+) to the product 
(THF/NADP+) complex. In contrast, for the conformationally impaired variant, such ligand 
variation led to a blueshift of 1.2 cm-1 (1.7 MV/cm). This shift was more significant in the 
EcDHFRcf T46C-CN, which undergoes a conformational change alongside the ligand change. 
But, more importantly, the conformationally impaired variant experienced a reverse electric field 
compared to EcDHFRcf T46C-CN, which signify the lack of the occluded conformations in the 
variant. These results show that electrostatic changes occurred in both enzymes despite their 
conformational difference. Hence, electrostatic changes at the microenvironment of EcDHFR is 
not only linked to conformational changes. 
Electrostatic changes in the enzymes are therefore induced by the ligand difference, which will 
only occur after the conversion of substrate to product. EcDHFR adopts the closed conformation 
in the Michaelis complex, but a minor (4%) population of the enzyme also form the occluded 
conformation.109 The formation of product (THF and NADP+) in the active site of EcDHFR 
cause a steric clash between the products as a result of the 1.8 Å overlap between C4 of the 
cofactor and C7 of the puckered THF.
99 This clash necessitates the reorganisation of the active 
site to accommodate the ligands.198 If S148 is present in the enzyme, active site reorganisation in 
EcDHFR can lead to the formation of the occluded conformation.117 Consequently, the initial 4% 
population will increase significantly due to the stability of the alternative conformation. An 
NMR study has shown that the transition of EcDHFR from the closed to the occluded 
conformations is 10-fold slower than the rate constant of hydride transfer and thus, could not be 
linked to its chemistry.109 
The transition of EcDHFR to the occluded conformation, however, has been associated with the 
rate of substrate turnover (kcat) and the prevention of product inhibition.
120 The conformationally 
impaired variant, with an electrostatic change of 1.7 MV/cm, only reorganizes its active site to 
accommodate the nicotinamide moiety of NADP+. Crystal structure of the occluded 
conformation revealed that Met16 and Glu17 of the M20 loop are projected into the active site 
and sterically block the binding of the nicotinamide moiety of NADP+.99 Interestingly, enzymes 
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that lack the occluded conformation show sensitivity to NADP+ inhibition.98,117,139 For instance, 
both EcDHFR S148P and MpDHFR were reported to be inhibited by NADP+.117 Similarly, 
human DHFR and a variant of EcDHFR (EcDHFR-N23PP/S148A) were ten times more 
sensitive to inhibition by NADP+ than EcDHFR.98 The half-maximal inhibitory concentration 
(IC50) for HsDHFR was 620 μM while EcDHFR was 5 mM.98 These enzymes (that is, HsDHFR 
and EcDHFR-N23PP/S148A) also bind tightly to endogenous NADP+ when expressed in E. 
coli.139 Therefore, the binding of the nicotinamide moiety of NADP+ within the active site might 
be linked to this inhibition and explains the small vibrational shift observed in the variant. 
4.3.2 Electrostatics changes at the active site of monomeric DHFRs 
The distinct position of charges and polar residues in enzymes, even when at some distance from 
the active site, are thought to be aligned to maximize the interaction of enzymes with their 
ligands.199 These charges are shown to reduce the configurational space of bound 
substrates.200,201 However, an adaptation of enzymes to different environments can modify their 
enzyme-ligand interactions.202 Hence, electrostatic changes at the microenvironment of the 
mesophilic EcDHFR and EcDHFR S148P, the psychrophilic MpDHFR and the moderately 
thermophilic BsDHFR were explored along conformationally relevant steps. 
In our study of these enzymes, the nitrile probe was found to experience an intense electric field 
in the holoenzymes leading to high-frequency absorptions of 2166.2 ± 0.15, 2166.6 ± 0.6, 2166.1 
± 0.4, 2162.7 ± 0.4 cm-1 for EcDHFR, EcDHFR S148P variant, BsDHFR and MpDHFR, 
respectively (Figure 4.7 and Table 4.1). Moderately high vibrational frequencies were also 
observed when the enzymes are bound to NADP+ but the binding of NADPH gave the highest 
frequency in all the homologs. The cofactor binding domain was shown to have a lower 
occupancy when NADP+ binds to EcDHFR than when NADPH is bound.99 
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Figure 4.7. (A) Bar charts of the vibrational frequencies of EcDHFRcf T46C-CN, EcDHFRcf S148P/T46C-
CN, BsDHFRcf T46C-CN and MpDHFRcf T47C-CN in different complexes. (B) Calibration of hydrogen 
bonding interactions of the complexes of EcDHFRcf T46C-
13CN (dark blue triangles), EcDHFRcf 
S148P/T46C-13CN (red diamond), BsDHFRcf T46C-CN ( green square) and MpDHFRcf T47C-CN 
(orange circle) Deviation from Stark model represented by the open circle connected by a broken line 
was ~7 cm-1.51 193 
The high-frequency absorptions in the holoenzymes also resulted in blueshifts, during the 
transition of apoenzymes to holoenzymes. These shifts were more significant in EcDHFR and 
EcDHFR S148P leading to 2.45 and 4.07 cm-1 shifts, respectively (equivalent to 3.5 and 5.81 
MV/cm) (Figure 4.7 and Table 4.1). However, the blueshifts were less significant in BsDHFR 
and MpDHFR. The result may be caused by the low affinity of BsDHFR for NADPH (KM of 
~100 μM) and the structural instability of MpDHFR at the experimental temperature (20 
°C).90,203 Overall, the enzymes appear to experience similar electrostatic trends when NADPH is 
bound (Figure 4.6).  
When folate binds to the holoenzyme (that is, forming the Michaelis complex), the resultant 
electric field experienced by the probe in this complex is a reverse of the high-frequency 
absorption observed in the holoenzymes. In other words, the progression of the enzymes from 
holoenzymes to the Michaelis complexes resulted in redshifts of similar magnitudes to the 
blueshifts experienced in the apo-to-holoenzyme transition. The observation was similar in the 
complex of EcDHFR with either folate:NADP+ or folate:NADPH.51 Since both the holoenzyme 
and the Michaelis complex adopt the closed conformation, the redshift during this transition 
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indicate that the binding of folate offsets the initial electric field projected unto the probe by the 
cofactor 
The transition of EcDHFR from the Michaelis (folate:NADP+) to the product ternary complex 
(THF:NADP+) has been the major focus of several studies because of the enzyme chemistry and 
the conformational change that accompanies it.12,51,100,117,126 Our study shows that this transition 
resulted in a redshift of ~4 cm-1 (equivalent to -5.3 MV/cm) in EcDHFR. However, for EcDHFR 
S148P, BsDHFR and MpDHFR the transition caused blueshifts of 1.2, 1.3 and 3.0 cm-1 (that is, 
1.7, 1.8 and 4.3 MV/cm), respectively (Figure 4.7 and Table 4.1).  
The fact that EcDHFR S148P, BsDHFR and MpDHFR experienced blueshifts indicate their lack 
of the occluded conformation as discussed earlier when electrostatic changes in EcDHFR and 
EcDHFR S148P were compared (Section 4.3.1). These blueshifts were minimal in all the 
enzymes except in MpDHFR, which was attributed to the unfavourable temperature used. When 
the experiment was conducted at a lower temperature (5 °C) for MpDHFR, the blueshift dropped 
significantly to 0.4 cm-1 (Table 4.1). This result shows that the relatively large electrostatic 
change between the Michaelis and the product complex of EcDHFR arises from the exclusion of 
the nicotinamide moiety from its binding cleft and the protrusion of the M20 loop into the active 
site in the occluded conformation.99 In all the enzymes, only EcDHFR exhibited a redshift during 
this transition. Hence, the occluded conformation could be regarded as a binary complex with 
regards to the active site probe since only the substrate binding cleft is occupied in this 
conformation. 
In all the monomeric enzymes, the electric field of the cofactor and the substrate counteracts in 
their ternary complexes. That is, the high-frequency absorption experienced by the probe in the 
holoenzyme is red-shifted and becomes identical to that of the apoenzyme when folate, DHF or 
THF binds to the substrate binding domain. To understand if this redshift relates to the 
interaction between the ligands, both EcDHFR and MpDHFR were complexed with 
MTX:NADPH. In both enzymes, the high-frequency absorptions of the holoenzymes were not 
reduced in the MTX:NADPH complex (Table 4.1). Instead, the frequencies were identical to that 
of the holoenzyme. However, the enzymes’ complexes with MTX:NADPH have distinctly 
narrow linewidth (FWHM = 8 cm-1) compared to other complexes. The lineshape might indicate 
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a less polar microenvironment due to the stronger interaction of the inhibitor with DHFRs.49,99 
Earlier study that employed deuterated Tyr100 to study electrostatic changes in EcDHFR 
reported similarity between the electrostatic experienced by the C-D probe in the holoenzyme 
and the enzyme complex with MTX:NADPH.50 
Table 4.1. Summary of 13C NMR shifts, the vibrational frequency at maximum peak, and Full Width at 
Half Maximum (FWHM) values for the IR spectra in monomeric DHFRs (EcDHFR, EcDHFR S148P, 
BsDHFR and MpDHFR) determined at 20 °C 
DHFR Complex 
Vibrational 
frequency (cm-1) 
FWHM  
(cm-1) 
Chemical 
shifts (ppm) 
EcDHFRcf T46C-
CN 
E 2164.1 ± 0.22 13.5 111.6 
E:NADPH 2166.2 ± 0.15 13.5 110.5 
E:FOL:NADP+ 2163.9 ± 0.18 13.2 112.4 
E:THF:NADP+ 2160.1 ± 0.93 14.3 112.72 
E:NADP+ 2164.6 ± 0.24 13.3 ND 
E:MTX:NADPH 2167.2 ± 0.13  8.4 ND 
EcDHFRcf 
S148P/T46C-CN 
E 2162.3 ± 0.52 13.1 116.3 
E:NADPH 2166.6 ± 0.60 14.5 110.5 
E:FOL:NADP+ 2161.9 ± 0.74 12.11 112.4 
E:THF:NADP+ 2163.1 ± 0.41 14.5 112.7 
E:NADP+ 2165.2 ± 1.04 14.0 ND 
BsDHFRcf T46C-
CN 
E 2165.0 ± 0.61 15.9 111.4 
E:NADPH 2166.1 ± 0.43 16.6 111.6 
E:FOL:NADP+ 2163.8 ± 0.23 17.2 111.4 
E:THF:NADP+ 2165.1 ± 0.66 14.4 111.3 
E:NADP+ 2165.5 ± 0.19 16.2 ND 
MpDHFRcf T47C-
CN 
 
E 2162.4 ± 0.61 13.2 111.7 
E:NADPH 2162.7 ± 0.43 11.5 112.1 
E:FOL:NADP+ 2159.5 ± 1.01 12.8 112.7 
E:THF:NADP+ 2162.5 ± 0.14 9.9 112.5 
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Continued from previous page 
E:MTX:NADPH 2167.4 ± 0.54 8.9 ND 
MpDHFRcf T47C-
CN at (5 C) 
E:FOL:NADP+ 2162.4 13.1 ND 
E:THF:NADP+ 2162.8 11.9 ND 
FOL = folate, ND = not determined 
4.3.3 Different electrostatic trends in monomeric and dimeric DHFRs  
Monomeric DHFRs and TmDHFR exhibit different flexibilities, hydride transfer mechanism and 
transition state dynamics.7,45,91,102 In addition, TmDHFR is currently the only chromosomal 
DHFR that is known to forms a homodimer and highly thermostable with melting temperature 
(Tm) of ~82 °C.
91 In this study, notable differences between the monomeric DHFRs and the 
dimeric TmDHFR were observed.  
 First, from the apoenzyme of TmDHFR to the subsequent complexes formed, the enzyme’s 
probe experienced redshift. (Figure 4.8A). Consequently, the apoenzyme of TmDHFR has the 
highest vibrational frequency unlike in monomeric DHFRs where the probe experienced the 
strongest electric field in the holoenzyme. The transition from apoenzyme to holoenzyme in 
TmDHFR was identical within error. However, equivalent transitions in the monomeric 
homologs were blueshifts. The binding of folate to the holoenzyme (to form the Michaelis 
complex) followed a similar redshift with the monomeric homologs, with a frequency shift of -1 
cm-1 (equivalent to -1.43 MV/cm). This redshift supports our hypothesis that the ligands’ electric 
fields are counterbalanced in the Michaelis complex. However, the Michaelis to product ternary 
complex transition in TmDHFR exhibited a redshift of -1.2 cm-1, equivalent to 1.71 MV/cm. In 
the monomeric enzymes, only EcDHFR exhibited a redshift during this transition. It is possible 
that TmDHFR has a different mechanism to prevent the inhibition of the NADP+ through 
selective electrostatic interaction with the product complex. These results show that electrostatic 
changes in TmDHFR follow a different trend to that of monomeric DHFRs. 
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Figure 4.8. (A) Bar charts of the vibrational frequencies of all the DHFRs studied in their different 
complexes. (B) Bar chart comparison between the complexes formed by the enzymes. (C) Calibration of 
hydrogen bonding interactions of the complexes of TmDHFR T47C-CN (black diamond). Deviation from 
Stark model represented by the open circle connected by a broken line was ~7 cm-1. 193 
Table 4.2. Summary of 13C NMR shifts, vibrational frequency at maximum peak, and Full Width at Half 
Maximum (FWHM) values for the IR spectra in TmDHFR determined at 20 °C 
DHFR Complex 
Vibrational 
frequency 
(cm-1) 
FWHM 
(cm-1) 
Chemical 
shifts 
(ppm) 
TmDHFR 
T47C-CN 
E 2165.6 ± 0.47 11.2 111.9 
E:NADPH 2165.3 ± 0.30 12.9 110.7 
E:FOL:NADP+ 2164.3 ± 0.59 15.6 111.4 
E:THF:NADP+ 2163.1 ± 0.19 13.0 111.7 
E:NADP+ 2165.6 ± 0.44 14.0 ND 
FOL is folate, ND = not determined 
4.4 Discussion 
All the DHFRs studied here experienced electrostatic changes at their microenvironment when 
bound to different ligands. The trend of electrostatic changes in EcDHFR S148P was identical to 
that experienced by BsDHFR and MpDHFR. This result suggests that the interactions of the 
enzymes with their ligands are conserved. This electrostatic trend was slightly different in 
EcDHFR due to conformational changes and in TmDHFR because of its structural rigidity. 
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The structural difference between TmDHFR and the monomeric enzymes studied could account 
for the different electrostatic trends. Monomeric DHFRs exhibit induced-fit ligand binding while 
TmDHFR rigidity can be described by the Fischer’s lock-and-key model.91 Consequently, the 
crystal structure of TmDHFR has a root-means-square-deviation (R.M.S.D) of only 0.5 Å 
between the unliganded and liganded states.91 However, movement of the M20 loop in EcDHFR 
transverse a distance of about 10 Å among other subdomain motions.99 In the same way, 
MpDHFR and BsDHFR exhibit significant flexibilities.125,126  
TmDHFR is not only structurally diverse from the monomeric homologs, but its catalytic 
mechanism also reflects that it has a different electrostatic trend. Monomeric DHFRs form 
closed conformation to exclude solvent from their active site,99 but in TmDHFR the major 
catalytic loops (M20, FG and GH loops) participates in the dimer interface, which keeps its 
active site accessible to solvent in all complexes.91,102 Because the M20 loop of TmDHFR adopts 
the open conformation and unable to stabilise the protonated form of DHF (H3F
+), hydride 
transfer occurs in the enzyme via a concerted mechanism.83 In contrast, catalysis in EcDHFR 
under the same condition occurs via a stepwise mechanism, with protonation before hydride 
transfer.83 Furthermore, enzyme KIE of TmDHFR is temperature-independent over 60 °C,7 
whereas that of monomeric DHFRs showed significant sensitivity to temperature change, which 
results in enzyme KIE of above unity at non-physiological temperatures (similar temperature 
sensitivity was observed in HsDHFR reported previously in chapter 3).7,45 This result shows that 
monomeric DHFRs experienced frictions along their reaction coordinate at lower temperatures 
but such friction does not occur in TmDHFR. 
The high-frequency absorption of the nitrile probe when the enzymes are bound to NADPH 
might indicate a higher energy structure of the enzymes or might be due to the electric field of 
the cofactor. The progression of most DHFRs through their catalytic cycle occurs via 
intermediate interaction with the cofactors by interacting cooperatively with either their substrate 
or product after the cofactors are bound.95,129,160,204 Crystal structures showed that when the 
cofactor binds to EcDHFR, the substrate binding cleft (involving the B and C helixes) is opened 
by 0.7 Å in comparison to the Michaelis complex.99 In addition, a higher energy conformational 
Electrostatic changes at the microenvironment of DHFRs investigated by vibrational Stark effects spectroscopy 
90 
 
sampling has also been observed in the holoenzyme of EcDHFR, which is thought to increase 
fluctuations in the substrate binding domain.205 
The counteraction of this electric field in the ternary complexes of the enzyme might result from 
the positioning of the cofactor and substrate (or product). The significantly different 
electrostatics observed in the occluded conformation of EcDHFR can be linked to the exclusion 
of the nicotinamide ribose moiety from its active site. But for other monomeric DHFRs, their 
ternary complexes (that is both Michaelis and product complexes) have highly similar 
electrostatics.  
In contrast, the high-absorption frequency observed in holoenzyme was not counterbalanced in 
the MTX:NAPDH, which can be related to the orientation of MTX when bound to DHFRs. 
Previously, crystal structure has shown that the pteridine ring of MTX in DHFRs is flipped by 
180° around the C6–C9 bond, relative to folate (Figure 4.9), which is different from that of the 4-
oxo-folates (folate, DHF, THF).99 Also, the pyrazine ring of the 4-oxo-folates binds deeper in the 
active site of DHFRs in comparison to MTX, which creates a vacancy at the active site where the 
C6 of folate normally resides.
204 Since the electric field of the ligands are aligned in the ternary 
complex (being vector quantities), the structural difference in the binding of MTX and the 
vacancy of the C6 could alter the superposition of the electric fields such that the resultant 
electric field of the MTX:NADPH complex results in high-frequency vibrations. 
T46C-CN
 
Figure 4.9. Ligands overlay from the crystal structure of EcDHFR in complex with folate:NADP+ (green, 
PBD: 1RX2) and MTX:NADP+ (cyan, PDB:4P66) showing the pteridine ring flip of MTX and wider 
distance from the nitrile probe. The thiocyanate probe from PDB:4P66 is shown as cyan, similar to 
ligands from the crystal structure. 
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The difference in the electrostatics of ternary complex with MTX and the 4-oxo-folates suggests 
that MTX does not represent the transition state structure of DHFRs.99 Previously, VSE study 
using a C-D probe of [D4] Tyr100-EcDHFR revealed a unique microenvironment in the 
Michaelis complex (enzyme:folate:NADP+) that was not observed in the enzyme:MTX:NADPH 
complex.50 The electrostatics of EcDHFR when complex with MTX/NADPH and folate/NADP+ 
were also found to be different when studied by the C-D bond probe of d3Met20.
49 Although 
MTX is usually employed to mimic the transition state of DHFRs, our result shows that the 
electrostatics of the enzymes when bound to MTX:NADPH did not reflect that of the transition 
state of DHFRs (at least for EcDHFR and MpDHFR studied).  
The transition state of DHFRs should properly align the cofactor and the substrate for catalysis. 
In earlier studies, geometric and angular orientation, as well as the proximity of reacting ligands, 
were suggested to be important for enzyme-catalysed reactions.206 This alignment of ligands 
might explain the difference in the reaction rates of diverse substrates. This observation is 
consistent with the report that photoactivation is required for a hydride transfer from NADPH to 
MTX to produce 5,8-dihydro-MTX.207 Since folate is structurally identical to MTX, the 
difference in their catalysis may be due to their alignment in the active site with respect to the 
cofactor. Substrate orientation has also been found to be important for catalysis in other 
enzymes. One example is xanthine oxidase where the substrate can adopt two configurations.208 
Only one of the two orientations was found to be favourable for catalysis and produces 98% of 
the product mixture.208  
One may, therefore, predict that the alignment of the cofactor and the substrate in DHFRs caused 
counterbalancing of the electric field in the ternary complexes and might play a role in their 
catalysis. Studies have shown that the pKa of protonated DHF (H3F
+) in EcDHFR changes from 
2.6 in solution to 4.0 in the binary complex and 6.5 in the Michaelis complex.209 Molecular 
dynamics simulation also showed that the pKa of the substrate in the Michaelis complex is 
significantly influenced by first, the proximity of the nicotinamide and pterin rings and second, 
the parallel orientation between the rings.105 In fact, the previous electrostatic investigation of 
EcDHFR using nitrile label showed that two-thirds of the total electric field calculated at the 
active site of EcDHFR arose from the cofactor-substrate positioning.51 Although the study 
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inaccurately concluded that conformational changes “facilitate hydride transfer” in EcDHFR 
despite showing that amino acid residues contributed only one-third of the total electric field.51 
Our results from other DHFRs that lack such flexibility supports that ligand alignment might 
have a greater effect on their catalysis. Overall, these studies agree with our hypothesis that the 
positioning of the cofactor and the substrate in DHFRs is important for modulating the pKa of the 
substrate and aiding the chemical step. 
Since electrostatics in the DHFRs studied here exhibit similar trends as they transit from one 
catalytic step to another despite having different flexibilities, their ability to catalyse identical 
reactions signify that electrostatics preorganisation at their active site dictate their catalytic rate. 
Homologs of other enzymes have also been found to possess identical electric fields at their 
active site.210 A study on lysozymes from bacteriophage, egg white and human found that the 
three homologs have similar charge distribution and electrostatic components at their active site, 
which was said to account for a rate enhancement of ˃37 kJ/mol.210 The total electric field 
calculated for the cofactor-substrate positioning and amino-acid residues in EcDHFR might 
result from preorganisation of the enzyme active site. 
4.5 Conclusions 
Electrostatic changes in DHFRs from organisms adapted to different temperatures were studied. 
A comparison between the monomeric DHFRs (EcDHFR, its conformationally impaired variant-
EcDHFR S148P, BsDHFR and MpDHFR) show that the large electrostatic changes in EcDHFR 
between the Michaelis and the product complex correlated with its conformational transition. 
However, the close-to-occluded transition relates to a product-induced active site reorganisation 
and is not linked to the chemical step since other homologs experience similar active site 
reorganisation to a lesser degree.  
Our investigation revealed that electrostatic trends in the enzymes are generally identical with 
the highest-frequency absorption observed in their holoenzymes. This high-frequency absorption 
was different in TmDHFR, where it occurred in both the apo and holoenzymes. The interaction 
of the enzymes with their ligands follows a similar pattern. 
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The high-frequency absorption of the holoenzyme is balanced out when the ligand bound to the 
substrate binding domain is correctly oriented and aligned with the cofactor. Since this cofactor-
substrate positioning has been shown to influence the substrate pKa, we hypothesise that the 
ligand-ligand interaction achievable through electrostatic preorganisation of the enzyme’s active 
site, have the greater influence on catalysis. Atomic-level details from computational 
calculations will be pursued to test the importance of the cofactor-substrate interaction and how 
they relate to catalysis in these enzymes. Our experimental data show that DHFRs have 
conserved active site electrostatic interactions despite having different dynamic flexibilities. 
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5.1 Summary and future work 
The importance of an optimised purification technique for studying enzyme kinetics was 
revealed in our investigation on HsDHFR. The truncated substrate (pABG) was shown to 
lessen the kinetic complexity observed when folate is used for stabilising the enzyme during 
purification. Also, the tight binding 28.9 kDa protein impurity observed during HsDHFR 
purification was sequenced and identified as β-lactamase. Because β-lactamase is produced to 
select the gene for expression in E. coli, the protein was removed by producing HsDHFR in a 
Kan-R vector. This optimisation afforded the purification of HsDHFR in two-steps rather than 
the five-step recommended in the previous report.139 Further study would involve 
understanding the interaction between HsDHFR and TEM-1 β-lactamase by co-crystallising the 
enzymes, especially with the aim of developing an inhibitor for either HsDHFR or TEM-1 β-
lactamase since both enzymes are known theraupetic targets. 
The chemical step of HsDHFR was also studied by both steady and pre-steady-state kinetics. 
The cryo-kinetic approach developed for reducing the transient kinetics of the enzyme allowed 
us to determine the temperature-dependence of the chemical step with a substrate KIE of ~2.3. 
In addition, we estimated hydride transfer in the enzyme under physiological condition and 
finally, the contribution of protein dynamics to the chemical step of the enzyme was elucidated 
by temperature-dependence of the substrate and enzyme KIEs. In this report, H-tunnelling 
contribution was not observed in the chemical step of HsDHFR even at non-physiological and 
sub-zero temperatures. However, dynamic coupling due to recrossing events at the dividing 
surface of the reaction predominate only at non-physiological temperature. Our result suggests 
that the quantitative description of enzyme catalysis require the inclusion of other quantum 
mechanical factors to provide a comprehensive explanation to experimental observations. Our 
findings from HsDHFR and other DHFRs clearly showed that the couplings of non-equilibrium 
protein dynamics to the chemical coordinate of these enzymes are minimized at their respective 
physiological temperatures. It would be interesting to investigate how mutation of the active 
site residue Phe31 to other residues will influence the dynamics of HsDHFR. 
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The investigation of the electrostatic at the microenvironment of EcDHFR, EcDHFR S148P 
BsDHFR and MpDHFR showed that the interaction of the enzymes with their ligands follow a 
conserved electrostatic trend. Except for the dimeric TmDHFR, which appears to follow the 
trend only partly. This is because, in most DHFRs, the formation of the closed DHFR−substrate 
complex excludes solvent molecules from the active site and allows the formation of a 
geometric and electrostatic environment conducive to hydride transfer. But in TmDHFR, such 
conformational sampling is prevented by the enzyme’s dimeric structure, which compromises 
the electrostatic preorganization.115 The fact that enzymes from different environmental niches 
and with different flexibilities display the same electrostatic behaviour in their cofactor-
substrate interactions strongly suggest that electrostatic preorganisation of the active site that 
maximises the interaction of the ligands is crucial for catalysis. There are still many questions 
that our VSE study could not answer. Some of which are: how do the enzymes differentiate 
their substrate and products if the ternary complexes of DHFRs are similar electrostatically? 
How did the mutations introduced altered the electrostatics of the native enzymes? Are these 
vibrational shifts due to electrostatic changes or artefacts of experimental conditions such as 
temperature, pH and buffer system? Therefore, we hope to answer some of these questions in 
further investigations. 
Overall, our study revealed that unlike dynamic effects which vary between DHFRs, 
electrostatics of the enzymes, especially in reactive complexes appears to be conserved. 
However, the enzymes have diverse electrostatics in their product complexes, suggesting that 
product release were tuned to the different species. Our results indicate electrostatic 
preorganisation in the reactive complex is crucial to enzyme catalysis. 
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6.1 Bacterial strains and preparation 
6.1.1 Bacterial strains 
The different Escherichia coli strains employed in these experiments are listed below (Table 
6.1). 
Table 6.1. E. coli strains used for experiments 
Strains 
Use 
XL1 Blue Plasmid amplification 
BL21(DE3) 
Gene expression of DHFR from Homo sapiens 
(HsDHFR), Bacillus stearothermophilus (BsDHFR) 
and Moritella profunda (MpDHFR) 
BL21- Star (DE3) 
Gene expression of DHFR from Escherichia coli 
(EcDHFR) 
BL21-CodonPlus (DE3)-RP 
Gene expression of DHFR Thermatoga maritima 
(TmDHFR) 
 
6.1.2 Competent cells 
6.1.2.1 Calcium chloride buffer I 
Calcium chloride (1.11g) was dissolved in 80 mL of deionised water. The total volume was 
taken to 100 mL. The solution was sterilized in an autoclave.  
6.1.2.2 Calcium chloride buffer II 
Calcium chloride (1.11g) and glycerol (15% v/v) were dissolved in 80 mL of deionised water. 
The total volume was taken to 100 mL before sterilization by autoclave.  
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6.1.2.3 Competent cell preparation 
50 µL of the desired strain (Table 6.1) were incubated in 20 mL of non-selective LB media 
overnight in a shaker at 37 °C. In the case of XL1-blue, tetracycline (50 mg/L) was added to the 
pre-culture and chloramphenicol (34 mg/L) for BL21-CodonPlus (DE3)-RP cell. 1 mL of the 
overnight culture was used to inoculate 100 mL of non-selective LB media (with 50 mg/L of 
tetracycline and 34 mg/L of chloramphenicol for XL1-Blue and BL21-CodonPlus (DE3)-RP 
cells respectively). The optical density of the cell was monitored to 0.89 at 600 nm. The cells 
were then placed on ice for 15 min before harvesting by centrifugation at 4000 rpm and the 
supernatant discarded. The cells were re-suspended in 60 mL of calcium chloride buffer I, 
incubated on ice for a further 15 min before repeating the centrifugation step. The cells were 
finally re-suspended in 6 mL of calcium chloride buffer II, divided into 50-100 µL aliquots and 
flash frozen in liquid nitrogen. The cells were then stored in -80 °C freezers. 
6.1.3 Super-competent cells 
6.1.3.1 Rubidium chloride buffer I 
Potassium acetate (0.294 g), rubidium chloride (1.21 g), calcium chloride (1.11 g), manganese 
chloride (0.692 g) and glycerol (15% v/v) were dissolved in 80 mL deionised water. The pH 
was adjusted to 5.8 using dilute acetic acid and the volume was taken to 100 mL with deionised 
water. A 0.2 µm syringe filter was used to sterilize the solution and then stored at 4 °C. 
6.1.3.2 Rubidium chloride buffer II 
3-(N-Morpholino) propanesulfonic acid (0.209 g), rubidium chloride (1.21 g), calcium chloride 
(0.832 g) and glycerol (15% v/v) were dissolved in 80 mL deionised water. The pH was 
adjusted to 6.5 using sodium hydroxide and the volume was taken to 100 mL with deionised 
water. A 0.2 µm syringe filter was used to sterilize the solution and then stored at 4 °C. 
6.1.3.3 Super-competent cell preparation 
Super-competent cells were prepared in the same manner as with competent cells but with 
calcium chloride buffer I and II replaced with rubidium chloride buffer I and II  
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6.2 Growth media and sterile solutions 
6.2.1 Luria-Burtani (LB) medium 
Tryptone (10.0 g) yeast extract (5.0 g) and NaCl (10.0 g) were dissolved in 0.8 L of deionised 
water and the final volume taken to 1 L. The solution was sterilized in an autoclave at 121 °C 
and stored at 4 °C. The required antibiotic was added before use. 
6.2.2 LB agar plates 
Tryptone (10.0 g) yeast extract (5.0 g), NaCl (10.0 g) and agar (15.0 g) were dissolved in 0.8 L 
of deionised water and the final volume taken to 1 L. The solution was sterilized in an 
autoclave at 121 °C. The required antibiotic was added once the solution was cool enough to 
hold by hand and the LB agar poured into Petri dishes under sterile conditions. The agar was 
allowed to solidify in the Petri dishes and the plates stored at 4 °C. 
6.2.3 Auto-induction media (AIM) 
6.2.3.1 AIM premix I 
Glucose (5.0 g), lactose (100 g) and NH4Cl (26.7 g) were premixed. 3.5 g of the premix were 
added directly to the media. 
6.2.3.2 AIM premix II 
KH2PO4 (68 g), Na2HPO4 (71 g) and glycerol 50% (v/v) were dissolved in 0.3 L deionised 
water and the final volume made up to 1 L before sterilization by autoclave. 
6.2.3.3 Trace Element 
EDTA (5mg) was dissolved in 0.8 L of deionised water and the pH adjusted to 7.5. FeCl3.6H20 
(0.83 g), ZnCl2 (84 mg), CuCl2.2H2O (13 mg), CoCl2.6H2O (10 mg), H3BO3 (10 mg) and 
MnCl2.4H2O (1.6 mg) were added and the final volume adjusted to 1 L with deionised water. 
The The solution was sterilized in an autoclave at 121 °C and stored at 4 °C. 
6.2.3.4 Preparation of AIM 
Tryptone (5.0 g), yeast extract (2.5 g), NaCl (5.0 g) and MgCl2 (0.5 g) were added into a 2L 
conical flask and made up to 0.5 L using deionised water. The solution was sterilized by 
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autoclave at 121 °C and allowed to cool to room temperature. AIM premix I (3.5 g) was 
weighed into sterile tube and added directly to the media. AIM premix II (10 mL) and trace 
element (500 µL) were added to the solution. The required antibiotic was added prior to use. 
6.2.4 Minimal (M9) media 
6.2.4.1 Preparation of M9 media 
Na2HPO4 (6.76 g), KH2PO4 (3.0 g) and NaCl (0.5 g) were added to 1 L of deionised water and 
sterilized by autoclave. After the solution is cooled, glucose (4.0 g), NH4Cl (1.0 g), 1 M MgSO4 
(2 mL), 1 M CaCl2 (100 L) and trace element (1 mL) were added to the sterile M9 salt solution. 
The required antibiotic was added under sterile condition immediately before use. 
6.2.4.2 Preparation of isotopically labelled media 
Na2HPO4 (6.76 g), KH2PO4 (3.0 g) and NaCl (0.5 g), 1 M MgSO4 (2 mL), 1 M CaCl2 (100 L) 
and trace element (1 mL) were added 0.9 L of deionised water. [15N, 98%] NH4Cl (1.0 g) and 
[13C6, 99%] glucose (4.0 g) were added and the volume taken to 1 L with deionised water. The 
media was sterilized by passing through a sterile 0.2 µm filter and stored at 4 °C. The required 
antibiotic was added under sterile condition immediately before use. 
6.2.5 Sterile solutions  
6.2.5.1 Ampicillin stock solution 
Ampicillin (400 mg) was dissolved in 4 mL deionised water to give a concentration of 100 
mg/mL. The solution was filtered with a sterile 0.2 µm syringe filter, aliquoted and stored at -
20 °C. 
6.2.5.2 Kanamycin solution 
Kanamycin (200 mg) was dissolved in 4 mL deionised water to give a concentration of 50 
mg/mL. The solution was filtered with a sterile 0.2 µm syringe filter, aliquoted and stored at -
20 °C. 
 
 
Materials and methods  
102 
 
6.2.5.3 Chloramphenicol solution 
Chloramphenicol (340 mg) was dissolved in 10 mL ethanol to give a concentration of 34 
mg/mL. The solution was filtered with a sterile 0.2 µm syringe filter, aliquoted and stored at -
20 °C. 
6.2.5.4 Isopropyl-β-D-1-thiogalactopyranoside (IPTG) solution 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) (360 mg) was dissolved in 3 mL deionised 
water to give a concentration of 120 mg/mL. The solution was filtered with a sterile 0.2 µm 
syringe filter, aliquoted and stored at -20 °C. 
6.2.5.5 50% (v/v) glycerol solution 
100 mL of glycerol was added to 100 mL deionised water to give 50% (v/v) solution of 
glycerol.  The solution was sterilized in an autoclave at 121 ᵒC for 20 minutes and stored at 4 
°C. 
6.3 DNA manipulation 
6.3.1 DNA visualization 
6.3.1.1 TAE buffer stock solution 
Tris base (242 g), glacial acetic acid (57.1 mL) and 100 mL EDTA (0.5 M, pH 8.0) were 
dissolved in 900 mL deionised water. The volume was taken to 1 L with deionised water. 
Immediately prior to use, the solution was diluted in a 1:49 ratio with deionised water. 
6.3.1.2 Agarose gel electrophoresis 
Agarose gels were prepared in a 1% agarose (w/v) ratio using dilute TAE buffer. The solution 
was preheated in a microwave for 2 min before pouring into a mould to set. 2 µL DNA green 
buffer (FastDigest buffer from ThermoFisher Scientific) was added to the DNA sample which 
was then loaded onto the gel. The run programme was set at a current of 80 mA for 1 hr before 
being placed in a dilute ethidium bromide solution for 10 minutes whilst shaking. The DNA 
bands were visualized using a Syngene GeneFlash UV light box (Syngene, Cambridge, UK) 
and compared to a molecular weight standard run on the same gel. 
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6.3.2 DNA extraction and purification 
6.3.2.1 DNA miniprep 
A single colony from an agar plate, or a spike from a glycerol stock, harbouring the required 
transformed plasmid was used to inoculate 10 mL of LB medium (with the appropriate 
antibiotic selection marker) and incubated overnight on a shaker at 37 °C. Cells were then 
harvested by centrifugation at 4000 rpm for 15 minutes. The QIAprep spin miniprep kit 
(QIAGEN, Crawley, UK) was used with EconoSpin All-in-1 mini spin columns (Epoch 
Biolabs, Inc, TX, USA) to purify the plasmid following the manufacturer’s protocol. 
6.3.2.2 Agarose gel DNA purification 
The required samples are subjected to agarose gel electrophoresis and the DNA visualized by 
staining with DNA Safe Stain from New England Biolab. The DNA bands were then visualized 
on a DNA lab view equipped with blue-led light and the appropriate DNA bands cut from the 
agarose gel using a razor blade. DNA was extracted from the agarose gel using QIAquick gel 
extraction kit (QIAGEN, Crawley, UK) with EconoSpin All-in-1 mini spin columns (Epoch 
Biolabs, Inc, TX, USA) following  the manufacturer’s protocol. 
6.3.3 Sub-cloning of gene  
6.3.3.1 Restriction digest of DNA 
Restriction enzymes NdeI/BamHI were employed to excise human DHFR (HsDHFR) gene  
from a pET21 (a) and similar treatment of the acceptor plasmid, pET(28a). The restriction 
digest was performed sequentially; first, NdeI was added to the required plasmid and incubated 
for 4 hours at 37 °C. NdeI was afterwards heat deactivated at 60 °C for 20 minutes before the 
addition of the BamHI which was activated for a further 4 hours at 37 °C. Restriction enzymes 
were removed via agarose gel purification. 
6.3.3.2 Ligation of DNA into expression vector 
Following successful restriction digest and agarose gel purification of HsDHFR gene and pET 
28(a) plasmid. The gene and the plasmid were ligated to form a new expression vector 
construct. Plasmid and gene in a 1:5 ratio were incubated with 2 µL T4 DNA ligase buffer and 
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sterile deionised water (sterilized by passing through a 22 µm syringe filter) in a volume of 20 
µL. 1 µL T4 DNA ligase was added and the ligation reaction incubated at 16 °C overnight. The 
reaction was immediately transformed into super-competent cells. The hexa-his tag region in 
the pET28 (a) was subsequently removed by overlapping primer site-directed mutagenesis 
method. 
6.3.4 Site-directed mutagenesis (SDM) 
Site-directed mutagenesis was used to delete, insert or alter DNA bases at specific location in a 
gene. Primer designs were based on established technique and a published strategy to aid 
exponential amplification of the desired plasmid sequence. For both type of primer design 
method, similar components (Table 6.2) and conditions  
Table 6.2. Components of the SDM reactions 
Components Volume (µL) 
dNTPs (40 mM total, 10 mM each NTP) 0.5 
Forward primer (62.5 ng/µL) 1 
Reverse primer (62.5 ng/µL) 1 
Template plasmid (5-15 ng/µL) 1 
pfU polymerase buffer + MgCl2 2.5 
Sterile dH2O Make up to 25 µL 
pfU polymerase (1 unit/ µL) 0.5 
 
Table 6.3. Conditions used for the SDM reactions 
Step Temperature (ᵒC) Time (min) 
Initial denaturation 96 3 
Denaturation* 
Annealing 
Elongation 
96 
60 
72 
1 
1 
2 per kilo bp 
Final Elongation 72 30 
*The denaturation, annealing and elongation step was cycled 16 times 
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6.3.4.1 Primer design 
Quick-change require the design of complementary primers following specific primer 
parameters published in the manufacturer’s manual. Specific primers (Table 6.4) are designed 
using this kit. Primers were designed with the appropriate mutation on each primer; however, 
each primer is also designed to overlap with the template.211 The overlapping region of the 
primer should have a melting temperature (Tm) of about 5 - 10 °C above the Tm of the 
complementary region between the primers. This method was used to design primers for 
deleting the hexa-histidine tag region of the HsDHFR gene ligated into pET 28(a). The yield 
from the SDM is exponential, hence could be successfully transformed into calcium competent 
cells.  
Table 6.4. Primers for Quikchange and overlapping site-directed mutagenesis technique 
Primer Sequence 
HsDHFR 
Del1 
5’ AGCCATCATAGCCATATGGTGGGTTCGCTGAATTGTATCGTC 3’, 
5’ CATATGGCTATGATGGCTGCTGCCGATGGTATATCTCCTTC 3’ 
HsDHFR 
Del2 
 
5' GAGATATACCATGGTGGGTTCGCTGAATTGTATCGTCGCCGTTTC 3' 
5' CAGCGAACCCACCATGGTATATCTCCTTCTTAAAGTTAAACAAAA 
TTATTTCTAGAGG 3' 
EcDHFR-
T46Cb 
5' GTGATTATGGGCCGCCATTGCTGGGAATCAATCGGTC 3' 
5' GACCGATTGATTCCCAGCAATGGCGGCCCATAATCAC 3' 
EcDHFR-
S148Pa 
5’ CAGAACCCTCACAGCTATTCTTTTGAGATTCTGG 3’ 
5’ CTGTGAGGGTTCTGCGCATCAGCATCGTG 3’ 
BsDHFR- 
C73Va 
5’ GAAGGCGTCCTGGTACTGCATAGCCTGGAAGAAGTG 3’ 
5’ GTACCAGGACGCCTTCCGGACGAAAGCTACGGTTC 3’ 
BsDHFR-
T46Ca 
5’ CGTAAATGCTTTGAAGCGATCGGGCGTCCGCT 3’ 
5’ CGCTTCAAAGCATTTACGACCCATTACAATGGCATGACC 3’ 
MpDHFR 
TAATAAa 
5’CGTGTTAAATAATAAGGATCCGAATTCGAGCTCCGTCGACAAGC 3’ 
5’CGGATCCTTATTATTTAACACGTTCCAGCAGCGAGAAGCGGTAATTG 
3’ 
MpDHFR-
C105Fa 
5’CTATAACCAATTTCTGGCAGCTGCGGACCGCCTGTACC 3’ 
5’CTGCCAGAAATTGGTTATAGATGGTTGCACCGCCGATAATCATC 3’ 
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Continued from previous page 
MpDHFR-
T47Ca 
5’ CGCAACTGCTTCGAAAGCATTGGTCGTCCGCTGCCG 3’ 
5’ GCTTTCGAAGCAGTTGCGACCCATCACAATCGGTTTGCCCA  3’ 
TmDHFR-
T47Cb 
5’CGTTGTGATGGGAAGAATCTGCTTCGAGGAAATAGGAAGACC 3’ 
5’GGTCTTCCTATTTCCTCGAAGCAGATTCTTCCCATCACAACG 3’ 
aOverlap SDM protocol employed and bStandard Quikchange mutagenesis protocols 
 
6.3.5 Transformation of DNA into competent cells 
The appropriate competent cells and plasmid DNA were thawed slowly on ice. 2 µL plasmid 
DNA solutions (5 – 10 µL in the case of SDM and ligation reactions) was mixed gently with 
the competent cells. The DNA/cell mixture was incubated on ice for at least 20 minutes, heat 
shocked at 42 °C for 45 seconds and returned to ice for at least 2 minutes. Non-selective LB 
medium (1 mL) was added to the DNA/cell mixture and incubated on a shaker at 37 °C for 1 
hr. Cells were harvested by centrifugation on bench top centrifuge (Eppendorf centrifuge 
5415R) for 1 minute at 13,000 rpm and the supernatant solution discarded. The cell pellet was 
re-suspended in 100 µL LB medium, plated on agar plates containing the appropriate antibiotic 
selection and incubated at 37 °C overnight in an oven. 
6.4 Gene Expression 
6.4.1 Production of unlabelled DHFRs 
6.4.1.1 IPTG induction 
E. coli cells containing a plasmid harbouring the target gene (picked directly from a plate or 
from glycerol stocks stored in the -80 °C freezer) were incubated overnight in antibiotic 
selective LB medium (10 – 100 mL) at 37 °C overnight in a shaker. This overnight culture was 
used to inoculate LB medium with the appropriate antibiotic (1 mL of culture per 100 mL of 
LB medium). The cultures were incubated at 37 °C until optical density of the medium reached 
0.6 at 600 nm. IPTG (0.5 – 1.0 mM) was added to the LB medium and incubated for the 
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required time and temperature (Table 6.5). The induced cells were harvested via centrifugation 
at 4000 rpm for 20 min. 
6.4.1.2 Auto-induction 
Cell culture preparation where similar to when IPTG is used for induction except the overnight 
culture are inoculated in AIM medium with the appropriate antibiotic (1 mL of culture per 100 
mL of AIM medium). After overnight growth the large-scale expression are carried out until 
OD600 is between 0.6 – 0.8. The shaker is then adjusted to the appropriate temperature and left 
for the required time. The induced cells were harvested via centrifugation at 4000 rpm for 20 
minutes. 
Table 6.5. Conditions for gene expression in E. coli 
DHFR 
E. coli expression 
strain 
Media for 
expression 
Induction 
temperature (°C) 
Time (hr) 
HsDHFR BL21 (DE3) IPTG (1.0 mM) 25 O/N 
EcDHFR BL21 (DE3) 
Auto-induction 25 
O/N 
IPTG (0.5 mM) 37 
TmDHFR 
BL21-CodonPlus 
(DE3)-RP 
IPTG (0.5 mM) 22 O/N 
MpDHFR BL21 (DE3) IPTG (0.5 mM) 16 O/N 
BsDHFR 
BL21–Star™ 
(DE3) 
Auto-induction 25 O/N 
 
6.4.2 Isotopically labelled enzymes 
Cells containing a plasmid harbouring the target gene (picked directly from a plate or from 
glycerol stocks stored in the -80 °C freezer) were incubated overnight in antibiotic selective M9 
medium (10 – 100 mL) at 37 °C overnight in a shaker. This overnight culture was used to 
inoculate M9 medium with the appropriate antibiotic (10 mL of culture per 100 mL of 
medium). The cultures were incubated at 37 °C until OD600 equal 0.8 – 0.9. IPTG (0.5 – 1.0 
mM) was added to the M9 medium and incubated for the required time and temperature. The 
induced cells were harvested via centrifugation at 4000 rpm for 20 minutes. The isotopically 
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labelled enzyme was produced with a similar protocol in M9 medium supplemented with heavy 
isotopes of glucose and NH4Cl. 
6.5 Enzyme purification 
6.5.1 Phosphate stock solutions 
6.5.1.1 1 M KH2PO4 
KH2PO4 (68.1 g) was added to 450 mL of deionised water. The volume was made up to 500 
mL and the solution stored at 4 °C. 
6.5.1.2 1 M K2HPO4 
K2HPO4 (87.1 g) was added to 450 mL of deionised water. The volume was made up to 500 
mL and the solution stored at 4 °C. 
6.5.2 Purification buffers 
6.5.2.1 Purification buffer A (Anion-exchange HsDHFR) 
Tris base (6.1 g) and ethylene diamine tetraacetate (EDTA, 1.86 g) were added to 900 mL of 
deionised water. The pH was adjusted to 8.5 using 6 M HCl and the total volume taken to 1 L 
with deionised water. The solution was filtered and degassed via vacuum pump (Vacuubrand 
GmbH + CO KG, MD4C, Werthein, Germany). β-mercaptoethanol (βME, 350 µL) was added 
to the solution to give a final concentration of 50 mM Tris, 5 mM EDTA and 5 mM βME. The 
solution was stored at room temperature. 
6.5.2.2 Purification buffer B (Anion-exchange HsDHFR) 
Tris base (6.1 g), NaCl (58.44 g) and EDTA (1.86 g) were added to 900 mL of deionised water. 
The pH was adjusted to 8.5 using 6 M HCl and the total volume taken to 1 L with deionised 
water. The solution was filtered and degassed via vacuum pump (Vacuubrand GmbH + CO 
KG, MD4C, Werthein, Germany). βME (350 µL) was added to the solution to give a final 
concentration of 50 mM Tris, 1 M NaCl, 5 mM EDTA and 5 mM βME. The solution was 
stored at room temperature. 
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6.5.2.3 Purification buffer C (Size exclusion HsDHFR) 
Tris base (6.1 g), KCl (7.44 g), paraaminobenzoyl glutamate (pABG, 0.399 g) and EDTA (1.86 
g) were added to 950 mL of deionised water. The pH was adjusted to 8.0 using 6 M HCl and 
the total volume taken to 1 L with deionised water. The solution was filtered and degassed via 
vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) 
was added to the solution to give a final concentration of 50 mM Tris, 100 mM KCl, 1.5 mM 
pABG, 5 mM EDTA and 5 mM βME. The solution was stored at room temperature. 
6.5.2.4 Purification buffer D (Anion-exchange EcDHFR) 
1 M KH2PO4 (19.5 mL), 1 M K2HPO4 (30.5 mL), NaCl (0.58 g) and EDTA (1.86 g) were 
added to 850 mL of deionised water. The pH was adjusted to 7.0 using 1 M NaOH and the total 
volume taken to 1 L with deionised water. The solution was filtered and degassed via vacuum 
pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) was added 
to the solution to give a final concentration of 50 mM potassium phosphate, 10 mM NaCl, 5 
mM EDTA and 5 mM βME. The solution was stored at room temperature. 
6.5.2.5 Purification buffer E (Anion-exchange EcDHFR) 
1 M KH2PO4 (19.5 mL), 1 M K2HPO4 (30.5 mL), NaCl (58.44 g) and EDTA (1.86 g) were 
added to 850 mL of deionised water. The pH was adjusted to 7.0 using 1 M NaOH and the total 
volume taken to 1 L with deionised water. The solution was filtered and degassed via vacuum 
pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) was added 
to the solution to give a final concentration of 50 mM potassium phosphate, 1 M NaCl, 5 mM 
EDTA and 5 mM βME. The solution was stored at room temperature. 
6.5.2.6 Purification buffer F (Size exclusion and IR buffer EcDHFR and BsDHFR) 
1 M KH2PO4 (19.5 mL), 1 M K2HPO4 (30.5 mL), NaCl (1.17 g) and EDTA (1.86 g) were 
added to 850 mL of deionised water. The pH was adjusted to 7.4 using 1 M NaOH and the total 
volume taken to 1 L with deionised water to give a final concentration of 50 mM potassium 
phosphate pH 7.4, 20 mM NaCl and 1 mM EDTA. The solution was filtered, degassed via 
vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany) and stored at room 
temperature. 
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6.5.2.7 Purification buffer G (Hydrophobic interaction TmDHFR) 
Sodium acetate (6.1 g), Na2SO4 (58.44 g) and EDTA (1.86 g) were added to 850 mL of 
deionised water. The pH was adjusted to 5.0 using glacial acetic acid and the total volume 
taken to 1 L with deionised water. The solution was filtered and degassed via vacuum pump 
(Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) was added to the 
solution to give a final concentration of 50 mM Na acetate, 1 M Na2SO4 pH 5.0, 5 mM EDTA 
and 5 mM βME. The solution was stored at room temperature. 
6.5.2.8 Purification buffer H (Hydrophobic interaction TmDHFR) 
Bis-tris propane (6.1 g) and ethylene diamine tetraacetate (EDTA, 1.86 g) were added to 950 
mL of deionised water. The pH was adjusted to 6.0 using 1 M HCl and the total volume taken 
to 1 L with deionised water. The solution was filtered and degassed via vacuum pump 
(Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). β-mercaptoethanol (βME, 350 
µL) was added to the solution to give a final concentration of 20 mM Bis-tris pH 6.0, 5 mM 
EDTA and 5 mM βME. The solution was stored at room temperature. 
6.5.2.9 Purification buffer I (Size exclusion and IR buffer TmDHFR) 
1 M KH2PO4 (58.5 mL), 1 M K2HPO4 (91.5 mL), NaCl (1.17 g) and EDTA (1.86 g) were 
added to 800 mL of deionised water. The pH was adjusted to 7.4 using 1 M NaOH and the total 
volume taken to 1 L with deionised water to give a final concentration of 150 mM potassium 
phosphate pH 7.4, 20 mM NaCl and 1 mM EDTA. The solution was filtered, degassed via 
vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany) and stored at room 
temperature. 
6.5.2.10 Purification buffer J (Anion-exchange MpDHFR) 
1 M KH2PO4 (7.8 mL), 1 M K2HPO4 (12.2 mL) and EDTA (1.86 g) were added to 850 mL of 
deionised water. The pH was adjusted to 7.0 using 1 M NaOH and the total volume taken to 1 
L with deionised water. The solution was filtered and degassed via vacuum pump (Vacuubrand 
GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) was added to the solution to 
give a final concentration of 20 mM potassium phosphate pH 7.0, 5 mM EDTA and 5 mM 
βME. The solution was stored at room temperature. 
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6.5.2.11 Purification buffer K (Anion-exchange MpDHFR) 
1 M KH2PO4 (7.8 mL), 1 M K2HPO4 (12.2 mL), NaCl (58.44 g) and EDTA (1.86 g) were 
added to 850 mL of deionised water. The pH was adjusted to 7.0 using 1 M NaOH and the total 
volume taken to 1 L with deionised water. The solution was filtered and degassed via vacuum 
pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). βME (350 µL) was added 
to the solution to give a final concentration of 20 mM potassium phosphate pH 7.0, 1 M NaCl, 
5 mM EDTA and 5 mM βME. The solution was stored at room temperature. 
6.5.2.12 Purification buffer L (Size exclusion and IR buffer MpDHFR) 
1 M KH2PO4 (7.8 mL), 1 M K2HPO4 (12.2 mL), NaCl (1.17 g) and EDTA (1.86 g) were added 
to 850 mL of deionised water. The pH was adjusted to 7.4 using 1 M NaOH and the total 
volume taken to 1 L with deionised water to give a final concentration of 20 mM potassium 
phosphate, 20 mM NaCl and 1 mM EDTA. The solution was filtered, degassed via vacuum 
pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany) and stored at room 
temperature. 
6.5.2.13 Purification buffer M (Anion-exchange BsDHFR) 
Tris base (6.1 g) and ethylene diamine tetraacetate (EDTA, 1.86 g) were added to 900 mL of 
deionised water. The pH was adjusted to 9.0 using 6 M HCl and the total volume taken to 1 L 
with deionised water. The solution was filtered and degassed via vacuum pump (Vacuubrand 
GmbH + CO KG, MD4C, Werthein, Germany). β-mercaptoethanol (βME, 350 µL) was added 
to the solution to give a final concentration of 50 mM Tris pH 9.0, 5 mM EDTA and 5 mM 
βME. The solution was stored at room temperature. 
6.5.2.14 Purification buffer N (Anion-exchange BsDHFR) 
Tris base (6.1 g), NaCl (58.44 g) and EDTA (1.86 g) were added to 900 mL of deionised water. 
The pH was adjusted to 9.0 using 6 M HCl and the total volume taken to 1 L with deionised 
water. The solution was filtered and degassed via a vacuum pump (Vacuubrand GmbH + CO 
KG, MD4C, Werthein, Germany). βME (350 µL) was added to the solution to give a final 
concentration of 50 mM Tris pH 9.0, 1 M NaCl, 5 mM EDTA and 5 mM βME. The solution 
was stored at room temperature. 
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6.5.2.15 Purification buffer O (Anion-exchange NADPD) 
Tris base (1.21 g) was dissolved in 400 mL of deionised water and the pH was adjusted to 9.0 
and the total volume taken 500 mL with deionised water to give a final concentration of 20 mM 
Tris. The buffer was filtered and degassed on a vacuum pump (Vacuubrand GmbH + CO KG, 
MD4C, Weithein, Germany) and stored at room temperature. 
6.5.2.16 Purification buffer P (Anion-exchange NADPD) 
Tris base (1.21 g) and NaCl (29.22 g) were dissolved in 400 mL of deionised water and the pH 
was adjusted to 9.0 and the total volume taken 500 mL with deionised water to give final 
concentration of 20 mM Tris and 1 M NaCl. The buffer was filtered and degassed on a vacuum 
pump (Vacuubrand GmbH + CO KG, MD4C, Weithein, Germany) and stored at room 
temperature. 
6.5.3 Purification methods 
6.5.3.1 Purification method for HsDHFR  
Frozen pellets of harvested HsDHFR cell expression (Section 6.4) were resuspended in pH 
adjusted purification buffer A (Section 6.5.2.1) with 2 mM pABG and 0.1 mM PMSF protease 
inhibitor (Melford).139 The suspension was lysed by sonication (pulse rate: 5 seconds, on cycle 
and 10 seconds, off cycle) for 15 minutes. The solution was clarified by centrifugation at 4 ᵒC, 
18,000 rpm for 30 minutes. The supernatant was passed through a 22 µm syringe filter before 
applying to a Q-sepharose column ( 70 mL CV) pre-equilibrated with buffer A. The flow-
through was collected and the column washed with 2 CV of buffer A until baseline absorbance 
was reached. A salt gradient was applied in two stages from 0.0 – 0.5 M NaCl (50% 
purification buffer B, section 6.5.2.2) over 2 CV followed by 0.5 – 1.0 M NaCl (100% buffer 
L) over 1 CV. Fractions were collected (12 mL) and the absorbance monitored at 280 nm. All 
fractions were analysed by SDS-PAGE and DHFR activity assay.  
The fractions containing the target protein were concentrated to 10 mL on 10,000 Da 
membrane using Amicon ultrafiltration device. The concentrated sample was applied to a 
Superdex75 (26/260) column pre-equilibrated with buffer C (Section 6.5.2.3). The fractions 
Materials and methods  
113 
 
collected (10 mL) were analysed by SDS-PAGE and activity assay of DHFR to identify the 
fractions containing HsDHFR due to high absorptivity of pABG at 280 nm. Protein 
concentration was determined by Bicinchoninic acid assay method (Section 6.8.1). 
6.5.3.2 Purification method for EcDHFR 
Frozen pellets of harvested EcDHFR cell expression (Section 6.4) were resuspended in buffer 
D (Section 6.5.2.4). The suspension was lysed by sonication (pulse rate: 5 seconds, on cycle 
and 10 seconds, off cycle) for 15 minutes. The solution was clarified by centrifugation at 4 ᵒC, 
18,000 rpm for 30 minutes. The supernatant was passed through a 22 µm syringe filter before 
applying to a Q-sepharose column ( 70 mL CV) pre-equilibrated with buffer D. The flow-
through was collected and the column washed with 2 CV of buffer D until baseline absorbance 
was reached. A salt step of 0.2 M (20% purification buffer E, section 6.5.2.5) over 2.5 CV 
followed by 2 stages of salt gradient from 0.2 M – 0.5 M NaCl (50% purification buffer E) over 
2 CV then 0.5 – 1.0 M NaCl (100% buffer E) over 1 CV. Fractions were collected (12 mL) and 
the absorbance monitored at 280 nm. All fractions were analysed by SDS-PAGE and DHFR 
activity assay.  
The fractions containing the target protein were concentrated to 10 mL on 10,000 Da 
membrane using Amicon ultrafiltration device. The concentrated sample was applied to a 
Superdex75 (26/260) ( 320 mL) column pre-equilibrated with buffer F for FTIR experimental 
samples (Section 6.5.2.6) . Fractions of 10 mL were collected over 1.5 CV and analysed by 
both SDS-PAGE and activity assay of DHFR to identify the fractions containing EcDHFR.  
6.5.3.3 Purification method for TmDHFR 
Frozen pellets of harvested TmDHFR cell expression (Section 6.4) were resuspended in buffer 
G (Section 6.5.2.7). DNase solution (1 µg/mL) and RNase (1 µg/mL) were added to the lysis 
buffer. The suspension was lysed by sonication (pulse rate: 5 seconds, on cycle and 10 seconds, 
off cycle) for 15 minutes. The solution was heated at 37 ᵒC for 30 minutes and heat shocked at 
75 ᵒC for 30 minutes on a water bath to precipitate E. coli proteins. The suspension was then 
clarified by centrifugation at 4 ᵒC, 18,000 rpm for 30 minutes. The supernatant was passed 
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through a 22 µm syringe filter before applying to a phenyl Sepharose column ( 15 mL CV) 
pre-equilibrated with buffer G. The flow-through was collected and the column washed with 8 
CV of binding buffer G before elution with 6 CV of buffer H (section 6.5.2.8) applied 1 CV at 
a time. Fractions were collected (20 mL) before being analysed by SDS-PAGE and DHFR 
activity assay.  
The fractions containing the target protein were concentrated to   ̴10 mL on 10,000 Da 
membrane using Amicon ultrafiltration device at room temperature. The concentrated sample 
was applied to a Superdex75 (26/260) ( 320 mL) column pre-equilibrated with buffer I 
(Section 6.5.2.9). Fractions of 10 mL were collected over 1.5 CV and analysed by both SDS-
PAGE and activity assay of DHFR to identify the fractions containing TmDHFR.  
6.5.3.4 Purification method for MpDHFR 
Frozen pellets of harvested MpDHFR cell expression (Section 6.4) were resuspended in buffer 
J (Section 6.5.2.10). The suspension was lysed by sonication (pulse rate: 5 seconds, on cycle 
and 10 seconds, off cycle) for 15 minutes. The solution was clarified by centrifugation at 4 °C, 
18,000 rpm for 30 minutes. The supernatant was passed through a 22 µm syringe filter before 
applying to a Q-sepharose column ( 70 mL CV) pre-equilibrated with buffer J. The flow-
through was collected and the column washed with 2 CV of buffer J until baseline absorbance 
was reached. Salt gradient were applied in two stages from 0.0 M – 0.5 M NaCl (50% 
purification buffer K, section 6.5.2.11) over 4 CV then 0.5 – 1.0 M NaCl (100% buffer K) over 
1 CV. Fractions were collected (12 mL) and the absorbance monitored at 280 nm. All fractions 
were analysed by SDS-PAGE and DHFR activity assay.  
The fractions containing the target protein were concentrated to 10 mL on 10,000 Da 
membrane using Amicon ultrafiltration device. The concentrated sample was applied to a 
Superdex75 (26/260) ( 320 mL) column pre-equilibrated with buffer L (Section 6.5.2.12). 
Fractions of 10 mL were collected over 1.5 CV and analysed by both SDS-PAGE and activity 
assay of DHFR to identify the fractions containing MpDHFR.  
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6.5.3.5 Purification method for BsDHFR 
Frozen pellets of harvested BsDHFR cell expression (Section 6.4) were resuspended in buffer 
M (Section 6.5.2.13). The suspension was lysed by sonication (pulse rate: 5 seconds, on cycle 
and 10 seconds, off cycle) for 15 minutes. The solution was heat shocked at 55 ᵒC for 30 
minutes on a water bath to precipitate E. coli proteins. The solution was clarified by 
centrifugation at 4 ᵒC, 18,000 rpm for 30 minutes. The supernatant was passed through a 22 µm 
syringe filter before applying to a DEAE column ( 50 mL CV) pre-equilibrated with buffer M. 
The flow-through was collected and the column washed with 2 CV of buffer M until baseline 
absorbance was reached. Salt gradient were applied in two stages from 0.0 M – 0.5 M NaCl 
(50% purification buffer N, section 6.5.2.14) over 4 CV then 0.5 – 1.0 M NaCl (100% buffer 
N) over 1 CV. Fractions were collected (12 mL) and the absorbance monitored at 280 nm. All 
fractions were analysed by SDS-PAGE and DHFR activity assay.  
The fractions containing the target protein were concentrated to 10 mL on 10,000 Da 
membrane using Amicon ultrafiltration device. The concentrated sample was applied to a 
Superdex75 (26/260) ( 320 mL) column pre-equilibrated with buffer F (Section 6.5.2.6). 
Fractions of 10 mL were collected over 1.5 CV and analysed by both SDS-PAGE and activity 
assay of DHFR to identify the fractions containing BsDHFR. 
6.6 Ligand synthesis and purification 
6.6.1 Dihydrofolate (DHF) 
Folic acid (400 mg) was dissolved in a minimal volume of 5 M NaOH and added to 80 mL of 
10% L-ascorbic acid solution (pH 6.0). The pH of the solution was readjusted to 6.0 if a change 
in pH occurred due to the mixture. The mixture was stirred under N2 and sodium dithionite (4.4 
g) added. The reaction was cooled on ice for 5 minutes and the pH slowly lowered to 2.8 by the 
addition of 1 M HCl. The mixture was centrifuged at 4, 4000 rpm for 10 minutes. The above 
step was repeated by dissolving the pellet in 80 mL of 10% L-ascorbic acid. After which the 
pellet was re-suspended in acetone (20 mL), purged with N2 and re-centrifuged. The washing 
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step and centrifugation was repeated once more with acetone and then with diethyl ether. The 
product was dried with N2 and stored at -20 °C in a N2 purged, foil wrapped container. 
6.6.2 Synthesis, purification and storage of (R)-[4-2H]-NADPH 
Thermoanaerobacter brockii ADH (1 mg) and NADP+ (7 mg) were dissolved in purification 
buffer O (2 mL, section 6.5.2.15) and d8-2H-isopropanol (0.2 mL) was added. The reaction 
mixture was incubated at 40 for 10 minutes and loaded onto a SAX10 (4X250 mm) anion 
exchange column equilibrated with purification buffer M. Salt (NaCl) gradient was applied 
from 0.0 -1.0 M (100% purification buffer P, section 6.5.2.16) over 30 mins. Absorbance at 260 
and 340 nm were monitored, and fractions collected when absorbance at 340 nm increased. 
DHFR assay method was used to ascertain the eluted NADPD. The fractions containing the 
heavy cofactor were pooled, aliquoted, lyophilized and stored at -80 °C. 
6.7 SDS-PAGE 
6.7.1 Resolving buffer 
Tris base (27.23 g) was dissolved in 80 mL of deionised water and the pH adjusted to 8.8. The 
final volume was taken to 150 mL. 
6.7.2 Stacking buffer 
Tris base (6.0 g) was dissolved in 80 mL of deionised water and the pH adjusted to 6.8. The 
final volume was taken to 150 mL. 
6.7.3 SDS sample loading buffer 
Tris base (6.0 g) was dissolved in 80 mL of deionised water and the pH adjusted to 6.8. The 
final volume was taken to 150 mL. 
6.7.4 Running buffer stock 
Tris base (30.3 g), glycine (144.0 g) and SDS (10.0 g) were dissolved in 900 mL of deionised 
water. The final volume was taken to 1 L with deionised water. Buffer was diluted 1: 9 with 
deionised water prior to use. 
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6.7.5 SDS staining buffer 
Coomassie Blue G250 (110 mg) was dissolved in ethanol (10 mL) and the volume taken to 900 
mL with deionised water. The solution was acidified with concentrated HCl (4 mL) and the 
final volume was taken to 1 L with deionised water.  
6.7.6 Resolving gel (12%) 
30% acrylamide/bis-acrylamide (4 mL), resolving buffer (2.5 mL, section 6.6.1), 10% (w/v) 
SDS (100 µL) and deionised water (3.4 mL) were mixed together. Immediately prior to 
pouring, freshly made 10% ammonium persulfate (APS, 100 µL) and N,N,N’,N’-
tetramethylenediamine (TEMED, 20 µL) were added and the solution gently mixed to initiate 
polymerisation. 
6.7.7 Stacking gel (5.0%) 
30% acrylamide/bis-acrylamide (0.83 mL), resolving buffer (1.25 mL, section 6.6.1), 10% 
(w/v) SDS (50 µL) and deionised water (2.85 mL) were mixed together. Immediately prior to 
pouring, freshly made 10% ammonium persulfate (APS, 50 µL) and N,N,N’,N’-
tetramethylenediamine (TEMED, 10 µL) were added and the solution gently mixed to initiate 
polymerisation. 
6.7.8 SDS-PAGE protocol 
The resolving gel was prepared (Section 6.6.6) and poured into an SDS-PAGE mould up to 
90% and allowed to polymerise.  Stacking gel was also prepared (section 6.6.7) and poured. A 
comb was inserted to create loading wells. Fraction samples (10 µL) were incubated with 
sample loading buffer (Section 6.6.3) for 10 minutes at 85 and loaded onto the gel. Running 
buffer (section 6.6.4) was added and gel allowed to run at 160V for 50 minutes. The gel was 
washed twice with water after heating in the microwave for 1 minute. Preheated SDS staining 
buffer (section 6.6.5) was then applied to the gel and the protein bands were visualized using a 
Syngene Gene Flash UV light box (Syngene, Cambridge, UK). The bands were compared to a 
protein standard run on the same gel. 
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6.8 Protein concentration 
6.8.1 Bicinchoninic acid (BCA) assay  
BCA assay is used to determine the total level of protein in a solution. In this assay, two 
molecules of bicinchoninic acid chelate a single Cu+ ion, forming a purple water-soluble 
complex that strongly absorbs light at 562 nm. Unlike Bradford assay, the protein backbone 
contributes to absorption intensity alongside cysteine, tryptophan and tyrosine residues. The 
reactions are measured using plate reader. 
6.8.2 UV/Vis spectrophotometer 
Filtered and degassed potassium phosphate (50 mM, pH 7.0) was used. The Beer-Lambert law 
was used to calculate the concentration (mg mL-1) of all the protein solution using Shimadzu 
UV/Vis spectrophotometer: 
   (6.1) 
where A = absorbance at the given wavelength, ε = the extinction coefficient, c = concentration 
of the sample and I = the pathlength of the cuvette (cm). Average extinction coefficients for 
proteins at 210, 215 and 220 nm (ε = 20, 15, 11 mL mg-1 cm-1 respectively) were used.  The 
concentration in mg mL was divided by the molecular weight of the protein ( 18,000 g mol-1), 
to give a molar concentration) 
The absorbance of the protein samples was also determined at 280 nm and used in combination 
with the previously calculated enzyme concentration to determine the extinction coefficient of 
the enzyme at 280 nm using the Beer-Lambert equation. 
  (6.2) 
Due to the higher extinction coefficient of enzymes at 210, 215 and 220 nm, the calculated 
extinction coefficient of the enzyme was used to determine the enzyme concentration at 280 nm 
using Shimadzu UV/Vis spectrophotometer. 
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Table 6.6. Extinction coefficients employed to calculate the concentration of DHFRs measured at 280 
nm 
Enzymes 
Approximate extinction 
coefficient at 280 nm 
EcDHFR 31,117 
TmDHFR 30,008 
MpDHFR 26,032 
BsDHFR 24,095 
 
6.9 Protein characterisation 
6.9.1 Assay buffer 
1 M K2HPO4 (12.3 mL), 1 M KH2PO4 (7.7 mL), NaCl (1.17 g) were added to 150 mL 
deionised water. The pH was adjusted to 7.0 and the total volume taken to 200 mL to give a 
final concentration of 50 mM potassium phosphate pH 7.0 and 100 mM NaCl. The solution 
was filtered and degassed via vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, 
Germany). The solution was stored at room temperature. 
6.9.2 Steady-state 
Steady state turnover numbers (kcat) were measured under saturating conditions by 
monitoring the linear decrease in the absorbance of the reduced cofactor NADPH at 340 
nm with time via UV spectroscopy. For all the steady state kinetics reported in this work, 
8-50 nM DHFR was incubated with NADPH/NADPD (100 M) in the appropriate assay 
buffer for 60 seconds at the experimental temperature, to avoid hysteresis,
 
prior to the 
addition of DHF (100 M) to initiate the reaction.  
6.9.3 Michaelis-Menten constant (KM) measurement 
Michaelis constants were measured following the same method as kcat (Section 6.9.2), except 
that an enzyme concentration of 10-20 nM was used. The concentration of NADPH was varied 
from 0.1 to 200 µM, and of the concentration of DHF was varied from 0.1 to 100 µM. When 
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the concentration of one substrate was varied, that of the other was maintained at 100 µM. Each 
data point is the result of three independent measurements. The Michaelis-Menten equation 
was fit to the change in initial rate with concentration using SigmaPlot 10. 
6.9.4 Stopped-flow (pre-steady state) measurement 
Pre-steady state kinetic experiments were performed on Hi-Tech TgK stopped-flow 
spectrophotometer. Hydride transfer rate constants were measured following the fluorescence 
resonance energy transfer from the protein to the reduced cofactor NADPH. The reaction 
mixture was excited at 292 nm and the emission was measured using an output filter with a cut-
off at 400 nm. DHFR (20-40 μM syringe concentration) was incubated with NADPH or 
NADPD (10-20 μM) at the experimental temperature for at least 3 minutes to avoid hysteresis. 
Then the reaction was started by rapidly mixing with an equal volume of dihydrofolate (200-
400 μM). 
6.9.5 CD 
All circular dichroism spectroscopy was carried out using a Chirascan
TM 
spectrometer 
(Applied Photophysics Limited, UK).  
5 mM potassium phosphate buffer (pH 7) was used to record the thermal melting temperature 
of the various enzymes used. The buffer was sterilised with a 0.2 μm syringe filter and 
degassed via vacuum pump. A blank run was always taken of the buffer alone before starting 
the experiment. 
The signal obtained from CD experiments was converted into mean residue ellipticity (MRE) 
using: 
MRE =  / 10.n.c.l (6.3) 
where:  = CD signal in millideg, n = number of backbone peptide bonds (i.e. number of 
amino acid residues - 1), c = molar concentration of sample, and l = pathlength of cuvette used 
in cm. Typically a 1 mm pathlength cuvette was used to monitor the CD spectrum of DHFR 
from 190-400 nm using ~10 μM enzyme. 
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6.10 Thiocyanate Labelling 
6.10.1 Enzyme thiocyanate (SCN) labelling  
Each enzyme containing a single cysteine residue was labelled using NTCB 1.1 molar 
equivalence and the release of 2-nitro-5-thiobenzoate (TNB) anion at spectrophotometer 
absorbance at 412 nm. However, in the second step 12 mM KCN was used to wash the enzyme 
three times with concentration step after each wash. Excess labelling reagent and TNB anions 
were removed by passing the labelled enzyme through Sephadex G-25 column pre-equilibrated 
with appropriate purification buffer (purification buffer F, I and L for EcDHFR/BsDHFR, 
TmDHFR and MpDHFR, respectively). Thiocyanate labelled enzyme were concentrated to 1.5 
– 4 mM for FTIR measurements. Enzyme labelling was confirmed by ESI-MS due to a mass 
increase of 25 Da (See Appendix III, Figure A12 – A22). 
 
Figure 6.1. Scheme for the post-translational modification of cysteine residues to produce nitrile 
labelled enzyme. 
6.10.2 Enzyme 13C-thiocyanate (S13CN) labelling  
The 13C-thiocynate labelling was carried out in similar manner to the natural abundance 
thiocyanate labelling. However, 5, 5’-dithiobis-2-nitrobenzoic acid (DNTB) was used and 
K13CN was finally used to cleave the mixed disulphide to give 13C-labelled thiocyanate. 
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6.10.3 Fourier Transform Infrared spectroscopy (FTIR) 
Approximately 2.0 – 4.0 mM of the enzymes (EcDHFRcf T46C-CN, EcDHFRcf S148P/T46C-
CN, BsDHFRcf T46C-CN, MpDHFRcf T47C-CN, TmDHFR T47C-CN) were employed to 
measure the vibrational frequency of the probe in the apoenzyme, holoenzyme (E:NADPH), 
Michaelis complex mimic (E:folate:NADP+) and the product ternary complex (E:THF:NADP+) 
similar to previous studies.99,120 Ten-fold excess of the ligands were equilibrated with the 
enzymes to form the complexes. The samples were purged under nitrogen prior to 
measurements and the temperature of the samples were kept constant at 20 °C by connecting 
the liquid cell to a thermocycler (water bath). Each spectrum was composed of 2000 scans at 1 
cm-1 spectra resolution and the peak of the absorption was obtained as the average of second 
derivative processing, first derivative processing and Gaussian fit of the background-subtracted 
spectra using Origin 9.0, OriginLab software (See Appendix III, Figure A23 - A24). 
Uncertainty in absorption energy is reported as the standard deviation of at least two 
independent measurements. 
6.10.4 Nuclear magnetic resonance spectroscopy (NMR) 
The NMR spectroscopy samples were prepared according to previous report with 2.0 mM of 
labelled protein, 10 mM ligands with 2.5 mM of 3-(trimethylsilyl)-1-propanesulfonic acid 
sodium salt as external standard. Each sample was purged with nitrogen and protected from 
light before measurement on a Varian INOVA-600 NMR. 
6.10.5 Errors and propagations 
The errors in this work are reported as the standard error of the mean (M) as in Equation 6.4 
which is defined as the standard deviation (Equation 6.5) of the values in the sample divided by 
the square root of the sample size. 
    (6.4) 
Where X is each value measured in the sample, M is the mean of the sample and n is the 
sample size 
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   (6.5 
6.10.5.1 Propagations of errors 
In this thesis the effect of the uncertainty of values directly measured experimentally (X or Y) 
on the uncertainty of a function based up on them (Z) was calculated using Equations 6.6-9. 
The equation used is dependent on the treatment of X and Y in order to obtain the value of Z. 
If Z = X + Y or Z = X – Y then  
    (6.6) 
If Z = X * Y or Z = X/Y then 
   (6.7) 
 
If Y = In X then 
     (6.8) 
Y = eX  then 
    (6.9) 
where X and Y are independently measured values,  and  are their errors or uncertainty, 
and Z is the calculated value and  is its propagated error. 
References  
124 
 
References 
1. Quinn, D. M. & Sikorski, R. S. Enzymatic Rate Enhancements. Wiley, John Wiley & 
Sons, Ltd. eLS 1–7 (2014).  
2. Kazemi, M., Himo, F. & Åqvist, J. Enzyme catalysis by entropy without Circe effect. 
Proc. Natl. Acad. Sci. 113, 2406–2411 (2016). 
3. Fried, S. D. & Boxer, S. G. Electric Fields and Enzyme Catalysis. Annu. Rev. Biochem. 
86, 387–415 (2017). 
4. Garcia-Viloca, M., Gao, J., Karplus, M. & Truhlar, D. G. How Enzymes Work: Analysis 
by Modern Rate Theory and Computer Simulations. Science (80). 303, 186–195 (2004). 
5. Wolfenden, R. Transition state analogues for enzyme catalysis. Nature 223, 704–705 
(1969). 
6. Kamerlin, S. C. L. & Warshel, A. At the dawn of the 21st century: Is dynamics the 
missing link for understanding enzyme catalysis. Proteins Struct. Funct. Bioinforma. 78, 
1339–1375 (2010). 
7. Luk, L. Y. P., Loveridge, E. J. & Allemann, R. K. Protein motions and dynamic effects 
in enzyme catalysis. Phys. Chem. Chem. Phys. 17, 30817–30827 (2015). 
8. Lichtenthaler, F. W. 100 Years Schlussel-Schloss-Prinzip: What Made Emil Fischer Use 
this Analogy? Angew. Chemie Int. Ed. English 33, 2364–2374 (1995). 
9. Pauling, L. Molecular Architecture and Biological Reactions. Chem. Eng. News 24, 
1375–1377 (1946). 
10. Koshland, D. E. The Key-Lock Theory and the Induced Fit Theory. Angew. Chemie Int. 
Ed. 33, 2375–2378 (1995). 
11. Klinman, J. P. & Kohen, A. Hydrogen tunneling links protein dynamics to enzyme 
catalysis. Annu. Rev. Biochem. 82, 471–96 (2013). 
12. Francis, K., Stojković, V. & Kohen, A. Preservation of protein dynamics in 
References  
125 
 
dihydrofolate reductase evolution. J. Biol. Chem. 288, 35961–35968 (2013). 
13. Sutcliffe, M. J. & Scrutton, N. S. A new conceptual framework for enzyme catalysis: 
Hydrogen tunneling coupled to enzyme dynamics in flavoprotein and quinoprotein 
enzymes. Eur. J. Biochem. 269, 3096–3102 (2002). 
14. Hammes-Schiffer, S. & Benkovic, S. J. Relating protein motion to catalysis. Annu. Rev. 
Biochem. 75, 519–541 (2006). 
15. Hanoian, P., Liu, C. T., Hammes-Schiffer, S. & Benkovic, S. Perspectives on 
electrostatics and conformational motions in enzyme catalysis. Acc. Chem. Res. 48, 482–
489 (2015). 
16. Pu, J., Gao, J. & Truhlar, D. G. Multidimensional tunneling, recrossing, and the 
transmission coefficient for enzymatic reactions. Chem. Rev. 106, 3140–3169 (2006). 
17. Singh, P., Abeysinghe, T. & Kohen, A. Linking Protein Motion to Enzyme Catalysis. 4, 
1192–1209 (2011). 
18. Hammes, G. G., Benkovic, S. J. & Hammes-Schiffer, S. Flexibility, diversity, and 
cooperativity: Pillars of enzyme catalysis. Biochemistry 50, 10422–10430 (2011). 
19. Kohen, A. Kinetic Isotope Effects as Probes for Hydrogen Tunneling in Enzyme 
Catalysis. Prog. React. Kinet. Mech. 28, 119–156 (2003). 
20. Fenwick, R. B., Esteban-Martín, S. & Salvatella, X. Understanding biomolecular 
motion, recognition, and allostery by use of conformational ensembles. Eur. Biophys. J. 
40, 1339–1355 (2011). 
21. Toney, M. D., Castro, J. N. & Addington, T. A. Heavy-Enzyme Kinetic Isotope Effects 
on Proton Transfer in Alanine Racemase. J. Am. Chem. Soc. 135, 2509–2511 (2013). 
22. Gutteridge, A. & Thornton, J. Conformational change in substrate binding, catalysis and 
product release: An open and shut case? FEBS Letters 567, 67–73 (2004). 
23. Joel Loveridge, E., Allemann, R. K., Loveridge, E. J. & Allemann, R. K. Chapter 8. 
Direct Methods for the Analysis of Quantum-Mechanical Tunnelling: Dihydrofolate 
Reductase. in Quantum Tunnelling in Enzyme-Catalysed Reactions 179–198 (2009).  
References  
126 
 
24. Sassa, A., Beard, W. A., Shock, D. D. & Wilson, S. H. Steady-state, Pre-steady-state, 
and Single-turnover Kinetic Measurement for DNA Glycosylase Activity. J. Vis. Exp. 1–
9 (2013).  
25. Bhabha, G. et al. A Dynamic Knockout Reveals That Conformational Fluctuations 
Influence the Chemical Step of Enzyme Catalysis. Science (80). 332, 234–238 (2011). 
26. Northrop, D. B. The Expression of Kinetic Isotope Effects during the Time Course of 
Enzyme-Catalyzed Reactions. 193, 177–193 (1989). 
27. Meek, S. J., Pitman, C. L. & Miller, A. J. M. Deducing Reaction Mechanism: A Guide 
for Students, Researchers, and Instructors. J. Chem. Educ. 93, 275–286 (2016). 
28. Roston, D., Islam, Z. & Kohen, A. Isotope effects as probes for enzyme catalyzed 
hydrogen-transfer reactions. Molecules 18, 5543–5567 (2013). 
29. McMahon, R. J. Chemistry: Chemical reactions involving quantum tunneling. Science 
299, 833–834 (2003). 
30. Kohen, A. & Klinman, J. P. Enzyme catalysis: Beyond Classical paradigms. Acc. Chem. 
Res. 31, 397–404 (1998). 
31. Sutcliffe, M. J. & Scrutton, N. S. Enzymology takes a quantum leap forward. Philos. 
Trans. R. Soc. A Math. Phys. Eng. Sci. 358, 367–386 (2000). 
32. Bell, R. P. & Le Roy, R. J. The Tunnel Effect in Chemistry. Phys. Today 35, 85–86 
(2008). 
33. Klinman, J. P. The role of tunneling in enzyme catalysis of C–H activation. Biochim. 
Biophys. Acta - Bioenerg. 1757, 981–987 (2006). 
34. Olsson, M. H. M., Parson, W. W. & Warshel, A. Dynamical contributions to enzyme 
catalysis: Critical tests of a popular hypothesis. Chemical Reviews 106, 1737–1756 
(2006). 
35. Roston, D., Cheatum, C. M. & Kohen, A. Hydrogen Donor − Acceptor Fluctuations 
from Kinetic Isotope Effects: A Phenomenological Model. Biochemistry 51, 6860–6870 
(2012). 
References  
127 
 
36. Roston, D., Islam, Z. & Kohen, A. Kinetic isotope effects as a probe of hydrogen 
transfers to and from common enzymatic cofactors. Archives of Biochemistry and 
Biophysics 544, 96–104 (2014). 
37. Pudney, C. R. et al. Fast protein motions are coupled to enzyme H-transfer reactions. J. 
Am. Chem. Soc. 135, 2512–2517 (2013). 
38. Masterson, J. E. & Schwartz, S. D. Evolution alters the enzymatic reaction coordinate of 
dihydrofolate reductase. J. Phys. Chem. B 119, 989–996 (2015). 
39. Loveridge, E. J., Evans, R. M. & Allemann, R. K. Solvent Effects on Environmentally 
Coupled Hydrogen Tunnelling During Catalysis by Dihydrofolate Reductase from 
Thermotoga maritima. Chem. - A Eur. J. 14, 10782–10788 (2008). 
40. Warshel, A. & Bora, R. P. Perspective: Defining and quantifying the role of dynamics in 
enzyme catalysis. J. Chem. Phys. 144, 180-901 (2016). 
41. Masgrau, L. & Truhlar, D. G. The importance of ensemble averaging in enzyme kinetics. 
Accounts of Chemical Research 48, 431–438 (2015). 
42. Zinovjev, K. & Tuñón, I. Quantifying the limits of transition state theory in enzymatic 
catalysis. Proc. Natl. Acad. Sci. 114, 12390–12395 (2017). 
43. Katarzyna, S., Javier, R.-P. J., Vicent, M. & Inaki, T. Heavy enzymes-experimental and 
computational insights in enzyme dynamics. Curr. Opin. Chem. Biol. 21, 11–18 (2014). 
44. Behiry, E. M. et al. Isotope Substitution of Promiscuous Alcohol Dehydrogenase 
Reveals the Origin of Substrate Preference in the Transition State. Angew. Chemie - Int. 
Ed. 57, 3128–3131 (2018). 
45. Ruiz-Pernía, J. J. et al. Minimization of dynamic effects in the evolution of dihydrofolate 
reductase. Chem. Sci. 7, 3248–3255 (2016). 
46. Kipp, D. R., Silva, R. G. & Schramm, V. L. Mass-dependent bond vibrational dynamics 
influence catalysis by HIV-1 protease. J. Am. Chem. Soc. 133, 19358–19361 (2011). 
47. Ranasinghe, C. et al. Protein Mass Effects on Formate Dehydrogenase. J. Am. Chem. 
Soc. 139, 17405–17413 (2017). 
References  
128 
 
48. Kholodar, S. A., Ghosh, A. K. & Kohen, A. Measurement of isotope effects. in Methods 
of enzymology 596, 43–77 (Elsevier Inc., 2017). 
49. Thielges, M., Case, D. A. & Romesberg, F. E. Carbon− Deuterium Bonds as Probes of 
Dihydrofolate Reductase. J. Am. Chem. Soc. 130, 6597–6603 (2008). 
50. Groff, D., Thielges, M. C., Cellitti, S., Schultz, P. G. & Romesberg, F. E. Efforts toward 
the direct experimental characterization of enzyme microenvironments: tyrosine100 in 
dihydrofolate reductase. Angew. Chemie Int. Ed. 48, 3478–3481 (2009). 
51. Liu, C. T. et al. Probing the electrostatics of active site microenvironments along the 
catalytic cycle for escherichia coli dihydrofolate reductase. J. Am. Chem. Soc. 136, 
10349–10360 (2014). 
52. Bublitz, G. U. & Boxer, S. G. Stark spectroscopy: applications in chemistry, biology, 
and materials science. Annu. Rev. Phys. Chem. 48, 213–242 (1997). 
53. Adhikary, R., Zimmermann, J. & Romesberg, F. E. Transparent Window Vibrational 
Probes for the Characterization of Proteins With High Structural and Temporal 
Resolution. Chem. Rev. 117, 1927–1969 (2017). 
54. Silverman, L. N., Pitzer, M. E., Ankomah, P. O., Boxer, S. G. & Fenlon, E. E. 
Vibrational stark effect probes for nucleic acids. J. Phys. Chem. B 111, 11611–11613 
(2007). 
55. Günzler, H. & Williams, A. Handbook of Analytical Techniques. Handbook of 
Analytical Techniques 1–2, (2008). 
56. Fabian, H. & Mäntele, W. Infrared Spectroscopy of Proteins Biochemical Applications 
Infrared Spectroscopy of Proteins. Handb. Vib. Spectrosc. (2006).  
57. Stuart, B. Infrared Spectroscopy: Fundamentals and Applications. Wiley (John Wiley & 
Sons, Ltd, 2004).  
58. Coleman, W. F. & Lim, K. F. The effect of anharmonicity on diatomic vibration: A 
spreadsheet simulation. J. Chem. Educ. 82, 126-133 (2005). 
59. Theophanides, T. Introduction to Infrared Spectroscopy. Infrared Spectrosc. - Mater. 
References  
129 
 
Sci. Eng. Technol. 1–10 (2012).  
60. Werner, H. & Gronholz, J. Understanding FT-IR Data Processing. Part 1: Data 
Acquisition and Fourier Transformation. Comput. Appl. Lab. 2, 216–220 (1984). 
61. Gemini Spectra Sciences. FTIR Gas Analysis. Available at: 
http://www.gascell.com/htmls/direct3a.htm.  
62. Neves-Petersen, M. T. & Petersen, S. B. Protein electrostatics: A review of the equations 
and methods used to model electrostatic equations in biomolecules - Applications in 
biotechnology. Biotechnol. Annu. Rev. 9, 315–395 (2003). 
63. Simonson, T. Electrostatics and dynamics of proteins. Reports Prog. Phys. 66, 737–787 
(2003). 
64. Bublitz, G. U., Ortiz, R., Marder, S. R. & Boxer, S. G. Stark spectroscopy of 
donor/acceptor substituted polyenes. J. Am. Chem. Soc. 119, 3365–3376 (1997). 
65. Park, E. S., Andrews, S. S., Hu, R. B. & Boxer, S. G. Vibrational Stark Spectroscopy in 
Proteins: A Probe and Calibration for Electrostatic Fields. J. Phys. Chem. B 103, 9813–
9817 (1999). 
66. Waegele, M. M., Culik, R. M. & Gai, F. Site-specific spectroscopic reporters of the local 
electric field, hydration, structure, and dynamics of biomolecules. J. Phys. Chem. Lett. 2, 
2598–2609 (2011). 
67. Błasiak, B., Ritchie, A. W., Webb, L. J. & Cho, M. Vibrational solvatochromism of 
nitrile infrared probes: beyond the vibrational Stark dipole approach. Phys. Chem. Chem. 
Phys. 18, 18094–18111 (2016). 
68. Boxer, S. G. Stark realities. J. Phys. Chem. B 113, 2972–2983 (2009). 
69. Stafford, A. J., Walker, D. M. & Webb, L. J. Electrostatic effects of mutations of Ras 
glutamine 61 measured using vibrational spectroscopy of a thiocyanate probe. 
Biochemistry 51, 2757–2767 (2012). 
70. Webb, L. J. & Boxer, S. G. Electrostatic Fields Near the Active Site of Human Aldose 
Reductase : 1. New Inhibitors and Vibrational Stark Effect Measurements. Biochemistry 
References  
130 
 
47, 1588–1598 (2008). 
71. Andrews, S. S. & Boxer, S. G. Vibrational Stark effects of nitriles II. Physical origins of 
Stark effects from experiment and perturbation models. J. Phys. Chem. A 106, 469–477 
(2002). 
72. Levinson, N. M., Fried, S. D. & Boxer, S. G. Solvent-induced infrared frequency shifts 
in aromatic nitriles are quantitatively described by the vibrational stark effect. J. Phys. 
Chem. B 116, 10470–10476 (2012). 
73. Bazewicz, C. G., Liskov, M. T., Hines, K. J. & Brewer, S. H. Sensitive, site-specific, and 
stable vibrational probe of local protein environments: 4-azidomethyl- l -phenylalanine. 
J. Phys. Chem. B 117, 8987–8993 (2013). 
74. Levinson, N. M., Bolte, E. E., Miller, C. S., Corcelli, S. A. & Boxer, S. G. Phosphate 
vibrations probe local electric fields and hydration in Biomolecules. J. Am. Chem. Soc. 
133, 13236–13239 (2011). 
75. Dalosto, S. D., Vanderkooi, J. M. & Sharp, K. a. Vibrational Stark Effects on Carbonyl, 
Nitrile, and Nitrosyl Compounds Including Heme Ligands, CO, CN, and NO, Studied 
with Density Functional Theory. J. Phys. Chem. B 108, 6450–6457 (2004). 
76. Schkolnik, G. Vibrational Stark Spectroscopy as a Tool for Probing Electrostatics at 
Protein Surfaces and Self Assembled Monolayers. MSc Dissertation, p116 (Technischen 
Universität Berlin, 2012). 
77. Fried, S. D., Bagchi, S. & Boxer, S. G. Measuring electrostatic fields in both hydrogen-
bonding and non-hydrogen-bonding environments using carbonyl vibrational probes. J. 
Am. Chem. Soc. 135, 11181–92 (2013). 
78. Adhikary, R., Zimmermann, J., Dawson, P. E. & Romesberg, F. E. Temperature 
Dependence of CN and SCN IR Absorptions Facilitates Their Interpretation and Use as 
Probes of Proteins. Anal. Chem. 87, 11561–11567 (2015). 
79. Slocum, J. D., First, J. T. & Webb, L. J. Orthogonal Electric Field Measurements near 
the Green Fluorescent Protein Fluorophore through Stark Effect Spectroscopy and 
pKaShifts Provide a Unique Benchmark for Electrostatics Models. J. Phys. Chem. B 
References  
131 
 
121, 6799–6812 (2017). 
80. Slocum, J. D. & Webb, L. J. Nitrile Probes of Electric Field Agree with Independently 
Measured Fields in Green Fluorescent Protein even in the Presence of Hydrogen 
Bonding. J. Am. Chem. Soc. 138, 6561–6570 (2016). 
81. Stafford, A. J., Ensign, D. L. & Webb, L. J. Vibrational stark effect spectroscopy at the 
interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an 
electrostatic mechanism for protein-protein interaction. J. Phys. Chem. B 114, 15331–
15344 (2010). 
82. Fried, S. D., Bagchi, S. & Boxer, S. G. Extreme electric fields power catalysis in the 
active site of ketosteroid isomerase. Biophysics (Oxf). 346, 1510–1513 (2014). 
83. Loveridge, E. J., Behiry, E. M., Swanwick, R. S. & Allemann, R. K. Different Reaction 
Mechanisms for Mesophilic and Thermophilic Dihydrofolate Reductases. J. Am. Chem. 
Soc. 131, 6926–6927 (2009). 
84. Anderson, D. D., Quintero, C. M. & Stover, P. J. Identification of a de novo thymidylate 
biosynthesis pathway in mammalian mitochondria. Proc. Natl. Acad. Sci. U. S. A. 108, 
15163–8 (2011). 
85. Sirawaraporn, W. Dihydrofolate reductase and antifolate resistance in malaria. Drug 
Resist. Updat. 1, 397–406 (1998). 
86. Schweitzer, B. I., Dicker, A. P. & Bertino, J. R. Dihydrofolate reductase as a therapeutic 
target. FASEB J. 4, 2441–2452 (1990). 
87. Polshakov, V. I. Dihydrofolate reductase: Structural aspects of mechanisms of enzyme 
catalysis and inhibition. Russ. Chem. Bull. 50, 1733–1751 (2001). 
88. Osborne, M. J., Venkitakrishnan, R. P., Dyson, H. J. & Wright, P. E. Diagnostic 
chemical shift markers for loop conformation and substrate and cofactor binding in 
dihydrofolate reductase complexes. Protein Sci. 12, 2230–2238 (2003). 
89. Schnell, J. R., Dyson, H. J. & Wright, P. E. Structure, Dynamics, and Catalytic Function 
of Dihydrofolate Reductase. Annu. Rev. Biophys. Biomol. Struct. 33, 119–140 (2004). 
References  
132 
 
90. Guo, J., Luk, L. Y. P., Loveridge, E. J. & Allemann, R. K. Thermal adaptation of 
dihydrofolate reductase from the moderate thermophile Geobacillus stearothermophilus. 
Biochemistry 53, 2855–63 (2014). 
91. Dams, T. et al. The crystal structure of dihydrofolate reductase from Thermotoga 
maritima: molecular features of thermostability. J. Mol. Biol. 297, 659–672 (2000). 
92. Guo, J., Loveridge, E. J., Luk, L. Y. P. & Allemann, R. K. Effect of Dimerization on 
Dihydrofolate Reductase Catalysis. Biochemistry 52, 3881–3887 (2013). 
93. Davies, J. F. et al. Crystal Structures of Recombinant Human Dihydrofolate Reductase 
Complexed with Folate and 5-Deazafolate. Biochemistry 29, 9467–9479 (1990). 
94. Liu, C. T. et al. Functional significance of evolving protein sequence in dihydrofolate 
reductase from bacteria to humans. Proc. Natl. Acad. Sci. U. S. A. 110, 10159–64 (2013). 
95. Fierke, C. A., Johnson, K. A. & Benkovic, S. J. Construction and evaluation of the 
kinetic scheme associated with dihydrofolate reductase from Escherichia coli. 
Biochemistry 26, 4085–4092 (1987). 
96. Appleman, J. R. et al. Unusual transient- and steady-state kinetic behavior is predicted 
by the kinetic scheme operational for recombinant human dihydrofolate reductase. J. 
Biol. Chem. 265, 2740–2748 (1990). 
97. Oyen, D., Fenwick, R. B., Stanfield, R. L., Dyson, H. J. & Wright, P. E. Cofactor-
Mediated Conformational Dynamics Promote Product Release From Escherichia coli 
Dihydrofolate Reductase via an Allosteric Pathway. J. Am. Chem. Soc. 137, 9459–9468 
(2015). 
98. Bhabha, G. et al. Divergent evolution of protein conformational dynamics in 
dihydrofolate reductase. Nat. Struct. Mol. Biol. 20, 1243–1249 (2013). 
99. Sawaya, M. R. & Kraut, J. Loop and subdomain movements in the mechanism of 
Escherichia coli dihydrofolate reductase: Crystallographic evidence. Biochemistry 36, 
586–603 (1997). 
100. Hughes, R. L., Johnson, L. A., Behiry, E. M., Loveridge, E. J. & Allemann, R. K. A 
References  
133 
 
rapid analysis of variations in conformational behavior during dihydrofolate reductase 
catalysis. Biochemistry 56, 2126–2133 (2017). 
101. Osborne, M. J., Schnell, J., Benkovic, S. J., Dyson, H. J. & Wright, P. E. Backbone 
dynamics in dihydrofolate reductase complexes: Role of loop flexibility in the catalytic 
mechanism. Biochemistry 40, 9846–9859 (2001). 
102. Loveridge, E. J., Rodriguez, R. J., Swanwick, R. S. & Allemann, R. K. Effect of 
Dimerization on the Stability and Catalytic Activity of Dihydrofolate Reductase from the 
Hyperthermophile Thermotoga maritima. Biochemistry 48, 5922–5933 (2009). 
103. Tuttle, L. M., Dyson, H. J. & Wright, P. E. Side chain conformational averaging in 
human dihydrofolate reductase. Biochemistry 53, 1134–1145 (2014). 
104. Hay, S. et al. Are the catalytic properties of enzymes from piezophilic organisms 
pressure adapted? ChemBioChem 10, 2348–2353 (2009). 
105. Khavrutskii, I. V, Price, D. J., Lee, J. & Brooks, C. L. Conformational change of the 
methionine 20 loop of Escherichia coli dihydrofolate reductase modulates pKa of the 
bound dihydrofolate. Protein Sci. 16, 1087–1100 (2007). 
106. Ercikan-Abali, E. A. et al. Variants of Human Dihydrofolate at Leucine-22: Effect on 
Catalytic Properties Reductase with Substitutions and Inhibitor Binding mc. Mol. 
Pharmacol. 49, 430–437 (1996). 
107. Prendergast, N. J., Appleman, J. R., Delcamp, T. J., Blakley, R. L. & Freisheim, J. H. 
Effects of Conversion of Phenylalanine-31 to Leucine on the Function of Human 
Dihydrofolate Reductase. Biochemistry 28, 4645–4650 (1989). 
108. Nakano, T., Spencer, H. T., Appleman, J. R. & Blakley, R. L. Critical role of 
phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding 
and in catalysis. Biochemistry 33, 9945–52 (1994). 
109. McElheny, D., Schnell, J. R., Lansing, J. C., Dyson, H. J. & Wright, P. E. Defining the 
role of active-site loop fluctuations in dihydrofolate reductase catalysis. Proc. Natl. 
Acad. Sci. U. S. A. 102, 5032–5037 (2005). 
References  
134 
 
110. Pitts, C., Bowen, D. & Southerland, W. M. Interaction energy analysis of nonclassical 
antifolates with human dihydrofolate reductase. J. Mol. Model. 6, 467–476 (2000). 
111. Lam, T. et al. Structure-based design of new dihydrofolate reductase antibacterial 
agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines. J. Med. Chem. 57, 651–668 
(2014). 
112. Lamb, K. M., G-Dayanandan, N., Wright, D. L. & Anderson, A. C. Elucidating features 
that drive the design of selective antifolates using crystal structures of human 
dihydrofolate reductase. Biochemistry 52, 7318–7326 (2013). 
113. Pu, J., Ma, S., Gao, J. & Truhlar, D. G. Small temperature dependence of the kinetic 
isotope effect for the hydride transfer reaction catalyzed by Escherichia coli 
dihydrofolate reductase. J. Phys. Chem. B 109, 8551–8556 (2005). 
114. Luk, L. Y. P. et al. Chemical Ligation and Isotope Labeling to Locate Dynamic Effects 
during Catalysis by Dihydrofolate Reductase. Angew. Chemie - Int. Ed. 54, 9016–9020 
(2015). 
115. Luk, L. Y. P., Loveridge, E. J. & Allemann, R. K. Different Dynamical Effects in 
Mesophilic and Hyperthermophilic Dihydrofolate Reductases. J. Am. Chem. Soc. 136, 
6862–6865 (2014). 
116. Luk, L. Y. P. et al. Protein Isotope Effects in Dihydrofolate Reductase from Geobacillus 
stearothermophilus Show Entropic–Enthalpic Compensatory Effects on the Rate 
Constant. J. Am. Chem. Soc. 136, 17317–17323 (2014). 
117. Behiry, E. M., Luk, L. Y. P., Matthews, S. M., Loveridge, E. J. & Allemann, R. K. Role 
of the occluded conformation in bacterial dihydrofolate reductases. Biochemistry 53, 
4761–4768 (2014). 
118. Agarwal, P. K., Billeter, S. R., Rajagopalan, P. T. R., Benkovic, S. J. & Hammes-
Schiffer, S. Network of coupled promoting motions in enzyme catalysis. Proc. Natl. 
Acad. Sci. U. S. A. 99, 2794–2799 (2002). 
119. Li, L., Falzone, C. J., Benkovic, S. J. & Wright, P. E. Functional Role of a Mobile Loop 
of Escherichia coli Dihydrofolate Reductase in Transition-State Stabilization. 
References  
135 
 
Biochemistry 31, 7826–7833 (1992). 
120. Falzone, C. J., Benkovic, S. J. & Wright, P. E. Dynamics of a Flexible Loop in 
Dihydrofolate Reductase from Escherichia coli and Its Implication for Catalysis. 
Biochemistry 33, 439–442 (1994). 
121. Cameron, C. E. & Benkovic, S. J. Evidence for a functional role of the dynamics of 
glycine-121 of Escherichia coli dihydrofolate reductase obtained from kinetic analysis of 
a site-directed mutant. Biochemistry 36, 15792–15800 (1997). 
122. Swanwick, R. S., Shrimpton, P. J. & Allemann, R. K. Pivotal Role of Gly 121 in 
Dihydrofolate Reductase from Escherichia coli : The Altered Structure of a Mutant 
Enzyme May Form the Basis of Its Diminished Catalytic Performance †. Biochemistry 
43, 4119–4127 (2004). 
123. Ruiz-Pernia, J. J. et al. Increased Dynamic Effects in a Catalytically Compromised 
Variant of Escherichia coli Dihydrofolate Reductase. J. Am. Chem. Soc. 135, 18689–
18696 (2013). 
124. Loveridge, E. J., Behiry, E. M., Guo, J. & Allemann, R. K. Evidence that a ‘dynamic 
knockout’ in Escherichia coli dihydrofolate reductase does not affect the chemical step 
of catalysis. Nat. Chem. 4, 292–297 (2012). 
125. Oyeyemi, O. A. et al. Comparative Hydrogen-Deuterium Exchange for a Mesophilic vs 
Thermophilic Dihydrofolate Reductase at 25 °C: Identification of a Single Active Site 
Region with Enhanced Flexibility in the Mesophilic Protein. Biochemistry 50, 8251–
8260 (2011). 
126. Loveridge, E. J. et al. The role of large-scale motions in catalysis by dihydrofolate 
reductase. J. Am. Chem. Soc. 133, 20561–20570 (2011). 
127. Cody, V., Pace, J. & Nowak, J. Structural analysis of human dihydrofolate reductase as a 
binary complex with the potent and selective inhibitor 2,4-diamino-6-{2’-O-(3-
carboxypropyl)oxydibenz[b,f]-azepin-5-yl}methylpteridine reveals an unusual binding 
mode. Acta Crystallogr. D. Biol. Crystallogr. 67, 875–80 (2011). 
128. Shrimpton, P., Mullaney, A. & Allemann, R. K. Functional role for Tyr 31 in the 
References  
136 
 
catalytic cycle of chicken dihydrofolate reductase. Proteins Struct. Funct. Genet. 51, 
216–223 (2003). 
129. Beard, W. A., Appleman, J. R., Delcamp, T. J., Freisheim, J. H. & Blakley, R. L. 
Hydride transfer by dihydrofolate reductase. Causes and consequences of the wide range 
of rates exhibited by bacterial and vertebrate enzymes. J. Biol. Chem. 264, 9391–9399 
(1989). 
130. Noé, V., MacKenzie, S. & Ciudad, C. J. An intron is required for dihydrofolate reductase 
protein stability. J. Biol. Chem. 278, 38292–38300 (2003). 
131. Sompornpisut, P., Wijitkosoom, A., Parasuk, V. & Sirawaraporn, W. Molecular 
dynamics simulation of the human apo-dihydrofolate reductase: An investigation of an 
unstable enzyme. Mol. Simul. 29, 111–121 (2003). 
132. Ainavarapu, S. R. K., Li, L., Badilla, C. L. & Fernandez, J. M. Ligand binding 
modulates the mechanical stability of dihydrofolate reductase. Biophys. J. 89, 3337–
3344 (2005). 
133. Maglia, G., Javed, M. H. & Allemann, R. K. Hydride transfer during catalysis by 
dihydrofolate reductase from Thermotoga maritima. Biochem. J. 374, 529–535 (2003). 
134. Swanwick, R. S., Maglia, G., Tey, L. & Allemann, R. K. Coupling of protein motions 
and hydrogen transfer during catalysis by Escherichia coli dihydrofolate reductase. 
Biochem. J. 394, 259–265 (2006). 
135. Hata, K. et al. High pressure nmr study of dihydrofolate reductase from a deep-sea 
bacterium Moritella profunda. Cell. Mol. Biol. (Noisy-le-grand). 50, 311–6 (2004). 
136. Loveridge, E. J. & Allemann, R. K. Effect of pH on Hydride Transfer by Escherichia 
coli Dihydrofolate Reductase. ChemBioChem 12, 1258–1262 (2011). 
137. Loveridge, E. J., Tey, L.-H. & Allemann, R. K. Solvent Effects on Catalysis by 
Escherichia coli Dihydrofolate Reductase. J. Am. Chem. Soc. 132, 1137–1143 (2010). 
138. Luk, L. Y. P. et al. Unraveling the role of protein dynamics in dihydrofolate reductase 
catalysis. Proc. Natl. Acad. Sci. U. S. A. 110, 16344–16349 (2013). 
References  
137 
 
139. Bhabha, G., Tuttle, L., Martinez-Yamout, M. A. & Wright, P. E. Identification of 
endogenous ligands bound to bacterially expressed human and E. coli dihydrofolate 
reductase by 2D NMR. FEBS Lett. 585, 3528–3532 (2011). 
140. Appleman, J. R., Prendergast, N., Delcamp, T. J., Freisheim, J. H. & Blakley, R. L. 
Kinetics of the formation and isomerization of methotrexate complexes of recombinant 
human dihydrofolate reductase. J. Biol. Chem. 263, 10304–10313 (1988). 
141. Chazarra, S. et al. Purification and kinetic properties of human recombinant 
dihydrofolate reductase produced in bombyx mori chrysalides. Appl. Biochem. 
Biotechnol. 162, 1834–1846 (2010). 
142. Rosowsky, A., Wright, J. E., Vaidya, C. M. & Forsch, R. A. The effect of side-chain, 
para-aminobenzoyl region, and B-ring modifications on dihydrofolate reductase binding, 
influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatable 
antifolate N(α)-(4-amino-4-deoxypteroyl)-N(δ)-hemiph. Pharmacol. Ther. 85, 191–205 
(2000). 
143. Roberts, V. A., Dauber-Osguthorpe, P., Ostguthorpe, D. J., Levin, E. & Hagler, A. T. A 
Comparison of the Binding of the Ligand Trimethroprim to Bacterial and Vertebrate 
Dihydrofolate Reductases. Isr. J. Chem. 27, 198–210 (1986). 
144. Fossati, E. Directed evolution of human dihydrofolate reductase : towards a better 
understanding of binding at the active site. (Université de Montréal, 2008). 
145. Schweitzers, B. et al. Probing the role of two hydrophobic active site residues in the 
human dihydrofolate reductase by site-directed mutagenesis. J. Biol. Chem. 34, 20786–
20795 (1989). 
146. Bhosle, A. & Chandra, N. Structural analysis of dihydrofolate reductases enables 
rationalization of antifolate binding affinities and suggests repurposing possibilities. 
FEBS J. 283, 1139–1167 (2016). 
147. Appleman, J. R. et al. Atypical transient state kinetics of recombinant human 
dihydrofolate reductase produced by hysteretic behavior. Comparison with dihydrofolate 
reductases from other sources. J. Biol. Chem. 264, 2625–2633 (1989). 
References  
138 
 
148. Ercikan-Abali, E. A. et al. Translational upregulation of dihydrofolate reductase by 
methotrexate is an intrinsic mechanism of resistance. Cancer Res. 65, 777–777 (2005). 
149. Antosiewicz, A. et al. Human dihydrofolate reductase and thymidylate synthase form a 
complex in vitro and co-localize in normal and cancer cells. J. Biomol. Struct. Dyn. 35, 
1474–1490 (2017). 
150. Wang, N. & McCammon, J. A. Substrate channeling between the human dihydrofolate 
reductase and thymidylate synthase. Protein Sci. 25, 79–86 (2016). 
151. McEntee, G. et al. The former annotated human pseudogene dihydrofolate reductase-like 
1 (DHFRL1) is expressed and functional. Proc. Natl. Acad. Sci. U. S. A. 108, 15157–62 
(2011). 
152. Schweppe, D. K. et al. Mitochondrial protein interactome elucidated by chemical cross-
linking mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 114, 1732–1737 (2017). 
153. Garau, G. et al. Update of the standard numbering scheme for class B β-lactamases. 
Antimicrobial Agents and Chemotherapy 48, 2347–2349 (2004). 
154. Philippon, A., Dusart, J., Joris, B. & Frère, J. The diversity, structure and regulation of 
beta-lactamases. Cell. Mol. Life Sci. 54, 341–346 (1998). 
155. Levy, S. et al. Identification of LACTB2, a metallo-β-lactamase protein, as a human 
mitochondrial endoribonuclease. Nucleic Acids Res. 44, 1813–1832 (2016). 
156. Suh, J. R., Herbig, A. K. & Stover, P. J. New perspectives on folate catabolism. Annu. 
Rev. Nutr. 21, 255–282 (2001). 
157. Carter, E. L. et al. Escherichia coli abg genes enable uptake and cleavage of the folate 
catabolite p-aminobenzoyl-glutamate. J. Bacteriol. 189, 3329–3334 (2007). 
158. Francis, K., Sapienza, P. J., Lee, A. L. & Kohen, A. The Effect of Protein Mass 
Modulation on Human Dihydrofolate Reductase. Biochemistry 55, 1100–1106 (2016). 
159. Happel, J. New Treatment of Enzyme Kinetics Applied to Human Dihydrofolate 
Reductase. Society 5209–5212 (2000).  
160. Birdsall, B., Burgen, A. S. V. & Roberts, G. C. K. Effects of coenzyme analogs on the 
References  
139 
 
binding of p-aminobenzoyl-L-glutamate and 2,4-diaminopyrimidine to Lactobacillus 
casei dihydrofolate reductase. Biochemistry 19, 3732–3737 (1980). 
161. Gawlita, E., Caldwell, W. S., O’Leary, M. H., Paneth, P. & Anderson, V. E. Kinetic 
isotope effects on substrate association: reactions of phosphoenolpyruvate with 
phosphoenolpyruvate carboxylase and pyruvate kinase. Biochemistry 34, 2577–83 
(1995). 
162. Thillet, J., Adams, J. A. & Benkovic, S. J. The Kinetic Mechanism of Wild-Type and 
Mutant Mouse Dihydrofolate Reductases. Biochemistry 29, 5195–5202 (1990). 
163. Kelly, S. M., Jess, T. J. & Price, N. C. How to study proteins by circular dichroism. 
Biochim. Biophys. Acta - Proteins Proteomics 1751, 119–139 (2005). 
164. Maglia, G. & Allemann, R. K. Evidence for Environmentally Coupled Hydrogen 
Tunneling during Dihydrofolate Reductase Catalysis. J. Am. Chem. Soc. 125, 13372–
13373 (2003). 
165. More, N., Daniel, R. M. & Petach, H. H. The effect of low temperatures on enzyme 
activity. Biochem. J. 305 Pt 1, 17–20 (1995). 
166. Meiering, E. M. & Wagner, G. Detection of Long-Lived Bound Water-Molecules in 
Complexes of Human Dihydrofolate-Reductase with Methotrexate and Nadph. J. Mol. 
Biol. 247, 294–308 (1995). 
167. Wang, Z., Singh, P., Czekster, C. M., Kohen, A. & Schramm, V. L. Protein Mass-
Modulated Effects in the Catalytic Mechanism of Dihydrofolate Reductase: Beyond 
Promoting Vibrations. J. Am. Chem. Soc. 136, 8333–8341 (2014). 
168. Liu, C. T. et al. Escherichia coli dihydrofolate reductase catalyzed proton and hydride 
transfers: temporal order and the roles of Asp27 and Tyr100. Proc. Natl. Acad. Sci. USA 
111, 18231–6 (2014). 
169. Henzler-Wildman, K. & Kern, D. Dynamic personalities of proteins. Nature 450, 964–
972 (2007). 
170. Stojković, V., Perissinotti, L. L., Willmer, D., Benkovic, S. J. & Kohen, A. Effects of the 
References  
140 
 
donor acceptor distance and dynamics on hydride tunneling in the dihydrofolate 
reductase catalyzed reaction. J Am Chem Soc. 134, 1738–1745 (2012). 
171. Kohen, A. Role of dynamics in enzyme catalysis: Substantial versus semantic 
controversies. Acc. Chem. Res. 48, 466–473 (2015). 
172. Stojkovic, V. Contribution of active site dynamics to enzyme catalysis : study on a series 
of mutants of dihydrofolate reductase. (2012). 
173. Liu, H. & Warshel, A. Origin of the temperature dependence of isotope effects in 
enzymatic reactions: The case of dihydrofolate reductase. J. Phys. Chem. B 111, 7852–
7861 (2007). 
174. Kohen, A. Kinetic isotope effects as probes for hydrogen tunneling, coupled motion and 
dynamics contributions to enzyme catalysis. Prog. React. Kinet. Mech. 28, 119–156 
(2003). 
175. Pang, J., Pu, J., Gao, J., Truhlar, D. G. & Allemann, R. K. Hydride Transfer Reaction 
Catalyzed by Hyperthermophilic Dihydrofolate Reductase Is Dominated by Quantum 
Mechanical Tunneling and Is Promoted by Both Inter- and Intramonomeric Correlated 
Motions. J. Am. Chem. Soc. 128, 8015–8023 (2006). 
176. Silva, R. G., Murkin, A. S. & Schramm, V. L. Femtosecond dynamics coupled to 
chemical barrier crossing in a Born-Oppenheimer enzyme. Proc. Natl. Acad. Sci. U. S. 
A. 108, 18661–5 (2011). 
177. Suarez, J. & Schramm, V. L. Isotope-specific and amino acid-specific heavy atom 
substitutions alter barrier crossing in human purine nucleoside phosphorylase. Proc. 
Natl. Acad. Sci. 112, 11247–11251 (2015). 
178. Warshel, A. and & Papazyant, A. Electrostatic effects in macromolecules: fundamental 
concepts and practical modeling. Curr. Opin. Struct. Biol. 8, 211–217 (1998). 
179. Warshel, A., Sharma, P. K., Kato, M. & Parson, W. W. Modeling electrostatic effects in 
proteins. Biochim. Biophys. Acta - Proteins Proteomics 1764, 1647–1676 (2006). 
180. Bennett, B. C., Xu, H., Simmerman, R. F., Lee, R. E. & Dealwis, C. G. Crystal structure 
References  
141 
 
of the anthrax drug target, Bacillus anthracis dihydrofolate reductase. J. Med. Chem. 50, 
4374–4381 (2007). 
181. Hecht, D., Tran, J. & Fogel, G. B. Structural-based analysis of dihydrofolate reductase 
evolution. Mol. Phylogenet. Evol. 61, 212–230 (2011). 
182. Fafarman, A. T., Webb, L. J., Chuang, J. I. & Boxer, S. G. Site Specific Conversion of 
Cysteine Thiols into Thiocyanate Creates an IR Probe for Electric Fields in Proteins. J. 
Am. Chem. Soc. 128, 13356–13357 (2008). 
183. Swanwick, R. S., Daines, A. M., Tey, L.-H., Flitsch, S. L. & Allemann, R. K. Increased 
Thermal Stability of Site-Selectively Glycosylated Dihydrofolate Reductase. 
ChemBioChem 6, 1338–1340 (2005). 
184. Iwakura, M., Jones, B. E., Luo, J. & Matthews, C. R. A Strategy for Testing the 
Suitability of Cysteine Replacements in Dihydrofolate Reductase from Escherichia coli 
1. J. Biochem 117, 480–488 (1995). 
185. Evans, R. M. Hydride transfer reactions in dihydrofolate reductase from Moritella 
profunda. (Cardiff University, 2010). 
186. Worth, C. L., Preissner, R. & Blundell, T. L. SDM--a server for predicting effects of 
mutations on protein stability and malfunction. Nucleic Acids Res. 39, W215–W222 
(2011). 
187. Gagnon, P., Mayes, T. & Danielsson, Å. An adaptation of hydrophobic interaction 
chromatography for estimation of protein solubility optima. J. Pharm. Biomed. Anal. 16, 
587–592 (1997). 
188. Sedlák, E., Stagg, L. & Wittung-Stafshede, P. Effect of Hofmeister ions on protein 
thermal stability: Roles of ion hydration and peptide groups? Arch. Biochem. Biophys. 
479, 69–73 (2008). 
189. Golovanov, A. P. et al. A Simple Method for Improving Protein Solubility and Long-
Term Stability. J. Am. Chem. Soc. 126, 8933–8939 (2004).  
190. Getahun, Z. et al. Using nitrile-derivated amino acids as infrared probes of local 
References  
142 
 
environment. J. Am. Chem. Soc. 125, 405–411 (2003). 
191. Maddams, W. F. & Southon, M. J. III. The effect of band width and band shape on 
resolution enhancement by derivative spectroscopy. Spectrochim. Acta Part A Mol. 
Spectrosc. 38, 459–466 (1982). 
192. Andrews, S. S. The Measurement and Physics of Vibrational Stark effects. (Stannford 
University, 2001). 
193. Fafarman, A. T., Sigala, P. A., Herschlag, D. & Boxer, S. G. Decomposition of 
vibrational shifts of nitriles into electrostatic and hydrogen-bonding effects. J. Am. 
Chem. Soc. 132, 12811–12813 (2010). 
194. Fafarman, A. T. et al. Quantitative, directional measurement of electric field 
heterogeneity in the active site of ketosteroid isomerase. Proc. Natl. Acad. Sci. U. S. A. 
109, 299–308 (2012). 
195. Brewer, S. H. & Franzen, S. A quantitative theory and computational approach for the 
vibrational Stark effect. J. Chem. Phys. 119, 851–858 (2003). 
196. Venkitakrishnan, R. P. et al. Conformational changes in the active site loops of 
dihydrofolate reductase during the catalytic cycle. Biochemistry 43, 16046–16055 
(2004). 
197. Nishimura, M., Saito, H., Kawaguchi, K. & Nagao, H. Conformational stability of 
Met20 loop of DHFR: A molecular dynamics study. in AIP Conference Proceedings 
1518, 654–657 (2013). 
198. Weikl, T. R. & Boehr, D. D. Conformational selection and induced changes along the 
catalytic cycle of Escherichia coli dihydrofolate reductase. Proteins Struct. Funct. 
Bioinforma. 80, 2369–2383 (2012). 
199. Morgenstern, A., Jaszai, M., Eberhart, M. E. & Alexandrova, A. N. Quantified 
electrostatic preorganization in enzymes using the geometry of the electron charge 
density. Chem. Sci. 8, 5010–5018 (2017). 
200. Head-Gordon, T. & Brooks, C. L. The role of electrostatics in the binding of small 
References  
143 
 
ligands to enzymes. J. Phys. Chem. 3, 3342–3349 (1987). 
201. Villa, J. et al. How important are entropic contributions to enzyme catalysis? Proc. Natl. 
Acad. Sci. 97, 11899–11904 (2000). 
202. Fields, P. A. Review: Protein function at thermal extremes: Balancing stability and 
flexibility. Comp. Biochem. and Phys. 129, 417–431 (2001). 
203. Xu, Y., Feller, G., Gerday, C. & Glansdorff, N. Moritella Cold-Active Dihydrofolate 
Reductase: Are There Natural Limits to Optimization of Catalytic Efficiency at Low 
Temperature Moritella Cold-Active Dihydrofolate Reductase : Are There Natural Limits 
to Optimization of Catalytic Efficiency at Low T. J. Bacteriol. 185, 5519–5526 (2003). 
204. Bystroff, C. & Kraut, J. Crystal Structure of Unliganded Escherichia coli Dihydrofolate 
Reductase. Ligand-Induced Conformational Changes and Cooperativity in Binding. 
Biochemistry 30, 2227–2239 (1991). 
205. Boehr, D. D., McElheny, D., Dyson, H. J. & Wright, P. E. The dynamic energy 
landscape of dihydrofolate reductase catalysis. Science 313, 1638–1642 (2006). 
206. Storm, D. R. & Koshland, D. E. A source for the special catalytic power of enzymes: 
orbital steering. Proc. Natl. Acad. Sci. U. S. A. 66, 445–52 (1970). 
207. Chen, Y. Q., Gulotta, M., Cheung, H. T. & Callender, R. Light activates reduction of 
methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate 
reductase. Photochem. Photobiol. 69, 77–85 (1999). 
208. Cao, H., Pauff, J. M. & Hille, R. Substrate Orientation and Catalytic Specificity in the 
Action of Xanthine Oxidase. J. Biol. Chem. 285, 28044–28053 (2010). 
209. Chen, Y. Q., Kraut, J. & Callender, R. pH-dependent conformational changes in 
Escherichia coli dihydrofolate reductase revealed by raman difference spectroscopy. 
Biophys. J. 72, 936–941 (1997). 
210. Sun, D., Liao, D. & Remington, S. Electrostatic Fields In The Active-Sites Of 
Lysozymes. Proc. Natl. Acad. Sci. U. S. A. 86, 5361–5365 (1989). 
211. Liu, H. & Naismith, J. H. An efficient one-step site-directed deletion, insertion, single 
References  
144 
 
and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91–99 (2008). 
Appendix I  
145 
 
Appendixes 
Appendix I 
 
Figure A1: Charge state envelope of TEM-1 -lactamase 
 
Appendix I  
146 
 
 
Figure A2: A deconvoluted mass of TEM-1 -lactamase 
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Figure A3: LC-MS chromatogram of trypsinated TEM-1 -lactamase 
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Table A1 showing sequence coverage of TEM-1 -lactamase 
No
. 
Retentio
n time 
(min) 
m/z 
Charg
e 
Mass Peptide sequence 
N-C 
termina
l 
protein 
sequenc
e order 
1* N/A N/A N/A 
2604.3
1 
ELCSAAITMSDNTAANLLLTTIGG
PK 
N/A 
2 13.98 
674.6
6 
+3 
2020.9
7 
IHYSQNDLVEYSPVTEK 7 
3 14.60 
892.4
5 
+2 
1782.8
8 
IVVIYTTGSQATMDER 18 
4 15.06 
870.9
3 
+2 
1739.8
4 
ELTAFLHNMGDHVTR 9 
5 15.92 
856.4
0 
+2 
1710.7
8 
WEPELNEAIPNDER 10 
6 15.49 
690.3
4 
+2 
1378.6
6 
DTTMPAAMATTLR 11 
7 17.86 
688.8
3 
+2 
1375.6
4 
QQLIDWMEADK 13 
8 12.11 
676.3
8 
+2 
1350.7
6 
GIIAALGPDGKPSR 17 
9 16.48 
654.3
5 
+2 
1306.6
8 
VGYIELDLNSGK 2 
10 20.10 
643.8
3 
+2 
1285.7
6 
LLTGELLTLASR 12 
11 19.07 
638.3
4 
+2 
1274.6
7 
SALPAGWFIADK 15 
12 11.64 
638.3
4 
+2 
1274.6
6 
ILESFRPEER 3 
13 15.85 
571.8
5 
+2 
1141.6
7 
QIAEIGASLIK 19 
14 8.86 
543.7
9 
+2 
1085.5
5 
IDAGQEIGASLIK 6 
15 8.09 
515.2
9 
+2 
1029.6
0 
VLLCGAVLSR 5 
Appendix I  
149 
 
16 8.51 
515.2
6 
+2 
1028.5
1 
HLTDGMTVR 8 
17 15.88 
988.4
6 
+1 987.46 FPMMSTFK 4 
18
* 
N/A N/A N/A 973.45 DAEDQLGAR N/A 
19 2.72 
412.2
4 
+2 822.46 HPETLVK 1 
20 10.08 
725.4
7 
+1 724.46 VAGPLLR 14 
21 1.05 
576.2
8 
+1 575.27 SGAGER 16 
*Peptide not detected. Result obtained by Dr Louis Luk and Thomas Williams  
 
 
 
28.9 kDa Protein sequence identified 
HPETLVKVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRIHYSQN
DLVEYSPVTEKHLTDGMTVRELTAFLHNMGDHVTRWEPELNEAIPNDERDTTMPAAMATTLRL
LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGIIAALGPDGKPSRIV
VIYTTGSQATMDERQIAEIGASLIK 
 
Appendix I  
150 
 
 
Figure A4: Charge state envelope of HsDHFR 
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Figure A5: Deconvoluted mass of HsDHFR showing a mass of 21451.5 kDa 
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Figure A6: 1H-15N HSQC overlay of HsDHFR complexed with (A) folate (blue) and 
folate:NADP+ (red); (B) folate + (blue) and DHF:NADP+ (red). (C) folate:NADP+ (blue) and 
DHF:NADP+ (red) and (D) DHF:NADP+ (blue) and THF:NADP+ (red) 
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Appendix II 
 
Time Course Graph
Time ( Second )
0.0000 10.0000 20.0000 30.0000 40.0000
A
b
s
.
1.3900
1.2000
1.0000
0.8000
0.7385
 
Figure A7: UV-Vis trace of unusual time course observed at pH 10.0 and 5 °C, starting at 
below 1.0 A.U (red trace) to 0.8 A.U (blue trace). Steady state kinetics at higher temperatures 
all have a trace less than 0.8 A.U (green trace).  
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Figure A8: Mass spectra of 13C, 15N -HsDHFR showing a mass increase of 5.1 % (22605.5 
kDa) 
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Labelling Optimisation  
Glutathione (GSH), a tripeptide containing N-terminal glutamate coupled via gamma carboxyl 
side chain to cysteine and glycine, was employed for optimisation of labelling and FTIR 
measurement. Reduced glutathione (GSH) was dissolved in 50 mM Tris buffer pH 7.4, 1 mM 
EDTA to a final concentration and reacted with 1.1 molar equivalence of Ellman reagent 
dissolved in 50 mL of 50 mM Tris buffer with pH readjusted to 7.4. The formation of 
glutathione-thionitrobenzoate mixed disulphide (GSTNB) was monitored by LC-MS and the 
second step of the reaction, which involves a nucleophilic attack on the disulphide bond by 
cyanide, was examined at different conditions, Table A2. The reaction only proceeds to 
completeness within 1 hr at 30 °C when 3.0 molar equivalence of KCN was used. The reaction 
was acidified with 0.1 M HCl to about pH 2.0 (by pH paper test) under the fume hood and the 
2-nitro-5-thiobenzoate (TNB) anion was extracted with ethyl acetate (3 x 50mL). Then, the 
aqueous layer containing thiocyanate labelled glutathione (GSCN) was lyophilised and purified 
by HPLC using Supercosil PLC-18 column, 25 cm x 21.2 mm. 12 µm. Isocratic method was 
used with 5% acetonitrile and 95% ddH2O pH 6.0. Purified GSCN was lyophilised and kept at -
20 °C. Labelling was confirmed by ESI-MS. 
Table A2: Optimisation of glutathione labelling reaction 
Molar ratio 
KCN:glutathione-
TNB 
Temp. 
(°C) 
Labelled % 
glutathione  
(1 hr) 
Labelled % 
glutathione  
(24 hrs) 
1:1 18  10 15 
1:1 25  25 40 
2:1 25 50 75 
3:1 30 99 nd 
nd means not determined 
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Figure A9. (A) LC and MS of glutathione (Mw: 307.3 Da) (B) LC and MS of glutathione-
thionitrobenzoate mixed disulphide GSTNB (Mw: 504.7 Da) (C) LC and MS of glutathione thiocyanate, 
GSCN (Mw: 332.3 Da). Each inset shows the mass spectra corresponding to the chromatogram. 
FTIR Sampling technique optimisation 
Concentration requirement for measurement were determined using different sample cells and 
optimising conditions such as resolution, number of background and samples scans afforded 
vibrational spectra of low concentrated sample to be obtained. 
A B
 
Figure A10: ATR cells with 0.7-micron pathlength (B) Transmission cell with 45-micron pathlength 
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Effect of temperature on nitrile peak 
 
Figure A11: Temperature dependence of maximum absorption peak of thiocyanate in nitrile labelled 
glutathione.  
Optimisation of purification for TmDHFR 
Analysis of residues in TmDHFR revealed significant hydrophobic residue. 37.5 % of residues 
in TmDHFR are hydrophobic: Ala: 3 %, Ile: 4.8 %, Leu: 8.9%, Phe: 9.5 % and Val: 11.3 %. 
Table A3: Hydrophobic interaction chromatography condition optimisation for Phenyl sepharose resin 
Binding Buffer  Elution Buffer Remark 
50 mM Tris 1 M NaCl, 
pH 7.0 
50 mM Tris, pH 7.0 No binding  
50 mM Tris 3 M NaCl, 
pH 7.0 
50 mM Tris, pH 7.0 Binds too tightly 
50 mM Tris 1 M (NH4)2SO4, 
pH 7.0 
- Salting out effect 
50 mM Tris 1 M Na2SO4, 
pH 7.0 
50 mM Tris, pH 7.0 
Precipitates during 
concentration step before 
SEC 
50 mM Na acetate 1 M 
(NH4)2SO4, pH 5.0 
50 mM Na acetate, pH 
5.0 
Low overall yield, poor 
elution 
50 mM Na acetate 1 M 
Na2SO4, pH 5.0 
50 mM Na acetate, pH 
6.0, 10% acetonitrile 
Low overall yield, poor 
elution 
50 mM Na acetate 1 M 
Na2SO4, pH 5.0 
20 mM Bis Tris, pH 6.0 
Higher overall yield and 
stable to concentration 
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MS of labelled DHFRs variants 
EcDHFR 
 
Figure A12: Charge envelope and deconvoluted mass spectra of EcDHFRcf T46C with mass of 17952.0 
Da. 
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Figure A13: Charge envelope and deconvoluted mass spectra of EcDHFRcf T46C-CN showing a mass 
of 26 Da (i.e. 17978.0 Da). 
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Figure A14: Charge envelope and deconvoluted mass spectra of EcDHFRcf T46C-
13CN showing a mass 
of 27 Da (i.e.17979.0 Da). 
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Conformationally impaired EcDHFR variant 
 
Figure A15: Charge envelope of EcDHFRcf S148P/T46C with a mass of 17964.0 Da. 
 
Figure A16: Charge envelope of EcDHFRcf S148P/T46C-CN showing a mass increase of ~26 Da (i.e. 
17989.3 Da). 
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BsDHFR 
 
Figure A17: Charge envelope of BsDHFRcf T46C showing a mass of 18694.2 Da. 
 
Figure A18: Charge envelope of BsDHFRcf T46C-CN showing a mass increase of ~26 Da (i.e. 18720.2 
Da). 
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MpDHFR 
 
Figure A19: Charge envelope of MpDHFRcf T47C showing a mass of 18338.4 Da. 
 
Figure A20: Charge envelope of MpDHFRcf T47C-CN showing a mass increase of ~26 Da (i.e. 18363.8 
Da). 
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TmDHFR 
 
Figure A21: Charge envelope of TmDHFR T47C showing a mass of 19239.8 Da. 
 
Figure A22: Charge envelope of TmDHFR T47C-CN showing a mass increase of ~26 Da (i.e. 19264.7 
Da). 
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Data analysis  
 
Figure A23: Scheme employed to determine the point of maximum absorbance of labelled DHFRs. 
Average of peaks obtained from data treatment (light brown boxes) are reported as peak of maximum 
absorption.  
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Figure A24: Graphical steps of spectra treatment employed for extracting the maximum vibrational 
frequency of labelled DHFRs. Reported peaks were averages of the minimum (2nd derivative), maximum 
(Gaussian fit) and inflection point (1st derivative) from at least two independent measurements. Error is 
reported as standard deviation of the treatments. 
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Figure A25: Gaussian fits of spectra measured for the Michaelis (FOL:NADP+, black) and product 
ternary (THF:NADP+, red) complexes of DHFRs at 20 °C.  
 
